Florida Institute of Technology

Scholarship Repository @ Florida Tech
Theses and Dissertations
9-2018

Self-Assembly of Protein Fibrils in Microgravity
Dylan Bell

Follow this and additional works at: https://repository.fit.edu/etd
Part of the Aerospace Engineering Commons

Self-Assembly of Protein Fibrils in
Microgravity
by
Dylan Bell
Bachelor of Science
Astronomy and Physics
University of Florida
2012
Masters of Science
Space Sciences
Florida Institute of Technology
2015

A dissertation submitted to Florida Institute of Technology
in partial fulfillment of the requirements
for the degree of

Doctor of Philosophy
in
Space Sciences

Melbourne, Florida
September 2018

We the undersigned committee hereby recommends that the attached document be
accepted as fulfilling in part of the requirements for the degree of Doctor of Philosophy
in Space Sciences
“Self-Assembly of Protein Fibrils in Microgravity”
a dissertation by
Dylan Bell

Samuel Durrance, Ph.D.
Professor, Physics and Space Sciences
Major Advisor

Daniel Batcheldor, Ph.D.
Professor, Physics and Space Sciences
Committee Member

Eric Perlman, Ph.D.
Professor, Physics and Space Sciences
Committee Member

Daniel Kirk, Ph.D.
Professor and Associate Dean, Engineering
External Committee Member

Boris Akhremitchev, Ph.D.
Associate Professor, Chemistry
External Committee Member

Daniel Batcheldor, Ph.D.
Department Head, Physics and Space Sciences

Abstract
Self-Assembly of Protein Fibrils in Microgravity
by Dylan Bell
Thesis Advisor: Samuel T. Durrance, Ph.D.

Deposits of insoluble protein fibrils in human tissue are associated with amyloidosis
and neurodegenerative diseases. Different proteins are involved in each disease; all
are soluble in their native conformation in vivo, but by molecular self-assembly, they
all form insoluble protein fibril deposits with a similar cross β-sheet structure. The
study of molecular self-assembly is also of interest to origin of life. The development of
cellular activity was dependent upon the creation of large complex molecular structures
in the chemical and environmental conditions present when life originated. Although
life probably arose in a planetary environment, microgravity is known to effect cellular
function.
This dissertation reports the preparation, results and analysis of an experiment in
molecular self-assembly, carried out in microgravity, on the International Space Station
(ISS). The Self-Assembly in Biology and the Origin of Life (SABOL) experiment was
designed to study the growth of lysozyme fibrils in microgravity. Lysozyme is used
as a model protein that has been shown to replicate the aggregation processes of other
amyloid proteins. The design and performance of the experimental hardware is described
in detail. Based on a 1U NanoLab module, two identical systems were built one for flight
and one for ground-control. The flight experiment was carried to the ISS in the Dragon
capsule of the SpaceX CRS-5 mission and returned to Earth in the same Dragon after
iii

about 32 days on board the ISS. The lysozyme fibrils formed in microgravity show
a distantly different morphology compared to fibrils formed in an identical groundcontrol experiment. Ground-based protein concentration trials were conducted to mimic
some of the effects done on fibril formation in microgravity. A detailed comparison of
the differing initial protein concentrations and how it affected fibril morphology was
conducted.
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Chapter 1
Introduction
The study of molecular self-assembly is of interest to research regarding the origin of
life. Initial development of cellular activity was dependent upon the creation of complex
molecular structures in the chemical and environmental conditions present at the time
life originated. In depth study of molecular self-organizing or self-assembling processes
involved in molecular development serves to highlight certain physical principles related
to this development that result in more complex products with properties that previously
were not present. These are called emergent properties. This study relates to one of these
properties or processes, that of self-assembly. The self-assembly process under study here
is the spontaneous growth of long, linear protein fibrils directly from a solution of the
individual proteins.
This self-assembly process may also have important implications in neurodegenerative disease research. One such disease is Alzhimer’s disease. Postmortem brain studies
of the neurons retrieved from victims of Alzheimer’s disease show an accumulation of
protein fibrils composed of either Tau proteins or Amyloid-β peptides (Shankar et al.,
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2008). Both types of protein, Tau and Amyloid-β have been shown to self-assemble in
solution through colloidal interactions (Rochet and Lansbury, 2000). The delineation
of specific conditions that effect the growth of such fibrils may shed light on potential
techniques to slow or alter the protein fibril growth.
It has been shown that the presence of gravity has an effect on biological processes even at the cellular level (Tabony et al., 2007). Self-assembly and organization
of particles into larger macromolecular structures can be affected by the presence of
this weak directional external force. This external factor can break the symmetry of
the internal system which inherently modifies the collective behavior (Tabony, 2007).
In a space-based laboratory as employed in this study there is no net external force.
Thus, gravitational pressure gradients in the liquids and gasses do not develop therefore
natural buoyant convection is not present. The fibril growth process must then rely
on the movement of protein molecules onto and off of the growing fibrils. In space this
motive force will be primarily molecular diffusion and liquid-surface interactions instead
of the more efficient natural buoyant convection process as evident under gravitational
conditions.
We hypothesize that if protein fibrils forming in microgravity remain suspended
in solution and self assemble without precipitating, then more complex macromolecular
structures should form. The experiments designed and executed in this study and carried out in microgravity may lead to a better understanding of the dynamics driving this
unique molecular self-assembly process. Florida Tech’s Self-Assembly in Biology and the
Origin of Life (SABOL) pilot study demonstrated protein fibril growth in microgravity
on-board the International Space Station (ISS) during the SpaceX CRS-5 (Commercial Resupply Services) mission using a novel, autonomous NanoLab developed for this
specific purpose. An explanation of the basis and basic concepts for this experiment
follows.
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1.1

Amino Acids

Proteins are complex molecules that have many roles in the body and are present in
all living organisms. Proteins do most of the jobs inside a biological cell and regulate
the function and structure of organs which are essential for life. This fact makes it
important to thoroughly understand the biological composition of proteins as well as
the forces which impact their development and structure.
The basic structure of proteins consists of a combination of smaller molecules called
amino acids. These amino acids attach to each other in one long chain which can fold
onto itself to create different three dimensional shapes. There are only 20 amino acids
involved in biology, but there are many more that can create large structures. The types
of amino acids, order, and orientation of the amino acid chain determines the function
and structure of the protein. If the protein has a similar sequence of amino acids they
will also have similar functions.

Figure 1.1: General structure of an amino acid (Koshland and Hourowitz, 2018)

The general structure of an amino acid is shown in Figure 1.1. The central carbon
atom is attached to an amino group (−N H2 ) and a carboxyl group (−COOH) on the
opposite end. The amino group loses a hydrogen ion (H + ) where −N H3+ becomes
−N H2 in basic solution of pH over 9. The carboxyl group gains a hydrogen ion in
acid solution of pH less than 4 so −COO− becomes −COOH. If the amino acid it in
a neutral solution of pH between 4 and 8 it has both a negative and positive charge
therefore becoming neutral but bipolar.
3

Figure 1.2 shows how amino acids are linked to each other to create a protein
molecule. The link is called a peptide bond and is between the amino group of one
amino acid and the carboxyl group of another amino acid.

Figure 1.2: Peptide Bond (Koshland and Hourowitz, 2018)

Differences in amino acids appear in the side chain (−R). The simplest side chain
consists of just a hydrogen atom and is called glycine, while more complex amino acids
have branched carbon chains for −R. These side chains can either be polar or nonpolar.
Proteins are very large macromolecular structures made of many amino acids connected with peptide bonds. Hundreds of amino acids can be connected to form proteins
as seen in Figure 1.3. Any change in the sequence or type of amino acids will change
the function of the protein.

1.2

Protein Structure

As noted above, the primary structure of a protein or peptide chain consists of the amino
acid sequence. This primary structure does not provide information on the arrangement
in space (configuration or conformation) of the peptide chain (see Figure 1.41 ).
1

https://bio.libretexts.org/TextMaps/
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Figure 1.3: General protein structure where (red) is carbon, (green) is nitrogen,
(blue) is hydrogen, (white) is oxygen. (Koshland and Hourowitz, 2018)

Figure 1.4: Protein conformation: Primary, Secondary, Tertiary and Quartenary.

The secondary structure is how the peptide chain is arranged without consideration
of the side chains. The chain can be arranged as either α helix or a β sheet as shown
in Figure 1.4. These structures are formed because of the bond angles and flexibility of
the peptide chains.
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Tertiary structure determines the spatial configuration of the protein. The protein
can either be coiled, looped, folded etc. This configuration is determined by the multiple
polar or nonpolar side chains −R of the protein, whether there is attraction or repulsion
between them or the chain itself. These structures are held together by hydrogen bonds
along with salt bridges (Koshland and Hourowitz, 2018). Salt bridges are bonds between
oppositely charged parts of the protein that are close enough to each other to experience
electrostatic attraction (Bosshard et al., 2004). These salt bridges contribute to the
structure and therefore the function of the protein. Polar side chains are positive or
negative and can attract water while nonpolar side chains repel water but attract each
other (see Figure 1.4).
The quaternary structure is the combinations of two or more peptide chains. These
can either be identical or different peptide chains but when attached they create a large
macromolecular protein (see Figure 1.4).

1.3

Protein Denaturation

Figure 1.5: Denaturation of a protein. Folded proteins unfold because of either
temperature or pH.
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Denaturation is a change of the tertiary structure of a protein. Many proteins are
comprised of peptide chain secondary structures folded on top of themselves many times
over due to hydrogen bonds and salt bridges between the side chains. These folds enclose
the hydrophobic (water-fearing) parts of the protein. During denaturation the protein
unfolds (see figure 1.52 ), exposes the hydrophobic interior, and becomes insoluble. The
protein may also lose its biological properties which are dependent on the structure.
There are two environmental conditions that can cause a protein to denature and
unfold, temperature and pH. High temperatures increase thermal energy which disrupts
hydrogen bonds. Once these bonds are broken the protein will unfold. The exact
temperature range in which a protein will unfold is dependent on other environmental
conditions along with the protein itself.
If the pH is altered to extreme conditions the chemical structure of some amino
acids change which also changes the number of hydrogen bonds that can occur. For
example: at a low pH there is an increased amount of H+ atoms which can bond with
negative portions of the amino acid. This inevitably changes the tertiary structure
which denatures and unfolds the protein.

1.4

Self-Assembly

Fundamentally, self-assembly encompasses structural organization in all scales from
molecules to galaxies (Subramani et al., 2008). It is the spontaneous organization of
individual components into patterns or structures without outside intervention. Selfassembly in biology can be defined as the ‘non-covalent interaction of two or more
2
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denaturation.html
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molecular subunits to form an aggregate whose novel structure and properties are determined by the nature and positioning of the individual components’ (Tecilla et al.,
1990). It is the inherent ability for biological structures to assemble from their component parts through random movements and weak chemical bonds (Subramani et al.,
2008).

1.4.1

Molecular Self-Assembly

Figure 1.6: Self-assembly of protein into many distinct types of aggregates (McManus et al., 2016).
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In biology discussion that deal with molecules, self-assembly refers to molecular self-assembly. There are two types of molecular self-assembly; intermolecular selfassembly which refers to molecules joining together to create structures (quaternary
structure), and intramolecular self-assembly which refers to the folding and the alteration of the internal structure (second and tertiary structure) of a molecule (Pelesko, 2007). Molecular self-assembly is the spontaneous organization of molecules in
thermodynamic equilibrium into stable arrangements through non-covalent interactions
(Zhang, 2003). These interactions consist of hydrogen bonds, electrostatic interactions,
hydrophobic and hydrophilic interaction, and van der Waals interactions (Zhang, 2003;
Pelesko, 2007). The collection of these weak forces can create chemically stable structures (Zhang, 2003). ‘Magnetic, capillary, electrostatic, and gravitational forces play a
vital role in self-assembly of structures on this scale’ (Pelesko, 2007; Subramani et al.,
2008). As noted in section 1.1, proteins are the building blocks of life composed of amino
acids and peptide chains that self-assemble. Protein can also spontaneous self-assemble
with subunits of single protein molecules (monomers) into ordered molecular structures
such as oligomers, globular proteins, aggregates and amyloid fibrils (see Figure 1.6).
This is accomplished by attractive inter-molecular forces overcoming repulsive intermolecular forces. The focus of this dissertation is on amyloid fibrils and how altering
the environmental conditions changes the self assembly process of said fibrils.
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1.5

Amyloid Protein Aggregation

Amyloid protein aggregation occurs when denatured or unfolded proteins clump together. This process can happen spontaneously either in vivo (in a living cell) or in vitro
(in a test tube or outside of a cell) (Stefani and Dobson, 2003; Aguzzi and O’connor,
2010). Protein aggregates can be correlated with neurodegenerative diseases under the
category of amyloidoses such as Alzheimer’s, Parkinson’s, Prion Disease and ALS (Ross
and Poirier, 2004; Lansbury and Lashuel, 2006; Kelly, 1996; De Felice et al., 2004; Tanzi
and Bertram, 2005).
Proteins have a native state where a certain tertiary structure is most thermodynamically favorable (Brüning and Jückstock, 2015). This native state is determined
by reducing contact of the hydrophobic parts of the protein with the surrounding solution (in vivo or in vitro). This process creates a hydrophobic interior and hydrophilic
exterior.

Figure 1.7: Misfolded/unfolded protein monomer conformation can lead to aggregation into β-sheet amyloid fibrils. The formation of intermediate species such as
oligomers and protofibrils (1st order fibrils) can occur. Mature amyloid fibrils (2nd
order, 3rd order etc.) eventually aggregate into the large macro-molecular structures
called amyloid plaques which are associated with several diseases. The aggregation
pathway depends on environmental conditions such as salinity, temperature, acidic
concentration, etc. (Burke et al., 2013; Woodard et al., 2014).
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When the temperature or pH of the exterior environment or solution is changed
the weak interactions holding the protein structure can break. This denaturing process
unfolds the native structure of the protein allowing for the possibility of aggregation to
begin (see Figure 1.7). The exposed hydrophobic interior portions of a single protein
monomer interacts with another exposed hydrophobic protein interior (Gething and
Sambrook, 1992). This aggregation process of amyloid proteins can form amyloid fibrils,
oligomers and amorphous aggregates (Demortiere et al., 2014).

1.5.1

Neurodegenerative Diseases

As previously stated, this self-assembly process may have implications in Alzheimer’s
disease research. It is not clear whether amyloid deposits are the cause or a symptom
of the disease (Shankar et al., 2008) or whether they will form in vivo the same way
they form in vitro, but it is clear that a better understanding of the oligomer (small
particle or nucleation unit nanometers in size) and fibril formation process will benefit
neurodegenerative disease research.
The study of self-assembling processes such as protein aggregation and Amyloid
fibril formation will also benefit from experiments conducted in microgravity. To perform
a study of selfassembling proteins in microgravity it was necessary to carefully select
several basic components of the experimental design that would be critical factors in
determining the success of the effort. These basic components are, the model protein,
microgravity environment, NanoLab creation, and atomic force microscope for analysis.
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Figure 1.8: Lysozyme amyloid fibril formation. Lysozyme monomer to Amyloid
fibril. The left image shows the lysozyme native structure with α-helices in red and
β-sheets in blue. The right image shows a typical mature amyloid fibril (Jiménez
et al., 2002; Hill, 2011).

1.6

Lysozyme as a Model Protein

Hen egg white lysozyme (HEWL) was chosen to be the model protein for this experiment because it is readily available, the structure has been extensively studied, and the
aggregation methods have already been cataloged. HEWL has a molecular weight of
14,399 g/mol and is a single chain of 129 amino acids connected with peptide bonds
(Hill, 2011). In an acidic solution below pH of 4 and elevated temperatures lysozyme
grows into amyloid fibrils (Arnaudov and de Vries, 2005). Lysozyme is considered a
model protein for studying the transition of ordered monomers with a native structure
to a amyloid fibril state with cross β-sheet structure (Sunde and Blake, 1997). Hen egg
lysozyme is a globular protein with a well-defined native structure largely composed of
α-helix and β-sheet; it serves as a model for amyloid aggregation. The optimal methods
for lysozyme preparation, fibril formation, and fibril characterization are well understood. For this experiment acid conditions near pH = 2.5 (Burnett et al., 2014) are
ideal to partially unfold the molecule and expose hydrophobic domains, rendering it
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susceptible to aggregation. At this pH, lysozyme has a measured charge of approximately +16 Coulombs resulting in a strong coulomb repulsion that inhibits aggregation
(Boström et al., 2006). This is overcome by heating the sample to 55 ◦ C to increase
Brownian motion (random motion of molecules due to collisions from other molecules
suspended in solution) and incubating it at this temperature for up to 30 days.

1.7

Microgravity Environment

With the ever increasing human presence in low-earth orbit upon the International Space
Station and inevitability of future spaceflight, microgravity and its effects on biological
substances has become a useful area of study. Life on the Earth has evolved in a 1g environment, understanding how microgravity effects protein aggregation and fibril
morphology provides a novel opportunity to study self-assembly without an external
gravitational force.
The transport of particles through solution is driven by two processes, convection
and diffusion (Klaus et al., 2004). On Earth convection causes material to sink or
float due to their local density compared to their surrounding solution. In microgravity
convection currents caused by natural buoyant convection do not occur because they are
depended on gravity. This leaves a diffusion-limited system for transport of particles in
solution which is slower.
In microgravity there is no natural buoyant convection and therefore no sedimentation of objects more dense than their surrounds. Any aggregating protein fibrils
would remain suspended in solution and continue to grow surrounded by seeding protein
monomers (see Figure 1.93 ).
3

https://microbewiki.kenyon.edu/index.php/Bacterial_response_to_microgravity
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Figure 1.9: In a gravitational environment protein fibrils are more dense than their
surrounding solution and they settle at the bottom of their growth vessel (vial or
microcentrifuge tube). This settling is believed to hinder access to protein monomers
suspended in the vial halting future growth. In microgravity the protein fibrils stay
suspended allowing the diffusing protein monomers to continue fibril growth.

1.8

Wetting: Cohesion and Adhesion

An unintended consequence noted during this experiment of introducing a dry lysozyme
powder to a buffer solution in micogravity is the changes that might occur in the general
dissolution process. In the case of a solid solute (lysozyme protein powder), dissolution
begins with the interactions between the lysozyme particles and the buffer solution
particles. These interactions are strong enough that the individual lysozyme particles
separate from each other and, surrounded by buffer solution molecules, enter the solution. This process is the first step of dissolution and is called “wetting”.
Wetting any particle is based on the ability of the solution to be attracted enough
to that particle to cover it entirely. Cohesion refers to the attractive forces between
identical molecules and, for example, is what hold liquids together. Adhesion is the
attractive forces between unlike molecules and, for example, is what allows liquids to
stick to a surface and even engulf/submerge objects.
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Cohesion forces between identical molecules in a liquid are uniform throughout
the bulk solution and there is a net zero force on each molecule except at the surface of
the liquid. The molecules at the surface do not have like molecules on all sides of them
and because of this are attracted with more cohesion forces to their neighboring surface
molecules. This increase in cohesive force allows the liquid to contract into the smallest
possible surface area and is called “surface tension”.
The ability of a solvent to wet a solute is dependent on surface tension (Remington,
2006). The work from adhesion forces between the lysozyme particle and the buffer
solution must overcome the work from the buffer solutions’ own surface tension and
cohesion forces to allow the solution to spread over the particle. This process of wetting
is dependent not only on the intermolecular forces between the liquid and solid but
whether they are fully in contact with each other. This wetting process is described in
more detail in chapter 8.

1.9

Convection-Diffusion Equation

The second part of the dissolution process in microgravity can be modeled by a diffusionlimited system. The following section show the derivation of the convection-diffusion
equation which is used to describe the rate of change of a certain concentration moving
through solution.
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1.9.1

Diffusive Flux

The derivation of diffusive flux starts with considering particles moving in one dimension
performing a random walk (Fick’s 1st Law). The particle at any time scale ∆t can move
either left or right within a length scale ∆x (Berg, 1993; Crank, 1979). At any step half
the particles would move left and the other half would move right. Use the movement in
only one direction and allowing N (x, t) to represent the number of particles at position
x at time t (Berg, 1993; Crank, 1979). The number of particles that move to the right
is represented by:

− 21 [N (x + ∆x, t) − N (x, t)]

(1.1)

Flux is the movement of particle through an area element (A) during a time interval
∆t.



1 N (x + ∆x, t) N (x, t)
~
−
JDif f usion = −
2
A∆t
A∆t

(1.2)

Multiply the top and bottom by (∆x)2 which is equivalent to 1:

(∆x)
J~Dif f usion = −
2∆t

2



N (x + ∆x, t)
N (x, t)
−
2
A(∆x)
A(∆x)2


(1.3)

Noting that the density of particles (or concentration c is:

c(x, t) =

N (x, t)
A∆x

and the diffusion constant in one dimension is:
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(1.4)

D=

(∆x)2
2∆t

(1.5)

Therefore if we substitute equations 1.4 and 1.5 into equation 1.3 we get:



c(x + ∆x, t) c(x, t)
~
JDif f usion = −D
−
∆x
∆x

(1.6)

When dealing with infinitesimal changes the equation becomes a derivative:

δc
J~Dif f usion = −D
δx

(1.7)

Changing the equation to cover 3 dimensions, the flux due to diffusion is finally:

J~Dif f usion = −D∇c

1.9.2

(1.8)

Convective Flux

In one dimension, the mass of the number of particles that travel through an area normal
to the initial position.

N = c∆xA

(1.9)

Where (N ) is the number of particles, (c) is the concentration or density of particles
and (A) is the area.
Convective flux is how much of this mass or number of particles passes from one
region into another through the area A per unit time (∆t).
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c∆xA
∆x
N
=
=
·c
J~Convection =
A∆t
A∆t
∆t

(1.10)

Now allowing for infinitesimal changes (i.e. Limit as ∆t goes to 0) and substituting
for velocity in the x direction (v~x ). The convective flux in one dimension is:

δx
J~Convection =
· c = ~vx · c
δt

(1.11)

Changing the convective flux equation to cover 3 dimensions:

J~Convection = ~v · c

1.9.3

(1.12)

Convection-Diffusion Equation Derivation

The convection-diffusion equation can be derived directly from the continuity equation:

δc
+ ∇ · J~ = R
δt

(1.13)

~ is the total flux of material (from both
Where (c) represents the concentration, (J)
diffusion plus convection), and (R) is the net volumetric source or if c is either being
created or destroyed. If we substitute the diffusive and convective fluxes the equation
becomes:

δc
+ ∇ · (−D∇c − ~v · ∇c) = R
δt
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(1.14)

Using a few common assumption; velocity describes an incompressible flow, the
diffusion coefficient is constant, and R = 0 when no sources or particles are created or
destroyed. This leaves the final convection-diffusion equation:

δc
= D∇2 c − ~v · c
δt

(1.15)

Equation 1.15 is used to describe particle motion in a fluid for this study. The
(D∇2 c) term represents the particle motion through solution due to diffusion and (~v · c)
represents the particle motion due to convection. In microgravity ~v , which represents
current flow due to natural buoyant convection, goes to zero and the particle motion is
diffusion-limited. This is seen in equation 1.16.

δc
= D∇2 c
δt

(1.16)

In this final diffusion-limited equation the movement of protein through solution
is dependent on two parameters, the initial protein concentration and the diffusion
coefficient.

1.10

Atomic Force Microscopy Background

The atomic force microscope (AFM) is a machine that can create 3D topographic images
of a surface heights widths and lengths. AFM demonstrates a resolution of fractions
of a nanometer. This level of resolution is much better than the optical microscopes
and can be used to image biological samples nanometers in size. This information is
collected by a mechanical probe called a cantilever coming in contact with the surface.

19

The AFM can be used to measure the forces between the probe and the sample it
is in contact with as a function of their distance. Chapter 2 has a detailed description
on the mechanical properties of the AFM and how a topographic image is created.

1.11

Research Base and Planned Approach

Deposits of insoluble protein fibrils are known to be associated with amyloidosis and
neurodegenerative diseases such as Alzheimer’s, Dementia and Parkinson’s (Ross and
Poirier, 2004; Lansbury and Lashuel, 2006; Kelly, 1996). Several different proteins are
involved in the different diseases. All of these so-called amyloid proteins are soluble in
their native conformation in vivo, but form insoluble protein fibril deposits with similar
cross β-sheet structure (Sunde and Blake, 1997; Jiménez et al., 2002).
Many amyloid proteins can also be shown to form protein fibrils with a cross
β-sheet structure in vitro. They will self-assemble into fibrils directly from solution
when the environmental conditions are right. The in vitro fibril formation process is
dependent on solution parameters such as protein concentration, pH, ion concentration
and temperature (Morel et al., 2010; Ramı́rez-Alvarado et al., 2000).
Depending on these parameters there are different paths followed where long thin
fibrils self-assemble directly from solution. The aggregation of protein monomers directly
into fibrils or an intermediate aggregation of oligomers before the formation of fibrils
(Aggeli and Boden, 2006; Estroff and Hamilton, 2006; Perutz et al., 2002; Hill et al.,
2011; Necula et al., 2007; Pellarin and Caflisch, 2006). These different paths change
fibril size, length and helicity (Woodard et al., 2014; Ward et al., 2012; Dahlgren et al.,
2002; Kayed et al., 2003). The study of amyloid fibril formation in vitro will help inform
amyloid disease research (Wolfe and Cyr, 2011).
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Amyloid formation is not limited to disease associated proteins, but also occurs
with proteins not associated with any known amyloid diseases (Guijarro et al., 1998;
Chiti et al., 1999; Kallberg et al., 2001). Hen egg white lysozyme (HEWL) is a prime
example of a non disease associated protein in which amyloid fibrils can form. It shares
a very similar morphology with amyloid fibrils formed from disease-associated proteins
(Bucciantini et al., 2002). Human mutants of lysozyme are an example of a protein
related to organ specific forms of amyloidosis (Pepys et al., 1993; Canet et al., 1999).
These disease related mutants are also morphologically similar to native lysozyme (Hill
et al., 2011). The growth of lysozyme fibrils has been extensively studied in the laboratory; it provides a model for the study of this self-assembly process (Booth et al., 1997;
Frare et al., 2006). Amyloid fibrils form from normally soluble proteins denatured by the
surrounding solution and become insoluble. Lysozyme fibrils form within many different
initial solution conditions. Figure 1.10 shows atomic force microscope (AFM) images of
early and late stages of the growth of fibrils from a solution of lysozyme proteins.

Figure 1.10: AFM images of lysozyme aggregation showing advanced stages of the
amyloid fibril formation process (Woodard et al., 2014). Left: Shows the merging of
fibrils into a helix configuration as indicated by the two arrows. Right: A tangled
interlocking network preventing fibrils from rotating and halting helix formation.
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Research shows that protein aggregation occurs when monomers begin to denature
from their native conformation (Fink, 1998). Protein denaturing can be controlled
by changing the temperature of the buffer solution. Other things that effect protein
aggregation are decreasing the pH and adding salt (Morel et al., 2010; Ramı́rez-Alvarado
et al., 2000). These changes destabilize a solution of protein by altering the electrostatic
barrier surrounding the proteins which prevent aggregation through repulsion.
Changes in pH alter the attractions between the groups in the side chains of
the protein (Gunner et al., 2006). The interactions between the amino acid and the
side chains determine the native conformation of protein. Adjusting pH sufficiently
neutralizes these side chains, nullifying the ionic bonds connecting the amino acids
(salt bridges). Altering the solution pH also disrupts hydrogen bonds changing the
conformation of the protein (Israelachvili, 2011).
Adding salt (electrolyte) to the solution can neutralize the effective electric charge
of the protein. The electric double layer encompassing the protein surface is compressed
when a sufficient amount of electrolyte is present (salt screening);(Israelachvili, 2011).
Increasing temperature increases Brownian motion allowing attractive Van der
Waals forces to overcome any residual particle repulsion so aggregation may occur.
Once amyloid proteins are denatured they can aggregate in multiple ways to form
amyloid fibrils with a secondary structure called cross-β-sheet (Sunde and Blake, 1997;
Jiménez et al., 2002). Several amyloid proteins, initially different in structure and
function, form amyloid fibrils with cross-beta-sheet structure. This suggests a common
driving physical effect. This effect may be explained with the physical structure of
polypeptide chains instead of the specific structure of the amyloid proteins (Hill et al.,
2011; Dobson, 2004).
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To date, most studies of protein aggregation have been carried out in ground-based
laboratories. After fibril formation and continued incubation these fibrils interact and
form macromolecular structures with mature fibrils interweaving with each other (see
Figure 1.10). This network of fibrils can suspend solution and convert the surrounding
fluid into a gel with increased viscosity and opacity (Terech, 2006). These networks
create the building blocks for protein plaques to form (Kodali and Wetzel, 2007; Chiti
and Dobson, 2006). Currently there is a lack of validation data and the morphology of
fibril growth cannot be predicted due to sensitivity in aggregate morphologies because
of changing solution conditions (Bitan et al., 2005; Kowalewski and Holtzman, 1999).
Understanding the colloidal chemistry and biochemistry of amyloid fibril formation may be helped by controlling the process parameters such as, manipulation of the
solution stabilization with ions and changes in temperature or pH. It may be possible to
inhibit or accelerate amyloid fibril formation. For example, increased salt concentration
in the initial buffer solution can increase aggregation and gelation rates (Woodard et al.,
2014; Hill et al., 2009, 2011; Fujiwara et al., 2003; Wang et al., 1996).
There is a lack of understanding of the effect of gravity at the cellular level on
biological functions such as growth rate and processes related to cellular organization
(Tabony et al., 2002). Earlier studies (Tabony et al., 2007; Tabony, 2007) have shown
that the development of larger macromolecular structures such as those formed during
the self-assembly and organization processes of proteins employed in these experiments
are affected by the presence of gravity. In this study the effects of different levels of
gravity on the molecular formation and assembly of amyloid fibrils in vitro is noted by
comparison of the protein fibril morphologies. Observations are made following analysis
of AFM topographic images of the protein fibrils that were formed in both a ground
based laboratory and the microgravity setting aboard the ISS. The lack of the external
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force of gravity in the space based experiment leads to variant behavior of liquids with
regard to the lack of natural buoyant convection. The self-assembly of these protein
fibrils is related to the movement of protein monomers through solution. In microgravity
the protein is in a diffusion-limited system different than that of on the ground.
To provide an environment for the experiments conducted during this study required the physical construction of two identical laboratory units called NanoLabs. One
NanoLab had to be developed to meet the special requirements of NASA for use on the
ISS and the other as a ground based Nanolab on the campus of FIT. Development of the
space based lab required stringent testing of materials compatible with ISS regulations
while being effective in meeting experimental functionality as well (see Figure 1.11)
Protein fibrils grown in microgravity demonstrated a morphology significantly different
from samples grown on earth in an identical Ground Control (GC) system.

(a)

(b)

(c)

Figure 1.11: The tools used and the setting in which the extreme condition of
microgravity used on the ISS. (a) NanoRack in which NanoLab attaches inside ISS.
(b) The ISS (location of flight project). (c) SABOL NanoLab autonomous experiment.

This difference in fibril morphology may be linked to the dissolution process and
how it changes in a microgravity environment. Two areas of interest within the dissolution process may be altered due to the lack of sufficient gravity, wetting and dissolving
of the lysozyme in the buffer solution. If these processes are different between the two
gravitational environments it could lead to a difference in initial protein concentration
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in the buffer solution while fibrils were forming. This concept is studied with a groundbased array of increasing initial protein concentrations in buffer solution. The objective
of this setting was to mimic the fibril morphology seen on the ISS in an earth based
laboratory.
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Chapter 2
Atomic Force Microscope

Figure 2.1: Basic diagram of how the Atomic Force microscope senses organic structures on top of a ﬂat substrate to create a topographic image.

There are many types of Atomic Force Microscopes (AFM) but in general they
all have a cantilever with a tip at the end as shown in ﬁgure 2.11 . The cantilever or
the sample surface is scanned in a raster pattern. When the tip is in close proximity
of a sample surface, contact forces produce a deﬂection of the cantilever. The raster
scan thus produces a map that is related to the contact forces between the tip and the
1

https://upload.wikimedia.org/wikipedia/commons/thumb/7/7c/Atomic_force_
microscope_block_diagram.svg/240px-Atomic_force_microscope_block_diagram.svg.png
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sample surface. Different modes of AFM operation are dependent on different ways the
cantilever can approach the sample and feel the forces. For the work presented here
the AFM is used in contact mode, in this mode a preset contact force is chosen. The
probe then moves up and down as it rasters across the sample surface as a result of a
feedback control system that maintains the preset contact force. A topographic map of
the sample surface under a constant compressing force exerted by the tip on the sample
is created.

2.1

AFM Block Diagram

Figure 2.2 shows the general AFM systems required to create a topographic image. The
force transducer (optical lever) measures the force between the sample surface and the
tip/probe of the cantilever. This signal is sent to the feedback controller which attempts
to keep the force constant at the predetermined value set by the operator (the force setpoint). The force is kept constant by the expansion and contraction of the z-piezoelectric
transducer. If the force is maintained it implies the tip to sample distance is also held
constant. The x-y piezoelectric elements are used to raster scan the cantilever probe
across the surface at a speed set by the operator. As the raster pattern is executed, the
z-piezoelectric element moves up and down to keep the tip-sample distance constant.
Because of this, the amount the tip moves up and down is a measure of the height
variation of the sample surface. Using z-movement a topographic image of the surface
is measured and created by the software.
The AFM presents many engineering challenges that must be overcome in order
to create an image with such high resolution (nm). The probe must be very sharp and
reproduced accurately. The force transducer (optical lever) must have a resolution of 1
nN or less in order to prevent breakage of the cantilever tip or damage the biological
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Figure 2.2: Block diagram of the AFM and the basic operational structure (Eaton
and West, 2010).

sample (Eaton and West, 2010). The feedback controller needs to allow rapid movement
of the probe so the topography of the sample can be followed in a reasonable time per
image capture. The x-y-z piezoelectric scanners must have linear movement capabilities
and be calibrated correctly. A stage with minimal vibrations for the AFM and the
computer running the acquisition software needs to have sufficient speed to allow the
program to run smoothly and display images in real time.

2.2

Piezoelectric Transducer

Certain materials termed ‘piezoelectric’ have the property of converting electric potential into mechanical motion. These materials can be shaped into electromechanical
transducers for various purposes. The materials are crystalline or amorphous and synthetically created. If an electric potential is applied across a piezoelectric transducer,
the geometry of the transducer changes. The magnitude of the applied potential determines the degree of geometric change. This change is usually around 0.1 nm per applied
volt for the size of the piezoelectric elements created for AFM(Eaton and West, 2010).
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These changes are very small and make these materials ideal for controlling the minute
changes of the AFM probe position. For the purpose of this paper, piezoelectric element
motions are labeled with lower case x-y-z. Coarse motions with stepper motors (motors
which turn bearing screws in discrete intervals controlled by the operator or software)
and screws will be labeled with capital letters X-Y-Z. This is done to help denote the
difference in distances these devices can move the cantilever.
For our AFM instrument the X-Y coarse movements are manually done with screws
that can shift the AFM stage millimeters at a time. There are three stepper motors in
a triangle formation which control the Z coarse motion (approach and retract). These
stepper motors are all turned in unison to ensure the sample surface is approached with
the same orientation each time. These stepper motors are used to adjust the angle in
the Z direction of the sample surface and are used for calibrating the flatness of the
surface. It is worth note that some AFM instruments have coarse motors on all axes
while others have no coarse motors.

2.3

Force Transducers

The force transducer converts the force between the sample surface and the cantilever
probe into a voltage. When the cantilever approaches a dry sample surface not submerged in liquid the contact force is at first attractive and then becomes repulsive as
modeled by the Lennard-Jones potential in figure 2.5. The force transducer consists of
two elements: the chosen cantilever with tip/probe and in most cases an optical lever
as shown in figure 2.3. The contact repulsive force between the tip and the sample,
set by the operator, needs to be small enough that the probe tip does not damage the
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biological sample when it comes in contact with the sample surface. There are many
different force transducers such as; interferometer, crystal oscillator and piezo-resistive
cantilevers but most AFMs employ an optical lever (Alexander et al., 1989; Weisenhorn
et al., 1989; Eaton and West, 2010; Hansma et al., 1994)(See figure 2.3).

Figure 2.3: Diagram of the optical lever sensor. A laser reflects off the tip of the
cantilever onto a quadrant photodiode. When the cantilever bends, the position of
the laser changes on the photodiode (Espinosa et al., 2007).

The back surface of the cantilever is made reflective. The beam from a small laser
is reflected from the back surface of the cantilever onto a four-segment photodetector
(quadrant photodiode). Any probe/tip interaction with the sample surface changes the
cantilever position which in turn changes the light path of the laser beam shown in figure
2.3. The force applied to the probe is calculated by measuring the voltage difference
between photodiodes. Typical cantilever dimensions are 50-300 µm long, 20-60 µm wide
and 0.2-1 µm thick and they are constructed using a MEMS process (Eaton and West,
2010). The optical lever is aligned by first placing the laser beam onto the back of
the cantilever directly above the tip. The reflected laser beam is then centered on the
photodetector using mechanical adjusting screws which moves the photodector vertically
or horizontally. The alignment process is essential. Any small changes in alignment
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affect the force sensitivity and may cause the probe to break or decrease resolution of
the image produced. Such alignment must be done regularly and is considered one of
the disadvantages of this type of force transducer because of the amount of time the
process takes away from imaging, depending on the quality of the AFM.

2.4

Contact Mode

There are many modes of operation for the AFM. The most commonly employed and
the one used in our research is contact mode. Contact mode is one of the specific
versions of the more general topographic modes. It is the first mode created, easiest
to understand conceptually, and the fastest way to create topographic images with the
AFM. A simplified force-distance curve is shown in figure 2.4. The linear region of the
repulsive part of the force curve is used for contact mode.

Figure 2.4: Force-Distance curve showing the withdraw of a cantilever from a sample
surface. The region of operation for contact mode is in the repulsive force region. The
operator should set the set-point in this region. On the right there is an illustration of
typical probe bending in the attractive and repulsive regimes (Eaton and West, 2010).
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The forces the cantilever probe encounters as it approaches the surface in this
linear repulsive region can be described by Hooke’s Law seen in equation 2.1:

F = −K × D

(2.1)

Where; F = force [N], K = Probe force constant [N/m], and D = Deflection
distance [m].
The forces the cantilever tip registers as it approaches an atom or molecule can be
modeled by the Lennard-Jones potential shown in Figure 2.5 2 . Contact mode places
the cantilever at a constant height above the sample close enough to where it registers
the repulsive force due to the exchange force resulting from the Pauli Exclusion principle
(Seo and Jhe, 2008). The exclusion principle states that no two fermions (half-integer
spin particles such as electrons) can occupy the same quantum state. They cannot have
the same values for the principal, orbital, magnetic, and spin quantum numbers. This
repulsive force has a very short range and decays rapidly with distance and can be
modeled with a power law as seen in figure 2.5.
A laser is pointed at an angle toward the back of the cantilever and reflected into a
quadrant photodiode detector. When deflection occurs the reflected laser light changes
its location on the quadrant photodiode array detector. As the intermolecular force
between the cantilever tip and the sample changes, the tip moves up or down to keep the
laser light centered on the quadrant photodiode detector as seen in Figure 2.1 3 . Thus as
the tip is rastered across the sample a topographical contact force map is created. This
allows the AFM to create a topographic image of the surface and any sample on top of
the surface while also creating a deflection image (from the change in deflection voltage
2

http://www.cmbi.ru.nl/redock/images/LennardJones.png
en.wikipedia.org/wiki/Atomic_force_microscopy#mediaviewer/File:Atomic_force_
microscope_block_diagram.svg
3
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Figure 2.5: The Lennard-Jones potential which explains the forces felt by the cantilever as it approaches a biological sample.

as the tip rasters across the surface, also known as the error signal). An AFM can
operate in many different modes but in general the contact and tapping modes are the
most popular. Topographic images are produced from spatial variations of the cantilever
deflection, while the deflection image is generated from the feedback error which is in
response to these forces and the cantilever attempting to keep a constant force/height
above the sample and substrate. Molecular Imaging Picoscan Plus is the software used
for the AFM to create and study the images. An alternative mode is tapping mode.
Which when used, the cantilever oscillates up and down near its resonance frequency.
This is done by a piezoelectric device attached to the AFM holder (Geisse, 2009). The
tapping mode was not used for our AFM instrument because the software would not
connect with the hardware creating many errors.
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The AFM was used to see the changes in different stages of protein aggregation. It
is used for the majority of the data analysis because it gives an informative view to the
structures including shape, height, texture and alignment. With our AFM the deflection
images are easier to see fibril texture and small changes in height, but topographic images
were used to measure the height of structures in the images.
In contact mode the error signal is the deflection signal. The amount of deflection is then reversed by the feedback circuit by changing the size of the z-piezoelectric
element. With these two signals of action and reaction, two different images created, deflection and topographic. The deflection image displays how the cantilever bends when
encountering a force. The topographic/height image shows how much the z-piezoelectric
material had to expand or contract to maintain the set-point and keep a constant force
given by the operator. Ideally the feedback circuit is calibrated correctly and optimized
so all the features shown in the deflection image are also present in the topographic
image. Lateral twisting of the cantilever can also be measured in contact mode and
is usually labeled as lateral deflection. This type of signal is used to measure material
sensitivity.

Figure 2.6: Image of the quadrant photodiode (photodetector) and how it detects
motion in the vertical and lateral directions while the cantilever is moving across the
sample (Eaton and West, 2010).
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The photodetector used in AFMs as the force sensor/transducer is a combination of
four photodiodes and also called a quadrant photodiode as seen in figure 2.6. To measure
vertical deflection the difference in signal collected between the top photodiodes and the
bottom photodiodes is calculated. For example: (A + B) − (C + D) and is measured
in [volts/Amps]. A similar approach is used to calculate lateral deflection, but now it
is the left two minus the right two, (A + C) − (B + D).
Force-distance curves are created to display the level of forces applied to the cantilever probe as a function of distance from the sample surface. These curves show
the forces as the probe approaches and is retracted from the surface as seen in figure
2.7. The cantilever deflection is used to express the force/deflection in the vertical axis.
Depending on the optimization of the feedback circuit the deflection and force graphs
are similar enough to be interchangeable.

2.4.1

Adhesion

As shown in figure 2.7, when the cantilever probe retracts from the sample surface it
takes more force to detach from the sample than when it initially approached. This
increase in force for retraction differs from the Lennard-Jones model and is due to a
stiction force. Stiction is the adhesion occurring between the contact surfaces due to the
surface forces including van der Waals, capillary forces, Casmir forces and electrostatic
forces (Birleanu and Pustan, 2015). Birleanu states the parameters that affect the
occurrence and strength of the adhesion are:

• Relative humidity
• Contact area
• Temperature
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Figure 2.7: Image of a generalized force-distance curve. The cantilever bends and
straightens depending on the distance from the sample surface or substrate. At point
(A) the cantilever tip is far from the surface and is approaching. At point (B) the
cantilever experiences attractive forces that pull the probe onto the surface quickly
through forces such as van der Waals (vdW) interaction, electrostatic force and chemical force. Leading to point (C) the forces becomes repulsive (Pauli-exclusion interaction and electronelectron Coulomb interaction). Once fully approached the cantilever
can retract from the sample. At point (D) the cantilever overcomes the adhesion to
pull off of the sample (Eaton and West, 2010).

• Surface energies
• Surface roughness
• Number of contact cycles
• Contact duration
• Compressive contact forces

The idealized force from these adhesion forces (pull-off forces) is:
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Fadhesion = CπγR

(2.2)

Where ‘C’ is a constant defined by specific models. ‘γ’ is the work of adhesion.
‘R’ is the tip radius of the cantilever (Birleanu and Pustan, 2015).

Figure 2.8: Lateral forces can occur due to two main reasons. (1) Changes in the
slope of the topography (2) Increased friction due to cantilever contact with different
materials and/or adhesion forces (Eaton and West, 2010).
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The adhesion forces typically help keep the cantilever in contact with the surface
when raster scanning to create an image. However, these same adhesion forces are bad
for the resolution of the image. The presence of adhesion creates large lateral forces when
dragging the tip across the sample twisting it which then affect the cantilever position
in the vertical direction when it twists. If the biological sample is fragile these forces
may also damage them. Samples placed on mica are dried to prevent excess adhesion
forces. The biological samples are first dried laterally with nitrogen gas to remove large
amounts of water, then placed in an oven for up to 2 hours at 55 ◦ C. Adhesion force is an
additional force acting on the cantilever tip which consequently degrades the resolution
of the topographic images. Image resolution and sample integrity are the two main
reasons that minimizing adhesion forces helps AFM imaging.

2.5

Feedback Control

The purpose of the feedback control is to maintain a set force between the probe/tip and
the sample surface, as indicated in figure 2.9. The force sensor (optical lever) measures
the deflection voltage signal and sends it to the feedback control system which generates
the control signal, an increasing or decreasing potential difference, to the piezoelectric
element. The piezoelectric element responds with change in size to increase or decrease
the distance form the sample.
The feedback control circuit receives a signal from the force sensor (optical lever)
and compares this value with the set-point number, a value of force input by the operator. Roughly, the difference between these values is the error signal or deflection. Using
the error value the feedback controller drives the z-piezoelectric material accordingly to
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Figure 2.9: Diagram of feedback control operations; when the force sensor senses a
change in sample height through and increased voltage, the piezoelectric device moves
in the z direction to maintain the same tipsample force or a constant height(Eaton
and West, 2010).

keep the set-point force constant. Many AFMs use a proportional integral device controller (PID) to compare the error signal and set-point and to track the surface (Eaton
and West, 2010). Both the error signal (deflection) and z voltage are digitized and
converted to deflection and height/topographic images.
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2.6

Probe Movement and Sample Approach

To provide for coarse positioning of the AFM’s probe in the Z direction stepper motors are provided that can produce up to a centimeter of motion in the Z direction.
These stepper motors drive linear bearing screws which produces a motion resolution of
approximately 80 µm before the cantilever is in contact with the sample. Once in contact/near the sample, the z-piezoelectric device has a dynamic range of approximately
10 µm with a resolution of 0.5 nm. Both of these devices are used in order that the
AFM’s probe can approach the sample safely without breaking. The Z-stepper motor
is used to approach quickly and cover more distance to get close to the sample surface.
The z-piezoelectric element is used for the final approach because it is more sensitive.
Once contact with a sample surface has been made the feedback controller is activated.
This typical approach method can be seen in more detail in figure 2.10 and is called the
‘Woodpecker’ method.

Figure 2.10: To avoid breaking the probe when it approaches the sample a Woodpecker probe approach method is implemented. The z motor is used in conjunction
with the expansion of the z piezoelectric element to avoid abrupt contact with the
surface. The feedback control is activated once contact with the surface has been
made (Eaton and West, 2010).
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The coarse movement of the cantilever in the X-Y direction is also accomplished
with stepper motors or by physically moving the AFM stage with micrometers. This
function is primarily used for locating the desired features on the sample surface and is
done in conjunction with an optical microscope. This device is not essential but allows
easier access to the desired regions for scanning. The optical microscope also allows for
positioning of the laser onto the cantilever and aligning the optical lever.

2.7

AFM Electronics

The primary function of AFM electronics controller is to allow the computer and AFM
to communicate. The controller is built with digital signal processing (DSP) chips. The
electronics controller:

• Generates the signal for the x-y piezoelectric controlling the raster scan.
• Uses the signal from the force transducer (optical lever) to generate the control
signal for the z piezoelectric
• Generates the control signal for the stepper motors in the X-Y-Z directions
• Gathers the output signal that the computer uses to create an image.

Every signal that comes from the AFM stage is digitized by the electronics. The
DSP chip controls all the feedback controller calculations while allowing the operator to
input values for the x-y raster pattern.
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There are many signals that can be collected in different types of AFMs, but some
are uniform across all types as noted in this paragraph. For example, the z voltage is
the signal that travels to the z-piezoelectric element from the PID to control its size and
in turn control the fine movement of the probe in the z direction. Another example is,
the z error signal also known as the deflection signal.

2.8

Computer and Acquisition Software

After initial calibration of the AFM and proper placement of the sample in the AFM
stage, the operator uses the computer and acquisition software to create an image. The
primary purpose of the acquisition software is to:
• Allow for the operator to manipulate controls to move X-Y stage to find desired
feature for scanning
• Operator chooses the probe approach and retract distance intervals and initial
distance to the sample surface
• Operator chooses a certain scan mode for cantilever probe
• Software implements operator’s input of control scanning parameters such as force
set-point and FOV (image size)
• Display the images in real time while scanning the sample
• Create force-distance curves to help understand the probe sample interaction
A typical display on the computer screen for the controls of the acquisition software
is shown in figure 2.11. The software can display images in real time as the data is
collected for both the trace and retrace of the topographic and deflection data. Two
dimensional profiles can be displayed for these images and height profiles of specific
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objects within images can be determined. The tab to enter the scan parameters is
also displayed. The feedback parameters such as force set-point are also input in this
window. This display is where the topographic images can be saved and used to collect
the necessary height length and width data needed for data analysis.

Figure 2.11: This is a screen typically seen in acquisition software for the AFM.
The software employed by our group is PicoView. Different parts of the screen display
unique information: (A) Displays both topographic and deflection images (B) Through
the oscilloscope a 2-D profile is displayed in real time. (C) This tab denotes some of
the scan parameters that are plugged in, such as speed of data collection. (D) This
tab shows where feedback parameters are plugged in, such as set-point(Eaton and
West, 2010).

The computer software controls the AFM stage and the rate at which the probe
approaches the sample surface. The Z motion with stepper motors is controlled to allow
the probe to approach rapidly but stop before the final contact. There are software
algorithms that are critical for placing threshold signal levels for the probe to sample
surface interactions. When the threshold is reached the probe is stopped and the AFM
feedback control sequence is initiated. The X-Y motion control is used with stepper
motors and can be controlled by the software to translate the FOV to find the sample
for imaging. At this point force-distance curves may also be produced by the software
to measure the forces experienced by the probe as a function of distance.
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The x-y scan control and the rate the cantilever tip is set to raster across the
sample surface is controlled by the software and the operator. The number of lines
and points of data per line collected allows for accurate data to be extracted from the
images. The more data points noted per line, the longer it takes to produce an image.
The image size or FOV is also controlled by the x-y scan tab.
Computer software is required to control the feedback electronics. The operator
must input the set-point voltage so that it may be sent to the amplifier in the controller.
The specific cantilever material and geometry must be known to find the elasticity
and correctly convert the set-point voltage to the actual force applied to the sample
surface. The PID parameters are also set by the software. These elements control the
responsiveness of the feedback control electronics and must be adjusted to ensure the
probe is following the surface as it scans at a constant height.

2.9

Cantilevers

The cantilever is connected to a chip to allow it to be handled without it being touched.
There are several types of cantilevers but the two most typically used are shown in
figure 2.12. The triangular cantilever is used for contact mode, which was employed
in this study, while the rectangular cantilever is often used for oscillating mode. The
geometry of the tip is very important for the resolution and quality of the images that
are collected by the AFM.
There are mainly two materials used in the construction of AFM cantilevers: silicon
nitride (Si3 N4 ) and silicon (Si). Si3 N4 is used with cantilever probes with low force
constants and mainly for triangular cantilevers for contact mode. Si probes are more
rigid and break more easily and are primarily used for cantilevers in oscillating mode.
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Figure 2.12: These are two examples of standard AFM cantilevers. The left image
displays v-shaped contact-mode cantilever while the right image is of a probe typically
used for oscillating mode. Contact-mode probe is used in our experiments and is made
from silicon nitride with a pyramidal probe tip (Eaton and West, 2010).

2.10

Scanner Calibration

Atomic Force Microscopy uses a known relationship between the magnitude of voltage
applied to the piezoelectric element and the distance the piezo expands or contracts.
This relationship is measured and programmed into the software when the AFM scanner is created. This relationship may change over time resulting in quantitative AFM
measurements that are inaccurate. To account for this voltage to distance relationship
of the scanner must be calibrated. It is typical to calibrate the AFM once per year, or
more often depending on the usage, to ensure scanner accuracy.
Calibration entails both measuring the errors and then correcting for them. The
correction is done by referring to the AFM user manual of the specific machine. Correcting for the errors is different for each machine but measuring the errors is a general
process used across most AFMs. Commercial samples are created with known heights,
widths and angles for the calibration process. These samples help calibrate the scanner
in the x-y-z directions along with angle and surface flatness.
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2.10.1

x-y Calibrating Sample

The x-y calibrating sample has features aligned in a grid pattern. About 20 features
in both directions which fill up the scan range. These features are ideally and most
commonly squares. When scanning in the lateral direction this measures the error in
the pitch (the distance between the features) as seen in figures 2.13 and 2.14 (Eaton
and West, 2010).

Figure 2.13: Standard grid pattern of square features for a calibrating sample. The
pitch is the distance from one feature to another (Eaton and West, 2010).

The actual distance between the features is known and compared to the measured
value to calculate the error. The scan range can be calculated and can be calibrated
with this same sample. This process should be done at multiple positions on the image
to ensure the pitch does not change in different locations of the image and to ensure
linearity.
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Figure 2.14: The probe is scanned both in the x and y directions to ensure linearity
(Eaton and West, 2010).

2.10.2

Z Height Calibrating Sample

A standardized step height of around 20 nm is generally used for the features in a z
height calibration sample. The sample holder is set to a known angle between the x-y
scanner axis and the sample surface. Then the sample is scanned as seen in figures 2.15
and 2.16.

Figure 2.15: the calibrating sample has a set angle ‘θ’ which is used along with the
length of the sample ‘L’ to calculate the value of ‘Z’ (Eaton and West, 2010).
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Figure 2.16: Across the entire z range the z linearity is calculated (Eaton and West,
2010).

The step height is measured on the image and compared to the known height value
for the feature. To ensure z-axis linearity the heights of the features across the entire
image are compared to each other.

2.11

Probe Shape Deconvolution

Horizontal resolution and the quality of an AFM image are dependent on the sharpness
of the cantilever probe. The probes are manufactured and the sharpness and shape
are the major limiting factors for resolution. As the AFM images a sample surface
the probe deteriorates over time and will become dull. In some more severe cases
cantilever probe/tip damage can occur during cantilever approach or rastering across a
large feature too quickly because of too much stress on the silicon. The probe can also
become dirty by material sticking to the end, changing the image captured.

2.11.1

Deconvolution for R < r

Knowing the probe/tip geometry, it is possible to remove the probes geometrical effects
(‘profile broadening’) in the image collection. This process is called probe deconvolution
(Eaton and West, 2010) and is shown in figure 2.17.
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Figure 2.17: This is a simplified cross-sectional image of a cantilever probe about
to drag over a nanoparticle when R << r (Eaton and West, 2010).

This figure shows a simplified cross-sectional view of probe deconvolution. When
the probe drags over the nanoparticle shown, equation 2.3 (Eaton and West, 2010) can
then be used to calculate the diameter of the nanoparticle while removing the effects
from the geometry of the probe. This equation uses the cantilever tip radius (R), the
feature curvature radius (rc ), tip half angle (θ) and actual feature radius (r). This is an
extremely ideal case where the probe has an upside-down triangle shape. This method
is not the best due to the inconsistent probe manufacturing when creating nanometer
sized devices. This method can be used when the tip radius R < r.

r
rc = r(cosθo +

2.11.2

cos2 θo + (1 + sinθo )(−1 + (

tanθo
) + tan2 θo ))
cosθo

(2.3)

Deconvolution for R > r or R ≈ r

In reality the AFM cantilever tip size is on the order of the features stuck to the sample
surface. As the tip rasters across the sample surface convolution of the tip and sample
occurs as shown in figures 2.184 and 2.19.

4

https://www.ntmdt-si.com/resources/spm-theory/theoretical-background-of-spm/
2-scanning-force-microscopy-(sfm)/22-cantilever-sample-force-interaction/
222-elastic-interactions-the-hertz-problem/2224-the-effect-of-elastic-deformations-during-experim
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Figure 2.18: This is a simplified cross-sectional image of a cantilever probe about
to drag over a nanoparticle when R≈r or R>r.

Figure 2.19: This the path the cantilever tip takes over several nanoparticles of
similar size to the tip radius. Several parameters can be calculated using this idealized
model (Eaton and West, 2010).

2.12

Cantilever Force Constant

The cantilever probes can not only vary in geometry but the cantilevers may have
different specifications for thickness, width and length. These parameters change the
cantilever force constant which has a direct effect on how the cantilever measures the
force of the sample surface. Table 2.1 shows some examples of some typical cantilever
properties (Eaton and West, 2010).
Knowledge of force applied is useful to know and critical when quantifying applied
forces. It helps to understand how to manipulate the force set-point.
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Table 2.1: Example of manufactured AFM cantilever properties and the how different geometries and material can create a range of force constants (Eaton and West,
2010).

Cantilever Data
Value
Range [nm]
Thickness
2 µm
1.5-2.5 µm
Mean width
50 µm
45-55 µm
Length
450 µm 445-455 µm
Force constant
0.2 N/m 0.07-0.4 N/m
Resonance frequency 13 kHz
9-17 kHz

Figure 2.20: Geometry and parameter labels of rectangular and triangular cantilevers (Sader et al., 1999).

A common way to measure the cantilever’s force constant is the ‘Sader method’
(Sader et al., 1999). This approach uses the measured geometry of the cantilever and
the ‘quality factor’ (Q) in the calculations. In oscillating mode a rectangular cantilever
is generally used while we use contact mode with a triangular cantilever. The Sader
method calculates the force constant of a typical rectangular cantilever first and then
uses this value to find the force constant of a triangular force constant. The typical
cantilever shapes attached to the chip are shown in figure 2.20. This method was not
used to find the force constant in our experiment because the slope of force-distance
curves were sufficient in providing a reasonable value for for preset inputs.
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2.13

Sample Deformation Hertzian Model

Using a method from Karpova (Karpova and Novikov, 2002), a total height deformation
∆z of a biological sample under a certain load force from a cantilever tip can be calculated. Figure 2.215 displays the general labels for two solids spheres in contact (Landau
and Lifshitz, 1986).

Figure 2.21: Hertz Problem and labels (Landau and Lifshitz, 1986). (Left) The
upper solid comes in contact with a lower solid each with there own labels for radius
in orthogonal planes, Young’s modulus, and Poisson ratio. (Right) Assuming both
solids are spheres r1 = r2 = r and r10 = r20 = r0 . The contact circle radius is a and the
penetration depth is h.

r0 is sample radius
r is cantilever probe/tip radius
E 0 is sample Young’s Modulus (elasticity)
E is probe Young’s Modulus (elasticity)
µ0 is Poisson ratio of sample
µ is Poisson ratio of cantilever tip/probe
5

https://www.ntmdt-si.com/resources/spm-theory/theoretical-background-of-spm/
2-scanning-force-microscopy-(sfm)/22-cantilever-sample-force-interaction/
222-elastic-interactions-the-hertz-problem/2222-the-hertz-problem-solution
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h is penetration depth
a is contact circle radius
Assumptions:
(1) Deformations are small compared to surfaces’ curvature radii. (2) Suppose
that both the cantilever and sample materials are isotropic
Curvature radius R from equation 2.4:

1
1
1
1
1 −1
= + 0 ==> R =
+ 0
R
r r
r r

(2.4)

Equation 2.5 shows the effective Young’s Modulus Kef f of a pair of materials in
contact:

3  1 − µ02 1 − µ2 
1
=
+
Kef f
4
E0
E

(2.5)

Inverting equation 2.6 shows the new Kef f :

Kef f =

h 3  1 − µ02
4

E0

1 − µ2 i−1
+
E

(2.6)

At small deformations the following geometric relation between penetration depth
and contact circle radius is shown in equation 2.7:

h=

a2
R
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(2.7)

Equation 2.8 demonstrates the relationship between loading force F and deformation height h between two materials. This equation can also be equated to the AFM
equevelant of Hook’s Law (in terms of the inverse deflection sensitivity and the change
in voltage applied):

F =

Ka3
= Kh3/2 R1/2 = K(InvOLS)∆V
R

(2.8)

Figure 2.22 shows a typical force spectroscopy graph of the AFM cantilever approaching a hard surface (mica). This graph is used to determine the deflection sensitivity (units of V/m) of the cantilever which is needed to calculate an accurate load
force. The slope represents the deflection sensitivity, the inverse is calculated for InvOLS
(inverse optical lever sensitivity). The ∆V represents the force-setpoint applied.
Therefore the new deformation height is:

r
h=

3

F2
RK 2

(2.9)

Equation 2.7 can be used to find the deformation height at several places throughout the scan as demonstrated in figure 2.236 .
In figure 2.23 h1 , h2 and h3 represent the height deformation at each contact
point. Equation 2.10 shows the total height change ∆z due to deformation of the elastic
biological sample under a certain load force from a cantilever tip.

∆z = h1 + h2 − h3
6

(2.10)

https://www.ntmdt-si.com/resources/spm-theory/theoretical-background-of-spm/
2-scanning-force-microscopy-(sfm)/22-cantilever-sample-force-interaction/
222-elastic-interactions-the-hertz-problem/2225-appendices
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Figure 2.22: Typical force spectroscopy graph of AFM cantilever approaching a hard
mica surface. The slope of this graph is used in determining the deflection sensitivity
which leads to the load force. The break in the x-axis between the approach and
retract represent hysteresis in the piezo.

It is worth note that deformation of h3 is inconsequential compared to the other
deformation values. Also, this model is only true when the deformation at h1 is not
affected by the deformation at h2 . This is only true when rcontactarea is much less than
the rsizeof molecule .

2.13.1

Lysozyme Sample Deformation

When using lysozyme, if the radii and Young Moduli of the fibrils are given the deformation can be calculated using the idealized Hertzian model:
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Figure 2.23: Sample deformation

• r = 3[nm] lysozyme molecule height approximately
• r = 12[nm] Cantilever silicon tip radius

7

• r = ∞[nm] Mica substrate radius
• Emica = 200[GP a] Young’s Modulus of substrate
• Esilicon = 150[GP a] Young’s Modulus of cantilever tip
• Elysozyme = 4[GP a] Young’s Modulus of lysozyme (Adamcik et al., 2012; Adamcik
and Mezzenga, 2012)
• µlysozyme = 0.33 Poisson’s ratio of lysozyme (Tachibana et al., 2000)
• µsilicon = 0.265 Poisson’s ratio of silicon

8

• µmica = 0.25 Poisson’s ratio of mica (Gao et al., 2001)
• F = 3[nN ] is the calculated load force on the sample using 0.12 N/m for the spring
constant, 8.93 nm/V for InvOLS and ∆V of 3 V for the force-setpoint.
7
8

https://www.brukerafmprobes.com/p-3693-snl-10.aspx
https://www.azom.com/properties.aspx?ArticleID=599
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Then using equation 2.4 the curvature radii are calculated:

• Rlys−sil = 2.4[nm] curvature radius between silicon-lysozyme
• Rmica−lys = 3[nm] curvature radius between mica-lysozyme
• Rmica−sil = 12[nm] curvature radius between mica-silicon

Plug these values in to equation 2.6 for each effective elasticity between each
material.

• Kef f,lys−sil = 3.28[GP a]
• Kef f,mica−lys = 3.30[GP a]
• Kef f,mica−sil = 68.9[GP a]

Then using equation 2.9 for deformation height at each location we get:

• h1 = 0.70[nm] (lysozyme-Silicon tip)
• h2 = 0.65[nm] (lysozyme-mica)
• h3 = 0.05[nm] (Mica-Silicon tip)

The total height deformation of the lysozyme due to the loading force of the tip
using equation 2.10 is:
∆z = 1.30 nm which is 43.4 percent of the lysozyme molecule size.
Unfortunately this model uses two spheres with similar sizes approaching each
other. A more physical measurement of the deformation by the load force is needed to
calibrate the sample heights accurately. The force that deforms the fibril is affected by
the underlying substrate when the radius of contact area of the sample-tip is comparable
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to the sample thickness (Guo and Akhremitchev, 2006). Ideally there needs to be a
correction to the Young’s moduli which will change the value for the deformation height
(Guo and Akhremitchev, 2006; Akhremitchev and Walker, 1999; Dimitriadis et al., 2002;
Kovalev et al., 2004).

2.13.2

Calibration of Lysozyme Fibril Deformation

Using the AFM a sample of lysozyme fibrils was imaged many times in the same location
with a FOV of 5 µm. These images were taken with increasing cantilever load force (force
setpoints) using the least amount of force first then increasing until the sample no longer
produces readable data. The sample deformation vs. load force can be seen in figure
2.24.
A decreasing trend in fibril height can be seen with increasing load force (force
setpoint voltage). A linear fit to this trend has an R-squared value of 0.93 and a yintercept of 2.29 nm. The intercept can be used as an estimate of fibril height with
no load force applied. This is a rough estimate because in reality the force applied vs
deformation does not follow a linear trend.
All topographic images in this study used a force setpoint of 3 volts. Figure 2.24
can be used to calibrate height measurements of the lysozyme fibrils to give undeformed
heights. 2.29 nm in height deforms to 1.77 nm, 29.4% of height decrease which is fairly
close to the idealized hertzian deformation stated in the previous section. Thus the
equation for calibrated height 2.11 applies.

hcal = h ∗ 1.294

58

(2.11)

Figure 2.24: A physical representation of the sample deformation of lysozyme under
different load forces (force setpoints). A clear trend is displayed with a linear fit. Each
data point represents an average of 20 height measurements made of lysozyme fibrils
at each setpoint.
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Chapter 3
Laboratory Methods

3.1

Lysozyme/Buffer Solution

Many combinations of buffer solution and lysozyme concentrations lead to protein fibril
formation. The objective here was to use a lysozyme/buffer solution optimized on earth
for a fibril growth period of 20 to 30 days from initiation through gelation, estimated
duration of microgravity experiment. The optimal methods for lysozyme preparation,
fibril formation, and fibril characterization are well understood (Burnett et al., 2014;
Hill et al., 2011; Woodard et al., 2014).
Stock buffer solution was prepared with 10 mM glycine (Sigma - G7126-5kG) in
de-ionized (DI) water, titrated to pH 2.5 with HCl. We have found the pH level to be
critical; to ensure uniformity across samples, the titration was performed in the stock
solution prior to the addition of lysozyme; the final HCl concentration was approximately
36 mM. The buffer was prepared with no added salt (NaCl). Lysozyme (BSG, Napa,
CA) was dissolved in the stock buffer solution at a concentration of 20 mg/ml. Acidic
conditions are required at the pH of 2.5, lysozyme has a charge of approximately +16
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(Boström et al., 2006). Heating the sample close to the denaturing temperature 55 ◦ C
(Hill et al., 2011), is also required. Previous testing found that fibril formation would
not occur in a 30 day period if the temperature was at or below 40 ◦ C. The incubation
oven used was a StableTemp Vacuum oven (model 281A).

3.2

AFM Equipment

Samples were imaged with a Molecular Imaging multi-purpose large scanner (laser 1
mW max at 630 nm) atomic force microscope (AFM). PicoView version 1.12 AFM
software was used and all images were acquired in contact mode. A Bruker model SNL10 silicon-tip on nitride cantilever was used and an Olympus IX71 optical microscope
was used to center the laser reflecting off the cantilever and the quadrant photodiode
(photodetector) was adjusted to null the signal. Cantilever tips are typically 600 nm
in height with a 10 nm curvature radius. The cantilever had a force constant or spring
constant of 0.12 N/m. AFM tips that were damaged or no longer produces readable
images were replaced. A detailed explanation of the AFM equipment and function can
be seen in chapter 2.

3.2.1

AFM Operation

A force setpoint of 3 volts was used, translating to 24 nN of load force due to an average
of 15 mV/nm deflection sensitivity and .12 N/m cantilever elasticity. This force setpoint
was used for the majority of images because at lower setpoint values the cantilever tip
would lose contact with sample at our set raster speeds. At this force setpoint the
lysozyme was deformed, in the future the lowest possible force setpoint that provides
consistent images would ideally be used. Raster speed ranged from 1 to 4 lines/sec and
all of images are 1024 x 1024 pixels. Field of view (FOV) of 2x2, 5x5, 10x10 and 20x20
61

µm2 were the most common. Contact mode, where the probe moves up and down to
maintain the constant set point force, was used throughout. Topographic images were
used to demonstrate three-dimensional structure and for dimensional measurements,
while deflection images were used to demonstrate shape and texture.

FDrif t = (k)(InvOLS)(∆V ) = (k)(InvOLS)(Vref −point − Vaway )

(3.1)

Before the cantilever approaches and comes in contact with the sample the deflection value is calibrated as close to 0 V as possible. There are thermal fluctuations
naturally occurring at all times that effect the deflection voltage and creates a voltage
drift form the intended calibration of 0 V. This thermal voltage drift leads to a change
in force applied to the sample over time (see equation 3.1). Where (k) represents the
spring constant of the cantilever, (InvOLS) represents inverse deflection sensitivity and
(∆V ) is the change if voltage due to thermal noise. The thermal drift is represented
by the Vaway and can therefore show us how much force change there is present in a set
time interval.
Figure 3.1 shows the how the deflection voltage changes with time due to deflection
drift for the AFM. Each measurement was take 3 minutes apart which is about the
estimated time it takes to create a full topographic image. The average ∆V measured
is 0.12 V. If (k) is 0.12N/m and (invOLS) is 8.9nm/V then this 0.12 V converts to 0.13
nN of force due to the thermal drift. When compared to the 3 V applied for the force
setpoint in contact mode (3 nN), this drift is inconsequential when taking a topographic
image.
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Figure 3.1: This plot shows how the deflection voltage read on the quadrant photodiode changes with respect to time because of deflection drift. The measurements were
taken every 3 minutes because this is the average time it takes to collect a topographic
image with the AFM at our scan speeds.

In contact-mode AFM the width of structures smaller than the AFM tip can be
greatly exaggerated by convolution. A circular fibril of height around 2-3 nm, smaller
then the radius R of the AFM tip, will have an apparent width of around 20 nm. This
width is exaggerated due to the width of the cantilever tip. Consequently we used height
rather than width as a measure of the diameter of particles and fibrils, although the
decompressing forces need to be accounted for. Measurement of the length of fibrils
is not affected because they are much larger than the AFM tip. The lengths can be
measured inside the Picoview software when the fibrils are short enough to be within
the image FOV.
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Figure 3.2: What do these images show and what does the pseudo-color correspond
to? AFM topographic images where the pseudo-color corresponds to the height of
the biological feature. This is a group of images showing the difference of helicity of
lysozyme protein fibrils which formed in buffer solutions incubated with different concentrations of NaCl (A) 0 mM NaCl, (B) 50 mM NaCl, (C) 150 mM NaCl (Woodard
et al., 2014).

Amyloid fibrils often display a helical or twisted-ribbon morphology; in the case of
primary lysozyme fibrils this takes the form of a simple open helical spiral, similar to a
stretched spring as shown in Figure 3.2 and 1.10. When a fibril is bound to a substrate
and viewed from above by AFM this helix has the appearance of a sinusoidal curve. We
examined many fibrils in a set of images to see if it consisted of at least two consecutive
sinusoidal cycles of equal period and amplitude; if it did so it was considered helical.
A fibril of comparable length with no sinusoidal curves was considered linear. Fibril
helicity is effected by NaCl concentration such that the higher concentration of NaCl
the less helical the fibrils that form are, and the day at which fibril begin to form is
less consistent. A NaCl concentration of 0 mM was selected for the flight experiment
because fibrils take longer to form but are more consistent. As a result of these tests
the flight samples were selected to use the stock buffer solution of 10 mM glycine, 0 mM
NaCl, and 36 mM HCl with a 20 mg/ml concentration of lysozyme introduced at the
scheduled times of vial incubation.
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3.2.2

AFM Height Calibration

Vertical and horizontal measurements were calibrated and convolution was measured
with a 20 nm vertical step calibrator. Step height of 20 nm is generally used for the
features in height calibration samples of features near the same height. The sample
holder is set to a known angle between the x-y scanner axis and the sample surface.
After imaging the surface, the step height is measured on the image and compared to
the known height value for the feature. To ensure z-axis linearity the heights of the
features across the entire image are compared to each other.
The specific calibrator used is a block test grating intended for Z-axis calibration
of Scanning Probe Microscopes and linearity measurements. The structure consists of a
silicon wafer with a silicon dioxide layer for grating the 20 ± 1 nm steps. The dimensions
of the chip as a whole are 5x5x0.5 mm3 1 . It is assumed that the forces applied by AFM
during calibration are inconsequential when considering the physical dimensions of the
vertical steps.

3.2.3

AFM Sample Preparation

Samples of the aggregated protein were prepared for AFM imaging as follows. Different
dilutions were made during sample preparation in order to ensure protein fibrils were
visible against the flat mica substrate and not covered with excess protein. To ensure
an excess protein layer did not adhere to the charged mica the slides were also gently
washed with DI water to remove protein not firmly attached to the substrate.
1

http://www.tedpella.com/calibration_html/AFM_STM_SPM_Calibration_Specimens.htm
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Dilution was accomplished as follows: For each dilution the microcentrifuge tube
was gently inverted several times to suspend colloids and 100 µl was extracted from the
center of the tube with a pipette and added to 900 µl of DI water, and again mixed by
tube inversion. Undiluted and diluted protein samples were preserved at 4 ◦ C, freezing
the samples causes damage to the fibrils.
It was difficult to draw gels into a standard pipette due to their large viscosity.
It was found that this also resulted in fibril breakage, apparently due to fluid shear
as the gel was drawn through the small orifice of the pipette (Woodard et al., 2014).
Consequently, when pipetting fibrils and/or gels, the tips of the pipettes were first cut
off to enlarge the orifice diameter to ∼1mm. This allowed for the protein gel to be
drawn into the pipette and released easily.
To prepare AFM slides, 10 µl of 0.01 N N H4 OH was applied near the center of
a freshly peeled mica slide to precharge the substrate. The substrate is muscovite mica
(KAl2 (AlSi3 O10 )(OH)2 ) made of stacked 10 Ȧ thick sheets, where each sheet is held
together by K + ions (Czajkowsky and Shao, 2003; Bailey, 1984; Klein and Hurlbut Jr.,
1993). When the mica is cleaved most of the exposed surface is plate where Si4+ , Al3+
and Mg2+ are present (Butt et al., 2006). The OH− in the basic 0.01 N N H4 OH
solution interacts with the exposed Si4+ , Al3+ and Mg2+ cations striping the mica plate
of positive charge making it negatively charged overall. This left over basic surface and
negative charge is the opposite of the positively charged lysozyme and H+ ions in the
acidic solution which allows the protein to attach to the mica. After two minutes of this
precharge procedure, 10 µl of the lysozyme sample was applied to the substrate at the
same location. After an additional 10 minutes the sample was gently rinsed with 2 ml
of DI water by allowing the water to flow slowly over the substrate in a Petri dish to
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remove salts and unbound proteins. The water was drained and any droplets adhering
to the substrate were removed with a tangentially applied soft jet of nitrogen gas. The
slide then was then dried for at least 2 hours at 55 ◦ C in the same oven that was used
for incubation.

3.3

Lessons Learned

3.3.1

Cryopreservation

In the course of repeated experiments, several issues became clear. One of these concerns
was flawed cryopreservation techniques and certain preparation methods. Cryopreservation damages protein fibrils rather than preserve them due to the formation of ice
crystals (Simione, 2009; Loutradi et al., 2008). This was observed while trying image a
sample that had been previously frozen for preservation. In this sample, the lysozyme
protein fibrils were fractured and sheared into smaller segments instead of being micrometers long as normally occurs.

3.3.2

Pipetting and Vortexing

Similar uniform destruction of the long fibril protein structures occurred when pipetting
the solution after incubation. If the opening to the pipette tip is too small the solution
(or gel) with fibrils in it is forced up the pipette tip too fast during extraction. This
leads to deformed and destroyed fibrils. Also vortexing the solution (to mix it) before
pipetting destroys the fibrils. Even though these amyloid fibrils are resilient enough to
be imaged several times with an AFM cantilever, they are not capable of keeping their
full structure when handled without care.
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3.3.3

Pipetting Location

The location of the pipette submerged in the protein-buffer solution after incubation may
change the density of protein collected. Sometimes the solution inside the growth vessels
is completely gelled over with protein fibrils, and sometimes only partially. This makes
where the pipette extracts the incubated solution important depending on what needs
to be imaged. When there is too much protein the charged mica becomes smothered
with layers of protein monomers which may cover smaller structures such as fibrils. In
order to remove all this excess protein several dilutions were mad to allow the lysozyme
fibrils to be seen.

3.3.4

Growth Vessel Material

The container material in which the lysozyme aggregation occurs seems to have an effect
on fibril formation. We went through several materials for the structure of the vials.
The material needed to be easy to machine. It needed to have good enough thermal
conductivity to heat the buffer solution inside the vial to 55 ◦ C. It needed to be resistant
to reactions with the acidic buffer solution.
We initially tried stainless steel for the vial and brass for the top bushing, this
resulted in a reaction with the buffer and no fibrils were created. The internal buffer
solution turned brown and seemed to rust the metal. The buffer solution was tested
in a mass spectrometer at the biology department (data not shown) and other heavier
metallic elements were found in the solution. The pH of the solution was also measured
and found to have increased to a pH of 5.5 no longer near the desired acidic pH of 2.5.
Metal would no longer be used because of these effects.
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We knew fibrils formed inside of polypropylene Eppendorf tubes, so our next trial
was to create all the vial parts out of plastic Delrin (Polyoxymethylene) because its
thermal properties and ease of machining 2 . Delrin is still considered an insulator but
allows for more heat transfer than other machinable plastics. This also failed to create
fibrils after 30 days of lysozyme protein incubation for unknown reasons. It was tested
several times to ensure proper lysozyme-buffer preparation and incubation was followed
and the material was the reason for failure in fibril formation.
The last material we used, which was successful, was polypropylene. This is the
same material the Eppendorf tubes are made from, but we did not initially use it because
it is difficult to machine. Other materials in the future, hopefully easier to machine, for
the creation of these vials/incubation chambers will continue to be tested.

3.3.5

Epoxy

Regular temperature measurements inside the solution were needed to provide data
to the temperature control system. In order to do this a thermocouple was installed
protruding through the center of the floating piston into the interior of the vial were the
solution would be incubating. The thermocouple was teflon coated and held in position
with epoxy. Several epoxy brands were considered until a chemically inert one was found
(Scotch-Weld epoxy adhesive DP 460 Off-white). The thermocouple was epoxied to the
floating piston. Once dry this floating piston and thermocouple were tested with the
buffer solution. Over a few days the epoxy seemed to melt away because of the buffer
solution, this made it so that the thermocouple was no longer secure and the seal was
no longer air tight. No fibrils formed in this test either.
2

http://www2.dupont.com/Plastics/en_US/assets/downloads/design/DELDGe.pdf
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3.3.6

Vial Modifications

The floating piston at the bottom of the vial was given a small polypropylene cap so that
the thermocouple could be inserted very close to the buffer solution and still measure
the internal temperature. In the final design every piece of the vial in contact with the
buffer solution was made out of polypropylene.
Each piece of the vial was initially ultrasonically cleaned and then wiped down
with alcohol before drying. This cleaning method was tested and shown to not interfere
with the protein self assembly process on earth.
Several greases (or lubricants) were tested for application on to the o-rings and the
x-rings. These lubricants would reduce the static friction enough to allow the stepper
motor to push the loading piston into the buffer solution and in turn moving the solution
and floating piston downward as needed. Some of the lubricant comes in contact with
the buffer-protein solution during incubation and therefore needed to be tested to see if
it hindered or accelerated the self assembly process. Several lubricants were tested until
one brand (Krytox RFE PFPE) was found to be chemically inert to our solution. No
lysozyme fibrils were formed in the other lubricant tested
For completeness we also tested the geometry of the interior vial and whether or
not it had an affect on the self assembly process of the protein. We found there were
no significant differences during our experiments.
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3.4

Roles and Responsibilities

SABOL is a multi-departmental group that builds off of previous work and uses resources
in several laboratories. Everyone in the group has their role and responsibilities. The
ideal concentrations of chemicals and pH of the buffer solution was a group effort from
the Biology Department and our KSC lab in the Physics and Space Sciences Department
(Woodard et al., 2014; Burnett et al., 2014).
The College of Engineering with the group of students and interns listed in the
acknowledgments had the role of constructing the vials and the NanoLabs that allow
actuation, incubation, and data collection. Many prototypes had to be made and tested.
The testing for protein aggregation occurred in the KSC lab in the Physics and
Space Sciences department. Once the desired buffer solution was selected a stock buffer
solution that could be used for all testing was produced. Several vial materials were
tested until one was found to be inert with the buffer solution as stated in section 3.3.4.
Sample preparation, incubation and imaging on the AFM was conducted in the Florida
Tech Physics and Space Sciences KSC lab. Every new sample, when incubating at 55 ◦ C
to test some method or material, would have to stay in the oven for long periods of time,
sometimes up to 60 days. Because of the amount of time the imaging process takes,
two undergrads were asked to join the group and taught how to use the AFM to speed
up qualitative and quantitative analysis of the amyloid protein fibrils. Many meetings
were held over several years and the design, creation, and protein fibril analysis of the
SABOL NanoLab experiment has been a large group effort.

71

Chapter 4
NanoLab SABOL Hardware

4.1

The International Space Station Experiment

The Self Assembly in Biology and the Origin of Life (SABOL) experiment was designed
to study the growth of lysozyme fibrils in microgravity. It was carried to the International Space Station (ISS) in the Dragon capsule of the SpaceX CRS-5 mission and
returned to Earth in the same Dragon after about 32 days on board the ISS.

4.1.1

Hardware

The SABOL experiment consists of two NanoLab Modules each with 9 individual specially developed sample holders or vials. A computer-aided design (CAD) model showing
the layout of the experiment is shown in Figure 4.1. This figure shows the key components of the SABOL experiment housed within the 1U volume. Shown in the schematic
is 9 vials, actuators, aggregation mechanisms used to introduce the two substances with
each other, the custom shell, peak supports for the vials, polypropylene vials, USB
interface, as well as the side and top printed circuit boards (PCB).
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The experiment is housed in a NanoRacks 1U chassis, measuring 10 x 10 x 15 cm3 .
There are 9 vials arranged in a 3 x 3 array. Each vial has linear stepper motor actuation
mechanism, to introduce protein powder into the buffer solution, an individual heater
and thermal control system. There is a custom aluminum shell, a support structure for
the vials, and a USB connector for power. There are two printed circuit boards. The
side PCB is used to measure and control the temperature of each vial individually and
perform data acquisition. The top PCB contains the components needed to operate the
actuation mechanisms at the appropriate times. Time is based on an internal battery
powered timer to protect against ISS main power loss events.

Figure 4.1: An exploded view of the SABOL experiment. The hardware was designed to fit within the volume, mass and power constraints of a 1U NanoLab module.
There are 9 independently operated vials used to provide a range incubation times
covering the growth phase of lysozyme fibrils. The PCBs are described in section 4.2.
The actuator is described in section 4.1.2. The vials/aggregating mechanism has a
detailed cross-section and description also described in section 4.1.2.

The fully assembled SABOL hardware with the outer cover removed is shown in
Figure 4.2. All 9 linear stepper motors can be seen above the vial support structure and
3 of the insulated vials can be seen below.
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Figure 4.2: Fully assembled SABOL NanoLab with samples loaded shown just before
the outer shell was installed. All parts labeled in the previous CAD image can be seen.
The insulation and tape surrounding each vial is also seen and explained in detail in
section 4.2.

4.1.2

Actuation Mechanism

An important design element of the SABOL experiment was to ensure that the lysozyme
powder remained separated from the buffer solution until the incubation period in orbit
is initiated. Furthermore, the vials must maintain a seal at all times and not allow
air bubbles to form. The vials and all their internal components are made out of
polypropylene. Two views of a vial are shown in cross-section in Figure 4.3. The image
on the left shows a vial in the unactuated configuration, the image on the right shows
it in the actuated configuration. Each vial has two separate compartments initially
isolated from each other. One compartment, containing the buffer solution, consists of
a 22 mm diameter tube with a volume of 2.5 ml bounded on the bottom by the floating
piston and on the top by the loading piston. The other compartment consists of the
filling slot on the side of the loading piston, with just enough volume to hold 0.05 g of
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lysozyme powder. The loading piston has a threaded hole in its top that is attached to
the shaft of a linear stepper motor. Actuation occurs when the stepper motor drives the
loading piston down, uncovering the filling slot and bringing the lysozyme powder into
contact with the buffer. The floating piston reacts back to maintain a constant volume.

Figure 4.3: Cross-section of polypropylene vials before (left) and after (right) actuation. The red signifies where the protein powder is stored in the filling slot. X-rings
seal the bushing/loading piston to ensure the solution does not leak and the protein
powder is not in contact before actuation. The stepper motor is screwed into the
groove located at the top of the loading piston. When the stepper motor is activated
it pushes the loading piston down into the solution located below, allowing the dry
protein powder to come into contact with the buffer solution. The floating piston with
the thermal couple in it moves down in conjunction with the stepper motor. The heating wire, which is covered in insulation, is then turned on to bring the protein-buffer
solution to 55 ◦ C for a pre-determined time frame. The thermal couple measures the
temperature of the solution at all times while the NanoLab is plugged in.
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4.1.3

Thermal Control System

Each vial has an independent thermal control system consisting of nicrome heater wire
wrapped around each vial, a layer of insulation over the heater wire, and a thermocouple
bonded into a capped hole in the bottom of the floating piston. The control system
consists of a simple set-point regulation system T = To ± ∆T originally chosen as
To = 55◦ C and ∆T = 1.5◦ C. The 2 Watts of electrical power available to the 1U
module through its USB connector was only sufficient to run 4 of the heaters at once,
so a heating schedule was developed where no more than 4 heaters were on at a time.
This allowed incubation times to cover from 3 to 27 days in increments of 3 days. One
vial remained unheated to serve as a control.
The start of an incubation period for a given vial is implemented as follows: first
all heaters are turned off to provide enough power to run a stepper motor. The stepper
motor of the vial to be actuated is turned on, run to completion, and then turned
off. That vials heater is then turned on and heaters for the other vials still within
their incubation periods are turned back on. When the time is reached for a vials
incubation period to end, its heater is turned off. Since the heating and cooling time
constants for the vials are near an hour and the incubation time periods are days the
few minutes it takes to execute the vial actuation has negligible effect on the incubation.
The incubation time period for a given vial is determined as the time the temperature
exceeds 50 ◦ C.

4.1.4

Ground Control NanoLab

An identical ground-control (GC) NanoLab was created so that it could be run with
the same time protocols and environmental conditions as the ISS NanoLab except for
microgravity.
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4.2

NanoLab Development

As shown in Figure 4.4 the side PCB contains the components used to measure and
control temperature, as well as those to perform the data acquisition while the top PCB
contains the components necessary to implement the actuation.

Figure 4.4: (Top) Top PC board. (Bottom) Inside and outside side PC board.
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One of the most challenging engineering aspects of the SABOL experiment was
how to introduce the two substances (buffer solution and lysozyme powder) with each
other at specific times during the life of the experiment in a microgravity environment.
Each vial has two separate compartments that are initially isolated from each other
as seen in Figure 4.3. One compartment consists of a tube with a volume of 2.5 ml
that contains 2.5 ml of the buffer solution; the other compartment consists of a small
polypropylene loading piston with a slot cut into the side to hold 0.05 g of lysozyme
powder. The aggregation mechanism design, based on dual sealed pistons (sealed by
Perfluoroelastomer o-rings and x-rings), ensures that there is a minimum amount of
unused volume inside the vial thus minimizing the possibilities of air gaps. During ISS
orbital operations, each of the samples were individually activated.
The microcontroller controlled the introduction of the proteins into the buffer
solution. Temperature of the solution was measured by a thermocouple attached to the
floating piston. The floating piston has a small polypropylene cap which stuck out into
the solution so that the thermocouple could get a more accurate measurement of the
solution’s temperature. The thermocouples analog signal was converted into a digital
number using two high accuracy Sigma Delta A/D converters that interact with the
microcontroller over an SPI bus, digital conversions were then scaled to a temperature
reading, while compensating for the cold junction with SPI temperature sensors. Using
the temperature readings from the fluid, the microcontroller implemented a closed loop
PID controller on each of the vials to maintain an accurate incubating environment with
the use of nichrome coils as heating elements, controlled by Darlington transistor sink
drivers. The parameters for the the controller were determined during ground testing.
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In order to obtain a better performance from the temperature controller and meet
the power requirements of the NanoRacks platform, the vials were given several layers
of insulation (see figures 4.2 and 4.3). The first layer which is in contact with the
polypropylene vial is graphite mesh, the second layer consisted of Kapton tape, the
third layer is Silica Aerogel for insulation, the fourth layer is Kapton tape again, and
the fifth and final layer was radiation isolation made out of aluminum foil. This allowed
the buffer solution inside to reach temperatures over 50 ◦ C which is needed for protein
fibril aggregation. Without these layers of insulation the solution failed to reach desired
temperatures.
Each of the sample holders also has an independent thermal control system with
a thermocouple. When a given sample was activated its temperature was set to the
incubation temperature 55 ± 1.5 ◦ C and maintained there by a thermal control system
throughout the incubation period. In this way the aggregation period for all the samples
is varied from the maximum of 27 days to the minimum of a day or so. The power
available through the USB connectors (2 Watts) was only enough to run 4 vials at a
time so a scheduling strategy was implemented. Vial position 1 would not actuate and
heat up (control), vial positions 2 through 5 would instantly actuate and heat up to 55
◦

C. After 15 day vial position 5 would stop heating, then the actuation of vial 9 would

occur followed by the heating for incubation. 3 days later vial position 4 would switch
with vial position 8, followed by in 3 day intervals by vial position 3 for 7 then vial
position 2 for 6.
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The o-ring sealing design was implemented to ensure that there was a minimal
chance of leakage from the vials during ISS operations, but also allowed the vials to
be reopened to extract the samples for analysis upon ground recovery. Polypropylene
is also rigid so it will not bend and deform while undergoing the forces of launch and
re-entry. This was important because fibrils that formed had to be recovered in order
to perform further testing on these specimens.
On the top of the vials there is an opening where the loading piston is introduced.
This is the piston containing the lysozyme powder in a slot called the filling slot. This
approach ensures that there are minimal preparation steps for the vials and it also takes
away the need for a separate buffer tank which saved essential space. This containment
chamber is big enough to hold 0.05 grams of the protein that needed to be introduced
to the 2.5 ml of buffer solution consistent in both NanoLabs.
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Chapter 5
The ISS Flight Experiment
Two identical NanoLabs were constructed and prepared in the same way to assure
consistency within the two experimental settings with one operating on orbit and the
other in the laboratory. Figures 4.3 and 4.4 show the essential parts and their respective
names. The following two sections show a list of procedures that describes the setup of
each NanoLab after the construction of the individual pieces had been completed.

5.1

Initial Cleaning Process

1. Clean all parts for one of the NanoLabs.
2. Setup lab so that all equipment is easily accessible.
3. Each polypropylene piece will be cleaned using disinfecting soap and a scrub brush,
then thoroughly washed with water to remove any soap or grim left on the surface.
4. Every part of the NanoLab that will be in contact with the buffer solution and
lysozyme powder is cleaned with an ultrasonic cleaner. Each piece is submerged
in Deionized water and ultrasonically cleaned for 180 seconds.
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5. Each piece is then wiped down with alcohol and allowed to dry.

5.2

Preparing the Vials

Once dry, the nine polypropylene vials are constructed individually as such:

1. The X-rings are installed in the correct grooves on the loading piston and floating
piston, then greased with Krytox RFE PFPE Lubricant (chemically inert). The
grease was tested and found to be inert with our sample and fiber formation
occurred.
2. The O-rings are installed in all the correct grooves on the bushing and also greased.
3. A thermocouple is installed inside the polypropylene cap in the center of the
floating piston, with thermal paste, Loctite 770 Primer and Bondit B-4811 Reltek
adhesive (epoxy).
4. The floating piston is placed in the polypropylene vial at the bottom.
5. Enough HCl-glycine-deionized water buffer solution (around 2.5 ml) is added to
each vial to achieve a concentration of 20 mg/ml of lysozyme.
6. The lysozyme powder (as much as possible, around 50 mg) is added to the filling
slot on the outside of the loading piston.
7. The loading piston is placed inside the bushing to seal the lysozyme powder in the
filling slot.
8. The bushing with the loading piston inside it is then greased.
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9. The floating piston is pushed upward until it is 0.7 inches or 1.78 cm from the top
of the vial. This measurement is found to be the perfect position to allow most
of the buffer solution to stay in the vial when the bushing and loading piston are
pressed down to seal the vial.
10. The bushing is now pressed downward so that the O-rings create a seal at the
top of the vial. The floating piston will move downward because the solution is
incompressible. A small amount of buffer will leak at the top showing us that
there are no air bubbles in the vial before actuation.

5.3

Assembly

1. All nine stepper motors are installed into the top peak support structure.
2. Each vial has several layers that wrap around them which include:
• On the exterior of the polypropylene vial a graphite mesh will cover the
surface.
• On top, the graphite Heating Wires (made from Nicrom) will be evenly
wrapped around to ensure even heating of solution.
• Kapton Tape will be used to hold these layers in place.
• A layer of Aerogel will be cut to shape and installed on top of this tape.
• Another layer of Kapton tape will cover this Aerogel.
• Aluminum tape for a radiation barrier will be installed on top of this Kaptan
tape.
3. Each vial is now screwed into their respective stepper motor actuation arm in the
top peak support.
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4. This assembly is now be placed on the bottom peak support structure and these
supports, with nine vials and stepper motors, are now be secured by large bolts.
5. The top PCB is placed over the top of the stepper motors and screwed in place.
6. The Stepper Motors are now plugged into their respective ports on the top PCB.
7. All nine heating wires and thermocouples will be plugged into their respective
ports ( Heating Wires : middle ports, Thermocouple : side ports) on the inside
of the side PCB. The side PC Board is now installed on the front of the vial and
support structure assembly mating with the connector on the top PCB.
8. Kapton tape is wrapped around the whole vial assembly to ensure all the wires
stay in position and take up the least amount of space as possible.
9. The whole assembly (PCB, Peak Support structure, Nine Assembled Vials) is now
placed inside the aluminum shell.
10. Two outside plates seal this aluminum shell on either side. The front plate has a
hole so that the USB port may stick through it for accessibility. The rear plate
has a pressure relief valve.
11. The NanoLab was sealed with Loctite (PL Heavy Duty Sealant).
The NanoLab is now completely configured and ready for 2 Watts of power at 5
Volts to be applied through the USB port.
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5.4

Preparation and Flight

The day before experiment hand over, samples were loaded as follows: Each vial was
filled with 2.5 ml of stock buffer solution and the floating piston was pushed up bringing
the fluid level up to the top of the vial. Then dry lysozyme protein powder was placed
in the open slot of the loading piston. The loading piston was placed inside the bushing
sealing off the protein powder. The bushing with loading piston installed was then
placed at the top of the vial and inserted in a manner that sealed the buffer solution
with no air bubbles. The complete vial assembly was then threaded onto the stepper
motor shaft. This was repeated for each of the nine vials.
The fully assembled NanoLab with samples loaded is shown in Figure 4.2 just
before the outer shell was installed. After the shell was installed the NanoLab was then
placed in a protective travel case and picked by NanoRacks personnel on 12 December
2014 and delivered to Kennedy Space Center (KSC). The first launch opportunity was
delayed due to issues with the rocket and a second opportunity was scrubbed due to
weather issues. The NanoLab was placed in the Dragon capsule with the cargo for the
second opportunity and taken out once the launch was scrubbed. After these delays
the ISS NanoLab was placed inside the Dragon capsule on top of a SpaceX Falcon 9
rocket and launched into orbit from Cape Canaveral SLC-40 at 5:47 PM EST on 10
January 2015. The Dragon docked (berthed) with the Harmony module on the ISS at
9:54 AM EST on 12 Januuary 2015, the NanoLab was moved into the ISS and plugged
into the designated USB port on the NanoLab rack at 1:22 PM EST on 13 January
2015. Table 5.1 describes when the NanoLab was plugged in and unplugged. After
26 days of operation the NanoLab was unplugged and restowed in the Dragon. The
Dragon capsule detached (unberthed) from ISS at 1:11 PM EST on 10 February 2015
and splashed down in the Pacific ocean at 7:44 PM EST on 10 February 2015.
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Table 5.1: NanoLab Procedural Timeline (EST)

Action
ISS NanoLab
GC NanoLab
Total Time Elapsed
Plugged In
Jan. 13th 1:22 PM Feb. 10th 4:41 PM
0d 0h 0m
Unplugged
Feb. 8th 7:40 AM Mar. 8th 11:09 AM 25d 18h 28m
Kept at 4 ◦ C Feb. 16th 7:40 AM Mar. 14th 11:09 AM 6d 0h 0m

The ISS NanoLab was kept near 4 ◦ C from deorbit throughout splashdown, retrieval and transportation back to the Florida Tech lab. It was kept at this temperature
for an additional 6 days before being taken apart for sample extraction.
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5.5

ISS NanoLab Post-Flight Handling

The ISS NanoLab was sealed with Loctite (PL Heavy Duty Sealant) during final assembly to ensure complete containment when inside the ISS. This made the removal of the
outer shell a bit more difficult. Once this was accomplished, the memory chip containing temperature data was accessible. Figure 5.1 shows the temperature as a function of
time for all 9 vials.
Vial 1 was a control that was not heated. In it, the unheated or ambient temperature remained between 33 ◦ C and 35 ◦ C for the duration of the experiment. The
ambient temperature was a little higher than expected probably due to heating from
the other vials. Previous testing showed that fibril growth would not start until the
temperature was greater than about 40 ◦ C. Vials 2 through 9 show proper heating for
different amounts of time. As one vial turned off another vial actuated the protein into
the buffer solution. Then the vial was heated to the incubation temperature.
Next, the four bolts holding the top and bottom support structure together were removed. All nine vials were then carefully unscrewed from their stepper motors mounted
to the top support structure, being careful not to disturb the position of the loading
pistons. Each of the nine vials were placed in individual plastic bags that were labeled
with the vial’s position and then stored in a 4 ◦ C refrigerator. All the wires were unplugged. The top support could then be examined to see if the stepper motors had fully
actuated their respective loading pistons. Figure 5.2 shows that only 3 of the stepper
motor shafts had extended because of too much friction, so only 3 of the vials had
successfully actuated while in orbit aboard the ISS. They were vials 5, 6 and 8.
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Figure 5.1: ISS Vial Temperature verses Time. Temperature profiles for each of
the ISS NanoLab vials shows the time when each heater was turned on, raising the
temperature to within the aggregation range (Hill et al., 2009; Woodard et al., 2014),
held there for its incubation period and then turned off. The cycling period of each
vial can be seen. The point at which the NanoLab was unplugged is shown by all the
vial temperature readouts shutting off simultaneously. The ambient temperature of
each vial is under the incubation temperature region when off.

Figure 5.1 shows that the vial 5 heater was turned on at the beginning of the
experiment and turned off at day 15. The temperature remained at about 53 ◦ C for
the duration of its operation. It dropped to 37 ◦ C when turned off and decayed to 36
◦

C by the end of the experiment. Vial 8 heater turned on at day 18. The temperature

remained at about 51 ◦ C until the experiment was terminated at day 25.75. Vial 6 heater
was turned on at day 24. It remained at 51 ◦ C until the experiment was terminated at
day 25.75.
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Figure 5.2: Top support plate that holds the vials in place. The stepper motor
shafts stick through this support, clearly showing that only vial positions 5, 6 and 8
were actuated.

Thus these three vials provide samples with incubation times (Vial : Time) as
follows: (5 : 15 day), (8 : 7.75 day), (6 : 1.75 day).

Figure 5.3: This figure displays how the loading piston is slowly un-actuated from
inside the vial assembly.

The loading piston was carefully extracted from each vial individually, as seen in
Figure 5.3 and samples from inside these vials were collected with a 200 µl pipette and
samples for imaging were prepared. The pre-extraction positions of the loading pistons
confirmed that only 3 vials (5, 6 and 8) had actuated properly. The solution inside the
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loading piston slots of vials 5 and 8 seemed to be more viscous than the majority of
the solution inside the vial and held its postion in the slot when the loading piston was
moved, shown in Figure 5.4. The gel can bee seen protruding from the loading piston
slot after it was pulled out from the vial. A sample of the solution from the loading
piston slot was taken for vials 5 and 8. Vial 6 did not have a viscous gel in the loading
piston slot.

Figure 5.4: Following the full extraction of the loading piston, the solution inside
the vial and the gelatinous solution inside the slot of the loading piston were clearly
visible. Both solutions were sampled for imaging. Vial 5 is shown in the image.

5.6

Preparation for Data Analysis

This section describes the necessary work after the flight NanoLab is returned to the
laboratory at Florida Tech and the ground-control NanoLab is disconnect from power
from the UPS for the GC experiment. After the ISS NanoLab was shipped to our lab
from Houston Texas the process of extracting the incubated solution was the same for
both NanoLabs.

1. The NanoLabs are taken apart in the reverse order of section 5.3 but leaving the
polypropylene vials fully constructed and sealed.
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2. A screw is placed in the loading piston, this allows the loading piston to be carefully
extracted from the vial assembly (slide up and out of the bushing) leaving a large
opening in the bushing. The incubated solution is no longer sealed and can be
extracted.
3. Remembering to cut the tip of the pippette to ensure no destruction of the protein
structure a pippette is used to extract 200 µl of the incubated solution (whether
it be viscous or non-viscous) and placed into a micro-centrifuge tube.
4. This incubated lysozyme-HCl-glycine solution in the micro-centrifuge tubes is diluted (0x,10x,100x,1000x, and 10000x) and placed into more separated microcentrifuge tubes and labeled by the date and their respective dilution.
5. The undiluted and diluted samples are pipetted out of these micro centrifuge tubes
onto clean mica sheets (3 cm by 2 cm). The top layers of the sheets have been
pulled off to reveal a clean layer and it has been pre-charged with NH4.
6. After pipetting the micro-centrifuge tubes are placed into the refrigerator at 4
◦

C to insure preservation and no further aggregation of the lysozyme protein for

future sampling.
7. These mica slides are washed with Deionized water and dried to insure only the
protein is left behind stuck to the substrate.
8. Each mica slide with its respective sample is contained inside its own small petri
dish to avoid contamination. Every petri dish is labeled by the date, which vial
it came from, and dilution of the sample and placed in a plastic shelving unit for
organization.
9. Thorough imaging of the samples on these mica slides is done using an atomic
force microscope (AFM).
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10. The AFM uses a small cantilever (on the nm scale) to drag across the surface of
the mica sheet and detect atomic forces as it approaches objects on top of the flat
surface. These detections are translated into a topographical image (See section
2 for more details about the AFM).

The incubated protein-buffer solution is now prepared for analysis as discussed in
detail in chapter 7.

92

Chapter 6
The Ground-Control Experiment
The ground control (GC) NanoLab contained only 8 vials with one thermocouple suspended in the position of the missing 9th vial to measure ambient air temperature. After
the completion of assembly and sample loading of the GC NanoLab, it was plugged into a
USB converter of an uninterrupted power supply (UPS) inside the laboratory at Florida
Tech. The initial GC NanoLab plug in date was February 10th at 4:41 P.M. EST. In order to match the ISS NanoLab, the ground-control experiment was unplugged on March
8th at 11:09 AM EST as seen in table 5.1. The GC NanoLab was then cooled to 4◦ C
and kept at that temperature for 6 days to match the conditions of the ISS NanoLab.
Removing the GC NanoLab from the refrigerator, the dissassembly proceeded in
the same way as for the ISS NanoLab as stated in section 5.5. Here 7 out of 8 vials
actuated in the GC NanoLab, one failed due to too much friction. Each vial was placed
in a labeled bag and placed back in the refrigerator. 200 µl of the sample was extracted
from each vial then prepared for imaging.
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Figure 6.1: Temperature profile of each vial within the GC NanoLab. When each
heating wire was turned on raising the temperature to within the aggregation range
(Hill et al., 2009; Woodard et al., 2014) is clearly shown. The bold lines represent
the temperature profiles from the vials that incubated periods of time close to the 3
that fully actuated in the ISS NanoLab. These 3 vials were used for comparison. The
NanoLab was unplugged after 25 days and 18 hours of continual use.

The dry protein once introduced to the buffer solution spread through the solution entirely and left no residual viscous opaque gel behind in the slot of the loading
piston. Just like in the ISS NanoLab the heater control circuit in the GC NanoLab kept
the solution inside each vial near the set-point temperature of 54 ◦ C ± 1.5 ◦ C for its
incubation time.
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Figure 6.1 shows the temperature as a function of time for all vials of the GC
NanoLab. The actuation and heating times were accidentally inverted in this GC
NanoLab as seen in Figure 6.1. Most of the vials in the GC NanoLab reached the
incubation temperature except vial 7. The ambient air temperature inside the GC
NanoLab was between 30 ◦ C and 35 ◦ C. For comparison with the ISS NanoLab, the
following GC NanoLab vials with the similar incubation times can be used (9 : 13.75
day), (4 : 9 day), (2 : 3 day).
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Chapter 7
Results of ISS and GC Experiments

7.1

Results

Slides for AFM imaging were prepared, as described earlier in chapter 3, using solution
taken from the three ISS NanoLab vials that actuated properly: vials 5, 6 and 8. A full
set of sample slides, including undiluted through 1000:1, were prepared from each.
Figure 7.1 shows an AFM image of undiluted solution taken from the large interior
portion where most of the solution was held in the ISS NanoLab vial 8. This sample
was incubated in microgravity for 7.75 days at 51 ◦ C. A 5 µm FOV was chosen for this
AFM image because it best illustrates the features of the fibrils formed. There is a clear
difference between the lysozyme fibrils seen here and those seen routinely in samples
incubated in ground-based laboratories, see for example Figure 1.10. The fibrils shown
in this image, formed in microgravity on ISS, are shorter, straighter and thicker (larger
diameter) than samples formed in the laboratory.
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Figure 7.1: Lysozyme amyloid protein fibrils. The pseudo-color represents difference
in height. ISS vial 8, 7.75 days of incubation, 5 µm by 5 µm FOV.

The fibrils normally formed in the laboratory, like those in Figure 1.10, use a
significantly different vial shape and protein powder mixing system. To determine if
this change in fibril morphology could be attributed to the more complex process of
actuation or significantly different geometry of the vials, a complete set of slides for
AFM imaging were prepared using solution taken from the three GC NanoLab vials
with closely matching incubation times: vials 2, 4 and 9, to create our three incubation
groups. Incubation group 1 is ISS vial 6 incubated for 1.75 days versus the GC vial 2
incubated for 3 days. Incubation group 2 is ISS vial 8 incubated for 7.75 days versus
the GC vial 4 incubated for 9 days. Incubation group 3 is ISS vial 5 incubated for 15
days versus the GC vial 9 incubated for 15 days.
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AFM images of the lysozyme solution from both the GC and the ISS settings show
the gradual steps of self-organization that lysozyme undergoes. Comparing these images
shows the differences in lysosyme aggregation between the two settings at three crucial
stages of fibril formation: nucleation, fibril formation, and the formation of soft gel.
The three vials that properly actuated in the flight NanoLab are compared to the GC
samples which were incubated near the same amount of time. There was a small time
offset due to the sample schedule being reversed between the ISS and GC experiments.
This small time difference does not have much of an impact on fibril morphology.
These images are used to see the changes of protein aggregation over time and
compare the ISS and GC environments. Some defining characteristics can only be seen
when the FOV is decreased and a closer view is seen. The images in sections 7.1.1, 7.1.2,
and 7.1.3 show successive decreasing FOV’s to show these differences.
The density of protein that is extracted from the vials after incubation is highly
dependent on the location of the pipette tip while extracting and the non-uniformity of
protein concentration throughout the protein buffer solution. When too much protein is
extracted there is a protein layer which adheres to the mica substrate either covering or
surrounding protein structures. This made it difficult to see smaller protein structures
and characteristics covered by the blanket of protein molecules. In order to counteract
this a higher dilution of the sample is sometimes used to remove the protein layer to
better see the definition of the fibrils without changing their morphology.
Figures 7.1, 7.4, and 7.7 in the following section compare ISS samples in the left
column to the GC samples in the right column with the same FOV and similar incubation
times. Because of the slight differences in time we created 3 distinct incubation groups.
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7.1.1

Incubation Group I

Figure 7.1 shows the difference in protein aggregation, at around 2 days, between the
flight NanoLab and the GC NanoLab. The left images show protein which self-assembled
in microgravity. Many large colloidal aggregates formed in microgravity which was not
seen in the GC sample. These protein aggregates or nucleation units are uniformly
spread out through the mica slide and are ≈2.2 nm in height on average. The GC
sample already show long helical lysozyme fibrils interacting with each other. These
fibrils in the GC sample are not very tall, as seen in Figure 7.2, or wide and seem to be
fibrils formed by lysozyme monomers. A higher dilution had to be used to remove the
protein layer and reveal the fibrils of the GC sample.
Figure 7.2 shows an overplotted histogram of the average measured heights of the
biological features for both the GC and ISS samples in incubation group I. Both the
aggregates in the ISS samples and the lysozyme fibrils in the GC samples were measured
3 times to give an average height value. The ISS grand average (average of the average
values) height is 2.2 nm with a standard deviation of 0.8 nm. The GC grand average
height is 2.3 nm with a standard deviation of 1.0 nm.
The lines represent a probability distribution function (PDF) using a gamma fit.
A gamma fit was chosen because it displayed a better overall fit than other PDFs. The
gamma distribution is based off of two parameters to create a continuous probability
distribution. These parameters are the shape parameter (k) and the scale parameter
(θ). In this version of the shape-scale gamma PDF the x > 0 and k, θ > 0 must hold
(Papoulis and Pillai, 2002). Γ is the gamma function represented by Γ(n) = (n − 1)!
where n represents a positive integer. The scale parameter was standardized and set
to 1 while the shape parameter was altered until the PDF fit the data. There is an
additional parameter called the location parameter which shifts the PDF left or right
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(a)

(b)

(c)

(d)

on the x-axis. These parameters where run through a scipy.stats.gamma fit command
in Python until the ideal parameters were found. Equation 7.1 represents the simplified
standard gamma PDF that was used to create the lines to guide the eye in all the
following histogram figures.

x

xk−1 e− θ
xk−1 e−x
f (x; k, θ) = k
=⇒ f (x, k) =
θ Γ(k)
Γ(k)

100

(7.1)

(e)

(f)

(g)

(h)

Figure 7.1: Comparison between ISS and GC fibrils with about the same incubation
time (3 Days) and different FOVs to see large and small differences in fibril morphology. (a) ISS, 2 days of incubation. No dilution. 20 µm by 20 µm FOV. (b) GC, 3 days
of incubation. 100x dilution. 20 µm by 20 µm FOV. (c) ISS, 2 days of incubation.
No dilution. 10 µm by 10 µm FOV. (d) GC, 3 days of incubation. 100x dilution. 10
µm by 10 µm FOV. (e) ISS, 2 days of incubation. No dilution. 5 µm by 5 µm FOV.
(f) GC, 3 days of incubation. 100x dilution. 5 µm by 5 µm FOV. (g) ISS, 2 days of
incubation. No dilution. 2 µm by 2 µm FOV. (h) GC, 3 days of incubation. 100x
dilution. 2 µm by 2 µm FOV.
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Figure 7.2: The height of the lysozyme fibrils were measured 3 times each in a
different location on the fibril and then averaged. This graph shows a histogram of
each average height measurement of the lysozyme fibrils adhered to the mica. In 1-g
the height of each nucleation unit formed was also taken three times and averaged to
display a histogram of average heights in microgravity for Incubation Group I. For the
ISS images the largest aggregates where outliers and where not included in the height
measurements. The average height and standard deviation were calculated directly
from the data. The lines represent a gamma fit to the histograms and are meant to
guide the eye.

Figure 7.3 shows an overplotted histogram of the average measured widths of the
biological features for both the GC and ISS samples in incubation group I. Both the
aggregates in the ISS samples and the lysozyme fibrils in the GC samples were measured
3 times to give an average width value. The ISS grand average (average of the average
values) width is 19.9 nm with a standard deviation of 5.6 nm. The GC grand average
width is 33.5 nm with a standard deviation of 6.2 nm.
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Figure 7.3: The width of the lysozyme fibrils were measured 3 times each in a
different location on the fibril and then averaged. This graph shows a histogram
of each average width measurement of the lysozyme fibrils adhered to the mica in
microgravity and in 1-g for Incubation Group I. The average width and standard
deviation were calculated directly from the data. The lines represent a gamma fit to
the histograms and are meant to guide the eye.

Figure 7.4 displays the lengths of the lysozyme fibrils formed in the GC sample
for Incubation Group I. The majority of the fibrils had a length greater than the field
of view and were labeled as 5 µm. The FOV of 5 µm by 5 µm was chosen because
it was ideal for finding and measuring the heights and widths of the individual fibrils.
However, this chosen FOV was too small to see the full lengths of the majority of GC
fibrils. Determining the length of each individual fibril was not possible sometimes either
due to merging with other fibrils, wrapping around other fibrils, losing the fibril in the
protein background, or the lengths outgrowing even increased FOVs. Because of these
reasons the length measurements were not prioritized and the 5 µm by 5 µm FOV was
used for fibril measurements to increase accuracy of height and width measurements.
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Figure 7.4: This graph shows a histogram of the average lengths lysozyme fibrils
formed in 1-g for Incubation Group I. The FOV chosen for measurements was 5 µm
by 5 µm so any fibril exceeding the FOV was cataloged and labeled as 5 µm.

7.1.2

Incubation Group II

Figure 7.4 shows the difference in protein aggregation at around 9 days between the flight
NanoLab and the GC NanoLab. The left images show protein which self-assembled in
microgravity versus in the GC NanoLab on the right. The fibrils formed in microgravity
are very short and thick. The uniformity of the fibril length suggests that they were not
sheared by ice crystals if the refrigerated packaging for travel got below 0 ◦ C, unless all
the fibrils were sheared at very similar lengths which seems unlikely. The GC sample
shows long helical lysozyme fibrils interacting with each other. The fibrils formed in
the GC sample are long, helical and thick which is a sign of fibrils wrapping around
each other, as seen in Figure 7.5. The 20 µm by 20 µm FOV for the GC sample shows
an artifact of washing and drying mica slides that can happen if too much nitrogen
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gas is used to dry the sample. When too much gas is applied the fibrils tend to reorient themselves on the mica along the path of applied nitrogen gas. A 10x dilution is
used for the ISS sample to remove the protein layer which sometimes covers the protein
structures. A list of major differences at this incubation group:

• The thickness, including height and width, of the fibrils formed in microgravity
are larger as seen in figures 7.5 and 7.6.
• The lengths of the fibrils formed in microgravity are shorter as seen in figure 7.7.
• Helicity is still present in the fibrils formed in microgravity but not to the same
degree as the fibrils formed in the GC setting. This was determined by an observation of fibrils displaying repeating sinusoidal shapes along with winding around
each other as shown in figure 7.4.

Figure 7.5 shows an overplotted histogram of the average measured heights of
the biological features for both the GC and ISS samples in incubation group II. Both
lysozyme fibrils in the GC and ISS samples were measured 3 times to give an average
height value. The ISS grand average (average of the average values) height is 5.8 nm
with a standard deviation of 1.8 nm. The GC grand average height is 2.6 nm with a
standard deviation of 0.8 nm.
Figure 7.6 shows an overplotted histogram of the average measured widths of
the biological features for both the GC and ISS samples in incubation group II. The
lysozyme fibrils in the GC and ISS samples were measured 3 times to give an average
width value. The ISS grand average (average of the average values) width is 35.3 nm
with a standard deviation of 5.9 nm. The GC grand average width is 27.3 nm with a
standard deviation of 5.7 nm.
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Figure 7.7 displays the length of the lysozyme fibrils formed in the GC and ISS
samples for Incubation Group II. The majority of the fibrils for the GC sample had a
length greater than the field of view and were labeled as 5 µm. The ISS average fibril
length was 0.5 µm with a standard deviation of 0.3 µm.
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Figure 7.4: Comparison between ISS and GC fibrils with about the same incubation
time (9 Days) and different FOVs to see large and small differences in fibril morphology. (a) ISS, 8 days of incubation. 10x dilution. 20 µm by 20 µm FOV. (b) GC, 9
days of incubation. No dilution. 20 µm by 20 µm FOV. (c) ISS, 8 days of incubation.
10x dilution. 10 µm by 10 µm FOV. (d) GC, 9 days of incubation. No dilution. 10
µm by 10 µm FOV. (e) ISS, 8 days of incubation. 10x dilution. 5 µm by 5 µm FOV.
(f) GC, 9 days of incubation. No dilution. 5 µm by 5 µm FOV. (g) ISS, 8 days of
incubation. No dilution. 2 µm by 2 µm FOV. (h) GC, 9 days of incubation. No
dilution. 2 µm by 2 µm FOV.
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Figure 7.5: The height of the lysozyme fibrils were measured 3 times each in a
different location on the fibril and then averaged. This graph shows a histogram
of each average height measurement of the lysozyme fibrils adhered to the mica in
microgravity and in 1-g for Incubation Group II. The average height and standard
deviation were calculated directly from the data. The lines represent a gamma fit to
the histograms and are meant to guide the eye.
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Figure 7.6: The width of the lysozyme fibrils were measured 3 times each in a
different location on the fibril and then averaged. This graph shows a histogram
of each average width measurement of the lysozyme fibrils adhered to the mica in
microgravity and in 1-g for Incubation Group II. The average width and standard
deviation were calculated directly from the data. The lines represent a gamma fit to
the histograms and are meant to guide the eye.
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Figure 7.7: This graph shows a histogram of the average lengths lysozyme fibrils
formed in 1-g for Incubation Group II. The FOV chosen for measurements was 5 µm
by 5 µm so any fibril exceeding the FOV was cataloged and labeled as 5 µm.
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7.1.3

Incubation Group III

Figure 7.7 shows the difference in protein aggregation at around 15 days between the
flight NanoLab and the GC NanoLab. The left images show protein which self-assembled
in microgravity versus in the GC NanoLab on the right. The fibrils formed in microgravity are very short and thick. The uniformity of the fibril length suggests that they
were not sheared by ice crystals if the refrigerated packaging for travel got below 0 ◦ C.
The GC sample show many long helical lysozyme fibrils interacting with each other.
The fibrils formed in the GC sample are long, helical and thick which is a sign of fibrils
wrapping around each other, as seen in Figure 7.8. The GC sample is at the point where
the protein buffer solution starts to turn into a soft gel. A list of major differences in
this incubation group:

• The thickness, including height and width, of the fibrils formed in microgravity
are larger as seen in figures 7.8 and 7.9.
• The lengths of the fibrils formed in microgravity are shorter as seen in figure 7.10.
• Helicity is still present in the fibrils formed in microgravity but not to the same
degree as the fibrils formed in the GC setting. This observation was made by
looking at figure 7.7 and seeing a repeating sinusoidal pattern along some fibrils
as they wind around each other.

Figure 7.8 shows an overplotted histogram of the average measured heights of the
biological features for both the GC and ISS samples in incubation group III. Both the
lysozyme fibrils in the GC and ISS samples were measured 3 times to give an average
height value. The ISS grand average (average of the average values) height is 4.8 nm
with a standard deviation of 1.6 nm. The GC grand average height is 2.7 nm with a
standard deviation of 0.9 nm.
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Figure 7.9 shows an overplotted histogram of the average measured widths of
the biological features for both the GC and ISS samples in incubation group III. The
lysozyme fibrils in the GC and ISS samples were measured 3 times to give an average
width value. The ISS grand average (average of the average values) width is 34.7 nm
with a standard deviation of 7.8 nm. The GC grand average width is 28.6 nm with a
standard deviation of 4.0 nm.
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Figure 7.7: Comparison between ISS and GC fibrils with about the same incubation
time (15 Days) and different FOVs to see large and small differences in fibril morphology. (a) ISS, 15 days of incubation. No dilution. 20 µm by 20 µm FOV. (b) GC,
13.75 days of incubation. No dilution. 20 µm by 20 µm FOV. (c) ISS, 15 days of
incubation. No dilution. 10 µm by 10 µm FOV. (d) GC, 13.75 days of incubation.
No dilution. 10 µm by 10 µm FOV. (e) ISS, 15 days of incubation. No dilution. 5 µm
by 5 µm FOV. (f) GC, 13.75 days of incubation. No dilution. 5 µm by 5 µm FOV.
(g) ISS, 15 days of incubation. No dilution. 2 µm by 2 µm FOV. (h) GC, 13.75 days
of incubation. No dilution. 2 µm by 2 µm FOV.

Figure 7.10 displays the length of the lysozyme fibrils formed in the GC and ISS
samples for Incubation Group III. The majority of the fibrils for the GC sample had a
length greater than the field of view and were labeled as 5 µm. The ISS average fibril
length was 1.5 µm with a standard deviation of 1.2 µm.
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Figure 7.8: The height of the lysozyme fibrils were measured 3 times each in a
different location on the fibril and then averaged. This graph shows a histogram
of each average height measurement of the lysozyme fibrils adhered to the mica in
microgravity and in 1-g for Incubation Group III. The average height and standard
deviation were calculated directly from the data. The lines represent a gamma fit to
the histograms and are meant to guide the eye.
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Figure 7.9: The width of the lysozyme fibrils were measured 3 times each in a
different location on the fibril and then averaged. This graph shows a histogram
of each average width measurement of the lysozyme fibrils adhered to the mica in
microgravity and in 1-g for Incubation Group III. The average width and standard
deviation were calculated directly from the data. The lines represent a gamma fit to
the histograms and are meant to guide the eye.
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Figure 7.10: This graph shows a histogram of the average lengths lysozyme fibrils
formed in 1-g for Incubation Group III. The FOV chosen for measurements was 5 µm
by 5 µm so any fibril exceeding the FOV was cataloged and labeled as 5 µm.
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7.2

Quantitative Analysis

Figure 7.11: Mosaic of images of lysozyme fibrils formed on the ISS in microgravity
versus lysozyme fibrils formed in the GC under the effects of gravity. Incubation time
of each vial is given. The image FOV is the same for incubation group comparison.

Several images were made from the solution in each of the three ISS vials and
three GC vials. Figure 7.11 shows a representative image from each vial. The images
on the left are the ISS formed fibrils, those on the right are the GC formed fibrils. The
incubation times in days are shown for each image.
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This set of images shows a clear morphological difference between the fibrils formed
in microgravity on ISS and those formed in the ground-control, earth based laboratory.
By 1.75 days of incubation the ISS images show no fibril formation but numerous small
isolated structures. By 3 days of incubation the GC images show fully formed fibrils
already longer than the 5 µm FOV. By 7.75 days of incubation, the ISS fibrils had formed
but they were relatively short (significantly less than the 5 µm FOV) and straight. By
9 days of incubation the GC fibrils were fully formed mature fibrils. By 15 days of
incubation, the ISS fibrils show continued growth with some fibrils almost as long as
the 5 µm FOV. By 13.75 days of incubation, the GC fibrils show continued formation
of long thin complex structures.
One difference in the fibril structure not obvious in these images is that the ISS
microgravity formed fibrils consistently appear about twice as thick as the GC formed
fibrils. This could be seen in higher magnification images with a 2 µm FOV. To quantify
this difference, the average height and width of the fibrils was determined.
Using the PicoView v1.12 software, and several images from each ISS and GC
incubation group, a trace was made perpendicular to every accessible fibril at 3 separate
places on each fibril. The height and width was determined from the trace at these 3
locations and averaged to give a height and width for that fibril. All together there
were 18 ISS images giving 513 fibril measurements and 14 GC images giving 232 fibril
measurements.
The height measurements related directly to fibril diameter using the calibration
shown earlier in Figure 2.24. The width measurements are less reliable since the radius
of curvature of the AFM tip is ≈10 nm, several times the width of the fibrils.
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Figure 7.12: A mosaic of the heights of protein fibrils formed on the ISS in microgravity versus protein fibrils formed in the GC under the effects of gravity in order
of Incubation Group. Note that the ISS average height measurements for Incubation
Group I are aggregates and not fibrils.
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Figure 7.12 shows a frequency distribution plot of fibril diameters for each of the
three similar incubation times with the exception of the ISS set in Incubation Group
I. The upper figure is for the incubation period of about 2 to 3 days. The average
diameters of the ISS and GC fibrils are DISS = 2.9 ± 1.0nm and DGC = 3.0 ± 1.3nm
respectively. The average diameter and standard deviation are calculated directly from
the data and not the gamma-fit trend line which is used to guide the eye. So at this
stage the diameters are the same within the experimental error. It should be noted
however that at this stage the ISS images showed only small isolated structures and
no fibrils. Equation 7.2 shows the percent difference equation used to compare the
calibrated isolated lysozyme structures and the average fibril diameters formed on earth
for Incubation Group I.

%Dd ISSvsGC =

|dISS − dGC |
|2.9nm − 3.0nm|
∗ 100% =
∗ 100% = 3%
dISS
2.9nm

(7.2)

The middle image of figure 7.12 is for the incubation time of about 8 to 9 days.
The average diameters of the ISS and the GC fibrils are DISS = 7.5 ± 2.3nm and
DGC = 3.4 ± 1.0nm respectively. This shows that ISS fibrils have about twice the
diameter as GC fibrils. Equation 7.3 shows the percent difference equation used to
compare the calibrated average fibril diameters formed in microgravity vs on earth for
Incubation Group II.

%Dd ISSvsGC =

|dISS − dGC |
|7.5nm − 3.4nm|
∗ 100% =
∗ 100% = 55%
dISS
7.5nm
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(7.3)

The lower image of figure 7.12 is for the incubation period of about 14 to 15
days. The average diameters of the ISS and GC fibrils are DISS = 6.2 ± 2.0nm and
DGC = 3.6 ± 1.1nm respectively. Again the ISS fibrils have about twice the diameter of
the GC fibrils. Equation 7.4 shows the percent difference equation used to compare the
calibrated average fibril diameters formed in microgravity vs on earth for Incubation
Group III. The percent difference of the height values for each Incubation Group is
summarized in table 7.1.

%Dd ISSvsGC =

|6.2nm − 3.6nm|
|dISS − dGC |
∗ 100% =
∗ 100% = 42%
dISS
6.2nm

(7.4)

Table 7.1: Percent difference of average fibril diameter of ISS fibrils and GC fibrils
for Incubation Groups II and III. Also shown is the percent difference between the
GC fibrils formed and the aggregates formed in the ISS vial for Incubation Group I.

Incubation Group I : ISS vs GC
Incubation Group II : ISS vs GC
Incubation Group III : ISS vs GC

3%
55%
42%

Figure 7.13 shows a frequency distribution plot of fibril widths for each of the
three similar incubation Groups with the exception of the ISS set in Incubation Group
I which displayed aggregates. The upper figure compares widths for Incubation Group
I. The average widths of the ISS aggregates and GC fibrils are wISS = 19.9 ± 5.6nm
and wGC = 33.5 ± 6.2nm respectively. The average width and standard deviation are
calculated directly from the data and not the gamma-fit trend line which is used to
guide the eye. It should be noted however that at this stage the ISS images showed
only small isolated structures and no fibrils. Extremely large structures were not as
common and treated as outliers. Equation 7.5 shows the percent difference equation
used to compare the isolated lysozyme structures and the average fibril widths formed
on earth for Incubation Group I.
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Figure 7.13: A mosaic of the average widths of protein fibrils formed on the ISS
in microgravity versus protein fibrils formed in the GC under the effects of gravity
in order of Incubation Group. Note that the ISS average width measurements for
Incubation Group I are aggregates and not fibrils.
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%Dw ISSvsGC =

|19.9nm − 33.5nm|
|wISS − wGC |
∗ 100% =
∗ 100% = 68%
wISS
19.9nm

(7.5)

The middle image of figure 7.13 is a comparison of fibril widths in the two environments for Incubation Group II . The average widths of the ISS and the GC fibrils
are wISS = 35.3 ± 5.9nm and wGC = 27.3 ± 5.7nm respectively. Equation 7.6 shows the
percent difference equation used to compare the calibrated average fibril widths formed
in microgravity vs on earth for Incubation Group II.

%Dw ISSvsGC =

|wISS − wGC |
|35.3nm − 27.3nm|
∗ 100% =
∗ 100% = 23%
wISS
35.3nm

(7.6)

The lower image of figure 7.13 is a comparison of fibril widths for the Incubation
Group III. The average widths of the ISS and GC fibrils are wISS = 34.7 ± 7.8nm and
wGC = 28.6 ± 4.0nm respectively. Equation 7.7 shows the percent difference equation
used to compare the calibrated average fibril widths formed in microgravity vs on earth
for Incubation Group III. The percent difference of the width values for each Incubation
Group is summarized in table 7.2.

%Dw ISSvsGC =

|wISS − wGC |
|34.7nm − 28.6nm|
∗ 100% =
∗ 100% = 18%
wISS
34.7nm
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(7.7)

Table 7.2: Percent difference of average fibril width of ISS fibrils and GC fibrils for
Incubation Groups II and III. Also shown is the percent difference in width between
the GC fibrils formed and the aggregates formed in the ISS sample for Incubation
Group I.

Incubation Group I : ISS vs GC
Incubation Group II : ISS vs GC
Incubation Group III : ISS vs GC

68%
23%
18%

Figure 7.14 shows a comparison frequency distribution plot of fibril lengths for each
of the three similar Incubation Groups with the exception of the ISS set in Incubation
Group I only displayed aggregates. The upper figure compares lengths for Incubation
Group I. The average length vlaue of the GC fibrils is not physically accurate because
fibrils larger than the FOV of 5 µm where all placed in the length bin.
The middle image of figure 7.14 is a comparison of fibril lengths in the two environments for Incubation Group II . The average length of the GC fibrils are again not
physical because they went beyond the FOV. The average length of the ISS fibrils is
lISS = 0.5 ± 0.3µm.
The lower image of figure 7.14 is a comparison of fibril lengths for the Incubation
Group III. The average lengths of GC fibrils is again not a physically correct because
the fibrils were larger than the FOV chosen for measurements. The average length of
the ISS fibrils is lISS = 1.5 ± 1.2µm.

124

Figure 7.14: A mosaic of the lengths of protein fibrils formed on the ISS in microgravity versus protein fibrils formed in the GC under the effects of gravity in order
of Incubation Group. Note that there are no ISS length measurements for Incubation
Group I because no fibrils formed.
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Chapter 8
Changing Initial Lysozyme
Concentration Before Incubation

8.1

Background

The SABOL experiment shows a difference in the morphology including height, width
and length of lysozyme fibrils grown in microgravity and in ground-control. We investigate a possible cause for this difference in morphology, an unintended change in initial
protein concentration during incubation of the lysozyme and the fibril formation process.
This concentration difference may have been altered by a different dissolution process
of the protein in buffer solution in the microgravity setting. The dissolution process
occurs in a number of steps before the solute is fully dissolved in the buffer solution
which include; contact with solution, wetting, submerging, dispersing and dissolving
(Schubert, 1993). In this dissertation these dissolution steps are grouped into two more
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general categories of wetting (contact, wetting and submerging) and diffusion (dispersing and dissolving) of the lysozyme in buffer solution. Changes in these processes due
to differences in gravity may lead to a difference in initial concentration of protein in
buffer solution at the time of fibril formation in the two gravitational environments.
In this experiment a dry lysozyme protein powder comes in contact with a buffer
solution. A common technique to measure wetting is to place the protein powder on the
liquid surface and measure the time it takes for all particles to sink below the surface
or show a wetted appearance (Börjesson et al., 2013). This was done in the lab and we
found that the amount of protein powder used dissolved in minutes. But for a more
technical approach a model is needed to show the kinetics of the individual powder
particles. The dissolution rate can be written generally as equation 8.1 (Cussler et al.,
1984; Börjesson et al., 2013) shows.

N = k(Csurf ace − Cbulk )

(8.1)

Where (N) is the dissolution rate form a particle and (C) represents concentration.
This equation assumes a stationary solution. The difference in concentration (∆C)
between the dissolving surface (protein powder particles) and the bulk liquid (buffer
solution) is the driving force of dissolution (Börjesson et al., 2013). (k) represents the
dissolution coefficient and consists of the sum of the resistances. These resistances
represent the energy demanded to break the crystalline structure of the protein during
the dissolution process and the transport of these molecules through the bulk solution
(Hsu and Liu, 1993; Nicklasson et al., 1983; Börjesson et al., 2013). The work or energy
that is required to breakdown larger structures to individual particles or aggregates in
the dissolution process is effected by heat, mixing and the flow of the solution (Forny
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et al., 2011). Because of different gravitational environment and the lack of fluid flow
from convection, microgravity affects the protein dissolution process from the initial
contact to transport through solution. The importance of this potential change in
initial protein concentration during fibril formation is discussed further in this chapter.

8.2

Dissolution of Lysozyme

An array of initial protein concentrations was made on earth to investigate how the fibril
morphology changes, and to see if similar values of height, width and length to fibrils
formed in microgravity could be obtained. As soon as dry lysozyme protein powder
is in contact with the buffer solution the dissolution process begins. Dissolution can
be broken up into two parts, wetting and diffusion. First, the lysozyme goes through
a wetting process then spreads out near the surface of the buffer solution. Next, the
lysozyme begins to diffuse through the buffer solution. Both these processes are affected
by the microgravity environment. Contact angle can change the surface tension of the
buffer solution which may lead to a change in the wetting of the protein powder. And the
lack of convection and current flow in solution leaves the transport of protein through
solution in a diffusion-limited system.

8.2.1

Wetting (Work of Adhesion and Cohesion)

To create the mixture of protein-buffer solution before incubation a solute powder
(lysozyme) is injected into a liquid solvent (buffer solution). Wetting, when the liquid is in contact with a solute’s surface, allows intermolecular forces to occur between
the lysozyme and the buffer solution and is the initial stage of dissolution.
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Wetting of a solute by the solvent can be hindered, slowing down the dissolution
process. For example: if air pockets are trapped inside the powder this can slow down the
ability of the powder to come in contact with the solvent. Physical contact is important
for interfacial interactions to occur. The ability of a solvent to wet a solute is dependent
on surface tension (Remington, 2006). One method of determining surface tension
values is with Young’s Equation (8.2) (Zisman, 1964; Israelachvili, 2011; Remington,
2006; Bonn et al., 2009) which describes how likely a solute will be wetted and then
ultimately dissolved.

γ S = γ S + γ L cos θ
A

L

(8.2)

A

Where (γ S ) is the surface tension of the solid-air boundary, (γ S ) is the surface
A

L

tension of the solid-liquid boundary, (γ L ) is the surface tension of the liquid-air boundA

ary, and (θ) is the contact angle between solid and liquid (hydrophilic if θ < 90 and
hydrophobic if θ > 90).

F
U
γ∼
=
= 2 ∼
2a
L

(8.3)

Where (U) is the cohesion energy, (a) is the exposed contact area, (F) is the
cohesive force and (L) is the length. U ∼
= kT for any van der Waals interactions in
solution. Surface tension can have units of mJ/m2 or N/m.
For dissolution the solvent needs to spread over the surface of the solute. This
process can be described with the Spreading Equation (8.4) (Zisman, 1964; Bonn et al.,
2009) where (S) is the spreading coefficient.

S = γ L (cos θ − 1)
A
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(8.4)

Figure 8.1: This image shows (A) the work of adhesion between solid and liquid and
(B) the work of cohesion for a liquid (Remington, 2006).

For the system in this experiment, solid-liquid, the forces that dominate the wetting process are adhesion and cohesion. The solid solute (lysozyme) has to be fully
wetted before the liquid can dissolve it. The solid is in contact with the liquid, so the
interaction energy between the solid and the liquid can be defined using intefacial free
energy or surface tension (γ S ) (Remington, 2006). Adhesive work is proportional to
L

the solid and liquid surface tensions, minus the solid-liquid interfacial tension as seen in
Figure 8.1. Equation 8.5 shows the work of adhesion is the amount of energy it takes to
separate the liquid from the solid (Zisman, 1964; Israelachvili, 2011; Bonn et al., 2009).

WAdhesion = γ L + γ S − γ S
A

A

(8.5)

L

The liquid (buffer solution) is in contact with itself. The energy between the liquid
and liquid interface is expressed by the work of cohesion. When separating the liquid
from itself two liquid-air interfaces are created each with the surface tension (γ L ). The
A

interfacial tension before separation does not exist (Remington, 2006). Equation 8.6
shows the energy of cohesion can then be described by:

WCohesion = γ L + γ L = 2γ L
A
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A

A

(8.6)

Wetting by spreading a liquid over a solid can occur when the work from the
adhesive force exceeds the work from the cohesion. Equation 8.7 shows if the forces of
like molecules are less than that of different molecules spreading is then favored (Zisman,
1964).

WAdhesion > WCohesion

(8.7)

When spreading occurs the spreading coefficient is positive therefore the spreading
equation can be altered to look like (Remington, 2006):.

S = WAdhesion − WCohesion = γ L + γ S − γ S − 2γ L ⇒ S = γ S − γ L − γ S
A

A

L

A

A

A

L

(8.8)

In order to increase the likelihood of the liquid (buffer solution) spreading over
the solute (lysozyme) through wetting, both γ L and γ S must be minimized. Once the
A

A

wetting of the solute (lysozyme) occurs the rest of the dissolution process can proceed
with diffusion (Remington, 2006).
The buffer solution is predominately water and if we use this generalization we can
visualize what would happen once the loading piston was actuated (see figure 8.2). The
contact angle for internal vial material polypropylene is θ = 102.1 degrees with a critical
surface tension of 30.5 mJ/m2 (units of surface energy)

1

and is therefore hydrophobic.

The vial may not have been completely devoid of air bubbles from the initial setup
1

https://www.accudynetest.com/polytable_03.html?sortby=cst
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procedure and/or there could have been a sufficient amount of air in the filling slot with
the loosely packed protein powder. If either of these were the case, then the air would
have created a small film encompassing the interior of the vial. Some of this air may
have trapped the protein powder slowing down the dissolution process.

Figure 8.2: Hand drawn scenario of loading piston after actuation. The protein
powder comes in contact with the solution and begins the dissolution process. The
loading piston, along with the rest of the interior of the vial, is made out of polypropylene. Polypropylene is hydrophobic. Because of this a thin layer of the air which came
with the loosely packed lysozyme powder in the filling slot may have create a thin
film engulfing the interior of the vial.

The material of the vial might be factor in the lysozyme fibril growth. Delrin
(polyoxymethylene) was initially used to create the vial and failed to create fibrils. The
contact angle for delrin is θ = 76.8 degrees with a critical surface tension of 37.0 mJ/m2
2

making it hydrophilic. The lysozyme-buffer solution may need to be housed in a

hydrophobic vessel like polypropylene to encourage fibril formation. The layer of air
may have hindered this contact.
2

https://www.accudynetest.com/polytable_03.html?sortby=cst
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A changing or dynamic contact angle and interfacial contact regions in microgravity may also alter the spreading function and wettability as noted in equation 8.4.
Consider microgravity making is so surface tension is the only dominant force which
controls the shape of the liquid in the growth vessel. If the vessel is symmetric the fluid
inside will create a spherical shape in order to decrease the surface tension potential
energy. In reality there are several factors that change the shape of the fluid including;
vessel geometry, volume of fluid in the vessel compared to maximum volume allotted
in vessel, contact angle between fluid and vessel wall/protein powder 3 . This contact
angle is dependent on the fluid in the container and whether it is wetting or non-wetting
(cohesion forces), and its interactions with the container itself (adhesion forces).
In reality the growth vessel geometry used is complex and not symmetric once
the loading piston was actuated. The loading piston, thermocouple cap and filling slot
change the internal geometry of the vessel (see figure 4.3). Due to all these variables
the internal shape of the fluid and a static contact angle are very difficult to ascertain
correctly.
The surface tension of the buffer solution may have made it difficult for the solution
to come in contact with the powder after actuation. If the dry lysozyme took an extended
time to fully come in contact with the solution it would delay dissolution. The gelation
and increased opaqueness of the fluid found located still in the filling slot where the dry
protein was stored before injection would support speculation of a slower dissolution
process.
3

http://www.esa.int/esapub/bulletin/bullet85/klein85.htm
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8.2.2

Diffusion Model

Diffusion begins when the lysozyme has completed the wetting process. The lysozyme
starts to move through the buffer solution with a rate that is affected by gravity. An
effective way to explain diffusion is through the diffuse double layer (DDL) model illustrated in Figure 8.3 (Remington, 2006).

Figure 8.3: This image displays the Diffuse Double Layer (DDL) model. It illustrates
diffusion, the last step of the dissolution process (Remington, 2006).

In this model the solid or solute (lysozyme) surface is in contact with the solvent
or solution (buffer solution). Dissolving consists of all or parts of the solid traversing
through a diffusion gradient (diffusion layer) until it finishes dissolving and enters the
bulk solution.
A thin film called the diffusion layer is located near the surface of the solid. This
thin layer has a thickness of (h) and the solution inside is considered saturated (Cs ). The
bulk solution concentration (Ct ) varies with time throughout the dissolution process.
The DDL model illustrates the rate of the diffusion process and it is quantified with the
Noyes-Whitney equation 8.9 (Remington, 2006).

dC
Ds
=
(Cs − Ct )
dt
Vh
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(8.9)

Where (D) is the diffusion coefficient of solute in liquid, (s) is the surface area of
solid exposed, (V) is the volume of the dissolution medium, (h) is the thickness of the
diffusion layer, (Cs ) is the concentration of solute at the saturated solid surface and (Ct )
represents the concentration of solute in the bulk solution.

D=

kT
6πηr

(8.10)

Where (D) is the Diffusion Coefficient of the solute in solution, (k) is the Boltzmann
constant, (T) is the Absolute Temperature, (η) is the Viscosity of the solvent and (r)
represents the radius of the solute molecule.
This is an ideal linearalized model that attempts to explain the movement of a protein particle in a diffusion-limited system and assumes no perturbations. Realistically,
other theoretical models (De Zarate and Sengers, 2006; de Zárate et al., 2004; de Zarate
et al., 2006) and simulations (Laguës and Lesne, 2003; Rosso et al., 1986; Chappa and
Albano, 2004) suggest that if there is a diffusion-limited system left undisturbed by
outside forces, such as gravity and the convective flow it creates, that diffusion would
continue only limited by the size of the vessel containing the solution. This extended
length scale for diffusion will naturally have fluctuations and lag times where wave fronts
of material gathers creating an uneven distribution. These fluctuations and changes in
concentration have an impact on the understanding of the growth of material in space
(Vailati et al., 2011). These density changes were tested with a polymer in solution by
(Vailati et al., 2011) and seen to occur in a diffusion-limited system in microgravity (see
figure 8.4).
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Figure 8.4: This is a shadowgraph with false-color images displaying changes in
density of polymer polystyrene in a toluene solution over time due to diffusion in
microgravity (Vailati et al., 2011). The samples are 1 mm thick, 5 mm in length, 5
mm in width, and heated to 17.4 K. The false color represents the higher and lower
density locations. The top images (a-d) represent the diffusion in microgravity while
the bottom images (e-h) represent diffusion on earth.

8.2.3

Diffusion-Limited Time Scale

Different gravitational environments are related to the transport of the protein molecules
in solution. Lysozyme transport in microgravity is dominated by diffusion. A idealized
description of the diffusion may be described by the simplified convection-diffusion equation (Stocker, 2011), which describes the motion of particles within an incompressible
fluid.

∂c
= D∇2 c − ~v · ∇c
∂t

(8.11)

Where (c) is the concentration of lysozyme, (D) is the diffusion coefficient or
diffusivity and (~v ) represents the average velocity. Where as shown in the introduction
becomes equation 8.12 when in a diffusion-limited system.
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∂c
= D∇2 c
∂t

(8.12)

This equation is only dependent on initial concentration and the diffusion coefficient.

D=

kT
cm2
= 2.386 × 10−6 [
]
6πηr
s

(8.13)

Where (k) is the Boltzmann constant, (T) is Temperature = 55 ◦ C, (η) is the
viscosity constant = 0.0005036 Pa·s for water at 55 ◦ C (Cooper and Dooley, 2008) and
(r) is the radius of diffusing particle = 2 nm (Woodard et al., 2014).

D=

x2
∆x2
⇒t=
= 14.6[hours]
2t
2D

(8.14)

In chapter 1 we first used the Stoke-Einstein relationship for the diffusion coefficient (left side of equation 8.14). Where (t) is the total time for diffusion (in hours) and
(x) represents the distance a colloidal particle travels = 5 mm the internal diameter of
the vial containing the buffer solution. Figure 8.5 shows how the time scales for a diffusing particle changes with radius. This uses the model described above assuming the
system is diffusion-limited, the lysozyme is spherical, and the diffusion is linear without
running into any pertubations.
The first term in Equation 8.11 represents diffusion while the second represents
advection. On the ISS the second term drops out, or becomes negligible, because the
dominant form of advection, buoyancy (Rayleigh convection), is not present in microgravity (Benedikt, 1961). This is because Rayleigh convection requires an acceleration.
There are other forms of advection, which may not allow the term to become negligible,
such as Marangoni convection where material transfers along interfaces of fluids. This
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Figure 8.5: Using the linearlized model for diffusion, and assuming the lysozyme
particle is a sphere, the diffusion time scale of a lysozyme particle vs its radial size
without perturbations is shown.

is caused when there is a gradient across surface tensions, but this does not become
dominant unless the solution dimension is smaller than 1 mm (Molenkamp, 1998), the
solution sample size in this experiment is on the order of 1 cm in size. The diffusion
constant is also dependent on the size of the lysozyme particle in motion. These conditions show us that, even if the lysozyme protein dissolves (fully wetted) into the buffer
solution, there could be a concentration gradient of lysozyme within the vial. The dry
lysozyme originally inside the loading piston may not have been able to mix into the
buffer solution uniformly. This process may make the initial stages of fibril formation
on the ISS different from that of the GC experiment. The simple difference in particle
transport could be the reason why the fibril morphology is so different from one setting
to the other.
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In equation 8.13 (Brinckmann, 2008) the diffusion coefficient is calculated for a
lysozyme molecule traveling through the buffer solution at 55 ◦ C. The viscosity of water
at 55 ◦ C is used because it makes up the majority composition of the buffer solution.
The radius of the particle is estimated to be 2 nm which is found to be a good estimate
for the lysozyme molecule size (Woodard et al., 2014). This assumes that lysozyme
molecules are spherical particles in solution.
Equation 8.14 shows the time it would take for a lysozyme particle to diffuse from
the center of the vial throughout all of the buffer solution is 14.6 hours. The equation
used to find this value is Einstein’s random walk theory (Brinckmann, 2008). Since
diffusion dominates colloidal transportation in microgravity, this time-frame shows us
what could be the crucial point at which the major changes in initial protein aggregation
and fibril formation occurred. The importance of this time frame becomes clear when
the length of time for lysozyme transportation in the GC experiment is much shorter
because of convection.

8.3

Lysozyme Concentration Trials

The change in the dissolution process in the two gravitational environments may have
lead to a difference in initial protein concentration for the forming fibrils. The shorter
thicker lysozyme protein fibrils formed in microgravity with a lower spreading coefficient
and lower mixing rate in the buffer solution. With the lack of convection in microgravity,
the lysozyme once dissolved into the buffer solution, was introduced to diffusion-limited
system and may not have dispersed uniformly throughout the buffer solution in the vials
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before fibrils started to form. This course of events may have resulted in certain regions
with higher concentrations and other regions with lower concentrations of lysozyme than
initially intended. The desired concentration was 20 mg/ml of lysozyme to glycine buffer
solution.
To test this hypothesis several higher concentrations of initial protein in the buffer
solution were incubated and analyzed. Protein concentrations of 50, 75, 100, 125,
150, and 175 mg/ml were chosen to incubate on the ground to see if fibril morphology would mimic what was seen on the ISS. Microcentrifuge tubes containing these
increased protein-buffer solution concentrations were incubated at 55 ◦ C. The tubes
were sampled at the same time intervals as the ISS vials. At these increased protein
concentrations the solution in the tubes began to form a gel near 2 days of incubation.
Once removed from the incubator, a pipette was used to extract 100 µl of solution.
It was diluted to 10x, 100x and 1000x. A sample of each of these dilutions was extracted
and placed on mica slides for imaging as described in chapter 3. The PicoView software
was used to image all mica slides. AFM images that showed fibrils were analyzed with
the same process used for the ISS and G-C experiment. Fibril heights and widths were
measured several times at different locations and an average fibril height and width was
calculated. The incubation, imaging and height/width analyzing process was completed
for each increased initial protein concentration.

140

141

Figure 8.6: Box-swarm plot of initial protein concentration vs. measured height at 3 volt force setpoint. An increased average
height and variability can be seen as the initial protein increases.
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Table 8.1: Statistics of fibril heights formed in different initial protein concentrations.

Figure 8.6 shows the results of varying initial lysozyme concentration before incubation. This is a swarm boxplot that displays several numeric values of the data.
The line that separates each box into 2 parts is the median of the data. The edges
of the boxes represent the upper and lower quartiles (Q1 = 25% and Q3 = 75% positions within the data). The “whiskers” or extreme lines represent the maximum and
minimum values of the data excluding outliers. The mean values of fibril heights are
represented by a red marker. The data is also presented on the graph with a bee-swarm
format over-plotted on top of the boxplot.
Table 8.1 displays several statistical values for fibril heights formed in different
initial protein concentrations. Several things can be seen in these data. The minimum
fibril height stays about the same for all concentrations. This is understandable because
the smallest fibrils (1st order fibrils) are made up of lysozyme monomers which have
a certain size. In buffer solutions with high salt concentration it has been shown that
when aggregating lysozyme first forms oligomers containing several lysozyme monomers,
then the 1st order fibril is formed as a chain of these oligomers instead of monomers as
an intermediate step (Hill et al., 2009). Higher order fibrils (2nd order, 3rd order, etc.)
can then form with these 1st order fibrils wrapping around each other. The maximum
does not show a trend possibly because of outliers or random higher order fibrils being
measured.
For concentrations 20 mg/ml to 75 mg/ml the average values of fibril height are
the same within the experimental error. There is a significant increase in height of
about a factor of 2 for 100 mg/ml. This then falls through 125 mg/ml and 150 mg/ml
to almost the heights of 20 mg/ml and then increases again to the mean of 4.9 nm for
the 175 mg/ml concentration. Interestingly for both the 100 mg/ml and 175 mg/ml
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concentrations, which had the largest average fibril heights, the buffer solution became
an opaque gel within the microcentrifuge tubes similar to what was seen in the filling
slot in the ISS vials. The standard deviation and the box size (interquartile range) also
increase at higher concentrations.
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Figure 8.7: Box-swarm plot of initial protein concentration vs. measured width at 3 volt force setpoint. An increased average
width and variability can be seen as the initial protein increases.
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Table 8.2: Statistics of fibril widths formed in different initial protein concentrations.

Figure 8.7 shows the results of varying initial lysozyme concentration before incubation on fibril widths. Table 8.2 displays several statistical values for fibril widths
formed at different initial protein concentrations. In addition to the fibril width the cantilever width must also be included as it travels over the lysozyme fibril during imaging.
The rate or speed at which the cantilever travels over the fibrils may also broaden the
topographic curve making the width readings larger than expected. The reaction of the
feedback circuit when the cantilever is rastering over biological objects can also play a
role in changing the apparent width. The raster speed was not always at a constant
setting and was changed frequently in order to gather a readable images in a reasonable
time. For these reasons the fibril height measurements are generally more reliable when
attempting to measure the size of the fibril.
As seen in table 8.2 and figure 8.7 the minimum fibril width stays about the same
for all concentrations. This is understandable because the smallest fibrils (1st order
fibrils) are made up of lysozyme monomers which have a certain size. The maximum
lysozyme fibril width values increases at each increasing initial lysozyme concentration.
The mean value for fibril width increases with increasing initial protein concentration.
The variability (IQR) shows an increasing trend with increased initial protein concentration. This increase in variability is present due to larger fibrils and an increase in
higher order fibrils created from these larger fibrils.
In any data set description using a boxplot the variability or spread of the data
is measured by the interquartile range (IQR). The IQR is calculated by subtracting the
lower quartile from the upper quartile, Q3 - Q1 . This gives the range of data covering the
middle 50%. We can define the spread or variability of any data set with calculated IQR
(Box Size). The IQR does not include the data lower than 25% and above 75% which
may contain outliers. These outliers can inflate variability to incorrectly represent the
spread of data. So if the data is skewed the IQR is a more reliable measure of variability

147

than standard deviation which is commonly used for a normal data distribution. The
IQR is not as mathematically manageable as the standard deviation, but is a useful tool
to measure spread because it is not influenced by extreme values in the data. The IQR
will not fluctuate nearly as much in a non-normal skewed data set.
Extremely high maximums and low minimums in data sets can be labeled as
outliers. Outliers are defined as 1.5 ∗ IQR more above the third quartile or 1.5 ∗ IQR
or more below the first quartile. These ranges are represented by whiskers that can be
seen extending out from the IQR box. Outliers are not necessarily a representation of
a mistake or a bad data point, therefore they are not removed.
Boxplots do have their downfalls. They do not show the shape or density concentration locations of data on either side of the median. Nor do they display the mean.
Because of this, over-plotting a“bee swarm” plot on top of the boxplot can show these
lumps of data if they are present. A bee swarm plot represents a scatter plot but in
one-dimension where every point is data.
When the IQR is calculated from a normal distribution of data it is 1.3498 ∗ σ,
where σ is the standard deviation. This range can be seen in Figure 8.84 . Therefore,
when using a boxplot for data analysis, if the IQR is not near 1.35 times the standard
deviation then the data does not come from a normal distribution and is skewed. Then
the IQR itself is needed to supplement the analysis of variability in the skewed data as
standard deviation is used for normal distributions.
The size of the boxes (IQR) on the swarm-boxplot represent the spread from
the mean fibril height. At larger initial concentrations these values tend to be larger
representing a broader frequency distribution or variability. This could be due to the
larger fibrils deforming more from the force applied by the cantilever at a force setpoint of 3 volts. Or the 1st order fibrils formed at larger initial protein concentrations
4

https://commons.wikimedia.org/wiki/File:Iqr_with_quantile.png
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Figure 8.8: The IQR range highlighted blue on top of a normal data distribution.

from oligomers not monomers and is inherently larger. Then, higher order fibrils (2
wrapped around each other or more) would form with these larger 1st order fibrils.
When collecting the height data on a large sample size of fibrils of the 1st order, 2nd
order, 3rd order, etc. the spread of the heights would naturally be larger.
There is a clear difference in average lysozyme fibril height and width when the initial protein concentration is altered from the 20 mg/ml expected for the ISS experiment.
Comparing these different average fibril heights and width to the results collected from
the fibrils formed in microgravity. Equation 8.15 is the percent difference in average
fibril height formed on the ISS (20 mg/ml) vs fibrils formed in an earth based setting
at the same concentration of 20 mg/ml. 5.3 nm was used as the average height between
incubation group II and III for ISS fibrils. This process is also done with the average
ISS width of 35 nm. This same equation is used to compare the ISS fibrils to each initial
protein concentration experiment for both height and width. Table 8.3 is a table with
the percent difference of the other concentrations respectively.
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%DISSvs20mg =

|5.3nm − 2.6nm|
|hISS − h20mg |
∗ 100% =
∗ 100% = 51%
hISS
5.3nm

(8.15)

Table 8.3: Percent difference of fibril height of ISS fibrils and fibrils formed in an
Earth based laboratory setting.

Concentration
ISS 20 vs 20
ISS 20 vs 50
ISS 20 vs 75
ISS 20 vs 100
ISS 20 vs 125
ISS 20 vs 150
ISS 20 vs 175

mg
ml

%D in Height %D in Width
51 %
15 %
57 %
21 %
47 %
40 %
2%
54 %
23 %
69 %
38 %
102 %
8%
157 %

The percent difference of fibril height decreases at higher initial protein concentrations and is smallest at 100 mg/ml and 175 mg/ml. This could indicate the lysozyme
fibrils formed in microgravity aboard the ISS were under similar increased protein concentration conditions due to decreased dissolution rates.
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Chapter 9
Discussion and Conclusion
In order to advance the biological study of self-organizing and self-assembling processes
with proteins, the SABOL project has conducted an experiment that required the design and creation of a functional autonomous NanoLab to accurately replicate ground
based studies upon the ISS. This study provides insight into the effects of microgravity
on the growth of amyloid fibrils. The experiment was successfully conducted within
similar time parameters on the ISS and in the KSC ground-based laboratory at Florida
Tech. The primary objectives of the SABOL program were to develop the capability
to grow protein fibrils in microgravity onboard the ISS and to demonstrate this process by actually growing lysozyme fibrils in microgravity. Both of these objectives were
met. Two identical sets of hardware were constructed providing a flight unit (ISS) and a
ground-control unit (GC). Both systems performed well enough to create a discrete time
series of lysozyme protein incubation. A major anomaly in the experiment operation
occurred when, during the ISS flight, only 3 of the 9 vial actuation mechanisms operated
properly. This anomaly can be easily corrected for any future experiments. If protein
is dissolved into the buffer solution before incubation there is no need for the entire
actuation mechanism. Also, this step will answer the question of whether or not the
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protein was uniformly dissolved and distributed throughout the solution. These adjustments could be accomplished using the same NanoLab structure with minor alterations.
Fortunately, the three ISS vials that properly actuated provided reasonable incubation
time coverage of 1.75, 7.75 and 15 days respectively for the lysozyme fibrils formed in
microgravity. Data from this experiment has revealed several interesting facts concerning fibril growth in various conditions that may be important in the ongoing study of
neurodegenerative diseases.
In the ISS NanoLab a full time series of fibril growth was not obtained due to
a malfunction of 6 out of 9 vials. However, the 3 functioning vials incubated samples
around 51 ◦ C for the time periods of 3, 9 and 15 days. The morphology of the protein
fibrils formed on the ISS differ markedly from those formed in GC. ISS grown fibrils
are relatively short and straight and are around 7 nm in diameter. Fibrils formed in
ground-control are around 3.5 nm in diameter and tend to be much longer (usually
exceeding the FOV of the measurements). This change in morphology is displayed in
left of figure 9.1. The ISS formed fibrils are shorter, straighter and larger in diameter.
The larger larger height (before deformation calibration) is shown in the right of figure
9.1. These images are shown again to emphasize the importance of this difference
in morphology. The noted differences are most likely related to the lysozyme fibril
formation in microgravity. However it is not clear what aspect of the microgravity lead
to this difference. To isolate any microgravity related differences, identical ISS and GC
NanoLabs were run through the same protocol with the only significant difference being
the gravitational environment during the incubation of the fibrils.
Another difference between the ISS and GC NanoLabs not related to microgravity
was the external forces due to launch, re-entry and landing. External forces experienced
during launch most likely did not affect the sample formation process because the buffer
solution and protein powder in the vials contained in the NanoLab remained in separate
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(a)

(b)

Figure 9.1: (Left) Mosaic of AFM images showing lysozyme fibril formation in
both the ISS and GC setting sorted by incubation group. (Right) The overplotted
comparison lysozyme fibril height histograms of each incubation group. Note: ISS
incubation group I did not have fibrils.

chambers throughout launch. Re-entry and splashdown external forces probably had
no effect on the already formed protein fibrils because the temperature of the NanoLab
was well below the aggregation temperature range for lysozyme. The NanoLab was in
a transfer bag that included bubble wrap to dampen vibration and cooling packs to
keep the sample cool during splashdown and recovery. Vibrations from the re-entry and
splash down making the fibrils collide and form larger fibrils is not feasible because no
smaller fibrils were observed to be present in the ISS sample. It is unlikely that every
single fibril merged with another because of vibrations.
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A distinct observation in the ISS vials that actuated properly was the presence of
a white opaque gel. The gel formed in the filling slot where the protein was initially
housed. Samples of this gel were collected and imaged with AFM. The gel was found to
contain lysozyme fibrils with the same morphology as the other ISS samples. During the
development of the experimental hardware, tests were conducted to determine if and
how long it would take for lysozyme powder to dissolve in the buffer solution without
any shaking or inverting. It was found that it took only a few minutes for the protein
powder to dissolve completely. One explanation for the formation of this gel could be
related to the geometry of the filling slot and the differences in transport properties
in microgravity. In microgravity, the large-scale fluid pressure gradients resulting from
gravity are not present, therefore natural buoyant convection is also not present. This
means, in the absence of any other small scale pressure gradients, the flow of solution
in each of the ISS vial was diffusion-limited. Another reason for the presence of the gel
could be due to surface tension and the contact angle between the buffer solution and
the polypropylene interior walls of the filling slot. Surface tension plays a significant role
in fluid transport and wetting of the protein powder in microgravity. Delrin, another
plastic, failed to grow fibrils in 1-g when it was used as the growth vessel. Possibly
because it is hydrophilic, while the hydrophobic material of polypropylene succeeded in
having fibrils grow.
Self-assembly of the protein occurs in both environments of this experiment. However, the differences observed in the morphology of the protein fibrils suggests that the
first few stages of aggregation are dependent at least in some degree on gravity and
the factors that depend on gravity such as natural buoyant convection. In the ISS
NanoLab the reaction-diffusion system could have been inhibited in the early stages of
self-assembly before fibril formation. Brownian motion and diffusion may have become
the dominant factors in the self-assembly process on the ISS. Because natural convection
is not present in weightless aggregation, the fibril formation undergoes diffusion limited
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aggregation. As soon as the aggregates begin to grow, the radius “r” of the aggregate or
at least the effective size increases so the diffusive coefficient “D” decreases. The time
“t” it takes for the aggregate to travel through the buffer solution increases. Effectively,
when the aggregates increase in size their diffusive motion slows down. Due to this
occurrence, at later stages of development immobile aggregates grow in length mainly
by capturing the faster moving single particles (Veen et al., 2012). In microgravity
the self-assembly of the larger fibrils over time becomes dominated by growth of small
particles moving onto them (Cohen et al., 2014).
It is not clear how these effects associated with microgravity would have altered
the flow and dissolution of lysozyme powder. However, the effects may have led to an
increase or decrease in protein concentration throughout the vial especially near the
filling slot. Some protein must have diffused in the vials because samples for most of
the imaging were taken from the central portion of the vial and fibrils were found. In
the GC NanoLab the dry protein once introduced to the buffer solution appears to have
diffused entirely and left no residual viscous opaque gel behind in the filling slots of the
loading pistons.
At a lower dissolution rate the protein would not disperse through the solution
as quickly. This would lead to protein fibrils forming at higher concentrations than
initially intended before the lysozyme was uniformly distributed throughout the vial in
microgravity. To test these ideas several levels of higher concentrations of initial protein
in buffer solution were incubated in subsequent ground-based vials and analyzed with
AFM.
These concentration trials showed an increase in fibril height above 75 mg/ml (see
figure 9.2), with the largest increase at 100 mg/ml and 175 mg/ml. The variability and
spread of the fibril height data increased at higher concentrations. The average fibril
height tends to increase with initial concentration. The fibril height results for some of
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Figure 9.2: Box-swarm plot of initial protein concentration vs. measured height at
3 volt force setpoint. An increased average height and variability can be seen as the
initial protein increases.

the high concentration trials were very similar to the fibrils formed in microgravity upon
the ISS. The average widths of each of these fibrils was also taken. At each increasing
concentration the average fibril width increased although with increased variability. The
width measurements are less reliable due to cantilever size, quality and raster speed at
the time of AFM imaging.
To summarize, part of the original hypothesis that protein fibril formation would
occur in the extreme environment of microgravity was proven. However, the lysozyme
fibril morphology formed in microgravity was surprising. Originally it was believed that
the fibrils would stay suspended in solution for longer periods of time without settling
becoming much longer and forming more complex structure than seen in ground-based
experiments. Shorter, thicker, non-helical fibrils were formed in microgravity. Even
though natural buoyant convection is not present in microgravity this experiment proves
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that protein self assembly can still progress. This shows us that without total removal of
the initial nucleation structures, aggregation will continue and eventually create macroscopic structures such as plaques and gels. These plaques and gels are associated with
neurodegenerative diseases. For example Alzheimer’s Disease is associated with plaques
of the proteins tau or Amyloid-β. These aggregates may slow down particle transportation in the brain whether they be nutrient or waste products (Woodard et al., 2014; Iliff
et al., 2012).

9.1

Simulating Microgravity

Performing experiments in a microgravity environment in space is both expensive and
time consuming. Alternative methods on earth have been created to recreate an acceptable simulation with clinostats and bioreactors. Actual microgravity can be reproduced
by free fall in parabolic flights in airplanes. But, the duration of paraboloc flights are
too short for many biological experiments to be completed. Simulated microgravity
through a clinostat or bioreactor allows for long duration biological experiments to take
place.
A clinostat is a machine which uses rotation to negate (average out) the effects of
gravity similar to the effects of microgravity in space. It is used to study the effects of
microgravity on samples such as cells, embryos and other organic material.
In horizontal clinostats (2D clinostats) gravitational effects still occur but the force
vector is moved around the axis of rotation so there is no net average force. This is
called omnilateral gravistimulation (Brown et al., 1976). To produce this effect, the
clinostat must rotate around an axis at a constant angular velocity and rotate slowly
enough not to encounter a great degree of centrifugal force (Dedolph and Dipert, 1971).
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The rate at which the clinostat rotates in order to achieve omnilateral gravistimulation
is called the ‘minimal presentation time’ or (MPT) (Dedolph and Dipert, 1971). The
MPT is different for a variety of samples such as cell cultures, plants and liquid samples
and is defined operationally by the physical properties of the sample.
The downside of using this mechanism is that microgravity is only simulated
along the one axis of rotation. Additionally there is an absence of convection in freefall/microgravity but it is still present in some degree with gravity compensation/omnilateral gravistimulation (Dedolph and Dipert, 1971). The observation that there is
not any reduced mass transfer in fluid within a clinostat suggests one reason for our
experiment to require microgravity and not a simulation through omnilateral gravistimulation. MPT changes depending on viscosity of solution along with the size of the
sample suspended in solution. Both of these variables change over time in a protein
aggregating system. Induced aggregation due to vibrations and fluid shear would most
likely occur. Clinostats are used to suspend larger biological samples that are not initially dissolved into solution. The clinostat and bioreactor were investigated thoroughly,
but for these reasons it was decided they would not be used to simulate microgravity in
this experiment.

9.2

Future Projected Plan

At this time we have an article in-print for publication in the journal of “Gravitational
and Space Research” regarding the findings of the ISS experiment at FIT. Given the
need for microgravity, the next step will be to request funding to facilitate design changes
to the NanoLab vial assembly to ensure complete operation on another space mission.
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Different vial materials can be used to test the protein fibril aggregation dependence on
the growth vessel composition. If the project is funded for another mission aboard the
ISS, testing of the new NanoLab designs would begin. Other amyloid proteins will be
tested to find ideal aggregation conditions and tested with the new NanoLab.
With regard to what was found by changing the initial lysozyme concentration
before incubation, another manuscript will be written for publication on how it effected
the fibril morphology.
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Jiménez, J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Dobson, C. M., and
Saibil, H. R. (2002), The protofilament structure of insulin amyloid fibrils. Proceedings
of the National Academy of Sciences, 99(14):9196–9201.
Kallberg, Y., Gustafsson, M., Persson, B., Thyberg, J., and Johansson, J. (2001),
Prediction of amyloid fibril-forming proteins. Journal of Biological Chemistry,
276(16):12945–12950.
Karpova, O. and Novikov, V. (2002), Scanning probe microscopy of biomacromolecules:
Nucleic acids, proteins and their complexes. Frontiers of Multifunctional Nanosystems,
57:321.
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W.,
and Glabe, C. G. (2003), Common structure of soluble amyloid oligomers implies
common mechanism of pathogenesis. Science, 300(5618):486–489.
Kelly, J. W. (1996), Alternative conformations of amyloidogenic proteins govern their
behavior. Current opinion in structural biology, 6(1):11–17.
Klaus, D. M., Benoit, M. R., Nelson, E. S., and Hammond, T. G. (2004), Extracellular mass transport considerations for space flight research concerning suspended and
adherent in vitro cell cultures. Journal of gravitational physiology: a journal of the
International Society for Gravitational Physiology, 11(1):17–27.
Klein, C. and Hurlbut Jr., C. (1993), Manual of mineralogy. 21th.
Kodali, R. and Wetzel, R. (2007), Polymorphism in the intermediates and products of
amyloid assembly. Current opinion in structural biology, 17(1):48–57.

166

Koshland, D. and Hourowitz, F. (2018), Protein. Reviews of modern physics, URL
https://www.britannica.com/science/protein.
Kovalev, A., Shulha, H., Lemieux, M., Myshkin, N., and Tsukruk, V. (2004), Nanomechanical probing of layered nanoscale polymer films with atomic force microscopy.
Journal of materials research, 19(3):716–728.
Kowalewski, T. and Holtzman, D. M. (1999), In situ atomic force microscopy study of
alzheimers β-amyloid peptide on different substrates: New insights into mechanism of
β-sheet formation. Proceedings of the National Academy of Sciences, 96(7):3688–3693.
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force microscopy (AFM) and transmission electron microscopy
(TEM), Xu proposed that colloidal interactions drive amyloid
aggregation, and that aggregation itself drives conformational
change [6].
The mechanism of cytotoxicity in amyloid disease also remains
uncertain; amyloid fibers are chemically stable and are not known
to possess specific biochemical toxicity. Small protein aggregates,
or oligomers, are often found with amyloid fibers and may be an
intermediate in the aggregation process. These oligomers are more
reactive than fibers, and it has been proposed that they play the
major role in toxicity [7]. Oligomers, however, consistently appear
before fibers, which form much more slowly. If the oligomers are
responsible for cytotoxicity, it is difficult to see how a cell could
survive long enough to accumulate the large number of
intracellular fibers often seen after neuronal death.
Moreover, amyloid aggregation does not end with fiber
formation. Molecular and macromolecular fibers of many types,
including amyloid, are often seen to self-assemble to form a
continuous network. The formation of such a network converts the

Introduction
A wide range of proteins and peptides are capable, under
appropriate conditions, of aggregating to form fibers with a unique
structure commonly referred to as amyloid. The accumulation of
these fibers is a consistent feature of at least a dozen pathological
conditions in humans, including both Alzheimer’s and Parkinson’s
diseases. Detailed structures have been modeled or proposed for
some amyloid fibers, particularly for those formed from short
peptides [1–3], however the complete molecular structure for most
amyloid fibers has not been determined. A unique feature of
amyloid fibers is that protein conformation is radically changed
from the native state. Most proteins are predominately alphahelix. Amyloid fibers, in contrast, characteristically contain a large
percentage of an unusual secondary structure called cross-betasheet, in which peptide backbones from multiple protein
monomers are straightened, arranged in parellel, and joined
together by hydrogen bonds [4,5]. The energy source for the
major conformational change that occurs when proteins aggregate
remains a matter of active debate. Based on evidence from atomic
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substrate were removed with a tangentially applied jet of nitrogen
gas. The slide was dried for at least 2 hr at 55C.
Samples were imaged with a Molecular Imaging Picoscan Plus
AFM in contact mode, using standard long thin-leg Veeco DNP
silicon nitride cantilevers. Vertical and horizontal measurement
was calibrated and convolution was measured with 20 nm and
200 nm vertical step calibrators. AFM tip radius was typically
10 nm and tips with radius greater than 30 nm were replaced.
Topographic mode was used to demonstrate three-dimensional
structure and for dimensional measurements, while deflection
mode was used to demonstrate shape and texture.
In contact-mode AFM the width of structures smaller than the
AFM tip can be greatly exaggerated by convolution. A circular
fiber of height H, smaller then the radius R of the AFM tip, will
have an apparent width W given approximately by
pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
W = 2 2RH{H 2 [14]. Consequently we used height rather
than width as a measure of the diameter of particles and fibers.
Measurement of the length of fibers is not affected because it is
much larger than the AFM tip.
Amyloid fibers often display a helical or twisted-ribbon
morphology; in the case of primary lysozyme fibers this takes the
form of a simple open helical spiral, similar to a stretched spring.
When a fiber is bound horizontally to a substrate and viewed from
above by AFM this helix has the appearance of a sinusoidal curve.
We examined each fiber in a set of images to see if it consisted of at
least two consecutive sinusoidal cycles of equal period and
amplitude; if it did so it was considered helical. A fiber of
comparable length with no sinusoidal curves was considered
linear.

surrounding suspension from a fluid into a gel, with the striking
effect of increasing its viscosity by a factor of as much as 1010 [8].
A wide variety of small and large molecules may act as gelators;
despite their different chemical structures, the physical properties
of gels appear to be determined largely by pore size, a measure of
the expected distance from an arbitrary point in the fluid to the
nearest fiber surface [9]. The dramatic physical changes in the
intracellular and extracellular environment resulting from gel
formation could potentially disrupt transport processes essential for
cell survival.
In preparation for an experiment in which amyloid aggregation
will be attempted in microgravity aboard the International Space
Station, we examined the morphology of amyloid fibers and the
kinetics of gel formation under various conditions using the
common laboratory model of hen egg white lysozyme. Amyloid
aggregation in this model is accelerated as lysozyme becomes
unfolded at 55C and peaks at 65C before amorphous aggregation
becomes the dominate pathway [10]. Salt concentration has been
shown to strongly influence the aggregation of lysozyme [11–13];
we therefore examined lysozyme aggregation under a range of salt
concentrations. We then considered the potential effects of
amyloid gel formation on intra- and extracellular transport.

Materials and Methods
Buffer was prepared with 10 mM glycine in DI water, titrated to
pH 2.5 with HCl. We have found the anion concentration to be
critical; to ensure uniformity across samples, the titration was
performed in the stock solution prior to the addition of lysozyme;
the final HCl concentration was approximately 36 mM. The
buffer was prepared with no added salt or with NaCl at
concentrations of 30 mM or 150 mM. Lysozyme (BSG, Napa,
CA) at a concentration of 20 mg/ml was dissolved in the buffer
and 1 ml samples were prepared in capped 1.5 ml microcentrifuge
tubes and incubated in an oven at 55C with minimal convection.
Limited tests were done with higher concentrations of lysozyme
and with agitation at 60 RPM in a Vortemp incubator.
Atomic force microscopy (AFM) slides were prepared from the
aggregating protein after up to 30 days of incubation. Samples
were applied to slides both undiluted and after serial dilution of up
to 1:10,000 with deionized (DI) water. We found that diluting
amyloid fibers by mixing the suspension with water in a
conventional vortexer resulted in breakage of virtually all fibers
longer than approximately 2mm due to fluid shear. For this reason
we performed dilution by the following procedure: For each
dilution the tube was gently inverted several times to suspend
colloids and 100 microliters was extracted from the center of the
tube with a pipette and and added to 900 microliters of DI water,
and again mixed by tube inversion. Undiluted and diluted protein
samples were preserved at 220C.
It was difficult to draw gels accurately into a standard pipette
due to their extreme viscosity. We found by AFM observations
that this also resulted in extensive fiber breakage, apparently due
to fluid shear as the gel was drawn through the small orifice of the
pipette. Consequently, when pipetting fibers and/or gels, the tips
of the pipettes were first cut off to enlarge the orifice diameter to
*1 mm.
To prepare AFM slides, 10ml of 0.01N NaOH was applied to
freshly peeled mica to precharge the substrate. After two minutes
10ml of the sample was applied to the substrate at the same
location. After an additional 10 minutes the sample was gently
rinsed with 2 ml of DI water by allowing the water to flow slowly
over the substrate in a Petri dish to remove salts and unbound
proteins. The water was drained and any droplets adhering to the
PLOS ONE | www.plosone.org

Results
Fiber formation was first seen by AFM after four days of
incubation with all three salt concentrations. Three stages of gel
formation are visible on gross examination. The first stage is
marked by increased fluid viscosity and the appearance of small
particles of soft gel in the solution. Visible gel particles are typically
1–3 mm in size and are visible when the tube is held against a
lighted background. Smaller particles may be present but would be
difficult to see, while larger ones tend to settle to the bottom of the
tube. The second stage is marked by conversion of the solution
into a clear soft gel which meets the tube inversion criterion [15]
but visibly changes in shape on inversion and will eventually
fracture on repeated inversion. The third stage demonstrates
conversion to a harder gel which does not change shape on
inversion and, after about 30 days, develops a faint yellow color.
With the standard preparation of lysozyme without added
NaCl, gel particles were seen at day 11 and soft gel formation
within 18 days. Hard gel formation was not seen. The addition of
NaCl at either 30 mM or 150 mM accelerated gel formation, with
increased viscosity and gel particles at day 8, soft gel at day 11, and
hard gel at day 22.
Gel formation can be accelerated by increasing lysozyme
concentration or by agitation. Lysozyme 40 mg/ml incubated in
buffer with 150 mM NaCl resulted in soft gel formation at 8 days.
Lysozyme at 20 mg/ml in buffer with 150 mM NaCl, agitated at
60 RPM in a Vortemp incubator, consistently reached the hard
gel state within three days.
To understand the self-assembly process we examined aggregating lysozyme at various stages using AFM. Early in the process
the most common aggregates are colloidal spheres and fibers
(Figure 1). Lysozyme fibers often demonstrate a left-handed helical
structure. Amorphous aggregates are also present; some appear to
be clusters of colloidal spheres. Protein monomers form a
2
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confluent layer at high concentrations, in which aggregates and
fibers may be partially submerged. When the sample is diluted
1:1000 or higher before being applied to the substrate, the
confluent protein layer is no longer present and numerous discrete
particles are seen, probably representing protein monomers and
small colloidal aggregates. Finally, amorphous aggregates up to
100 nm in size are occasionally seen. The smallest fibers are
typically 1.4–1.6 nm in height; larger fiber bundles up to 8 nm in
diameter are also seen.
Figure 2. Transition to helical structure is inhibited by high salt
concentration. Lysozyme aggregating in buffer with no salt (left) or
30 mM NaCl (center) demonstrate transformation of virtually all fibers
to helical structure after incubation for 11 days. The helical curve of the
lysozyme fiber bound to the substrate typically appears from above as a
sinusoid (left, inset) although other patterns such as twisted ribbons are
occasionally seen. The triangular symbols show the length of one turn
of the helix is approximately.4mm. Fibers forming in buffer with 150 mM
NaCl (right) demonstrate virtually no helical structure even after 31
days.
doi:10.1371/journal.pone.0094789.g002

Evolution of Fiber Morphology
Under TEM or AFM many gel-forming fibers that have been
incubated for an extended period demonstrate a helical appearance. Terech [8] provides a conceptual mechanism for the
development of this helicity; initially the fiber is a chain of discoid
organic molecules loosely bound by colloidal forces, without
specific orientation. Consequently the newly formed fiber has no
long-range helical structure and appears linear. With time the
monomers rotate into a minimum energy orientation in which
each monomer is bound to those adjacent to it by multiple
hydrogen bonds. At this stage there is often a structure-dependant
angular offset in rotation and tilt between each monomer and the
next, resulting in the overall helical shape.
Our observations were consistent with this model, however the
transition to helical morphology in lysozyme was markedly
affected by salt concentration (Figure 2). In all buffers, lysozyme
fibers were linear in appearance when initially observed. With no
added salt, helical fibers first appeared at day 5 and by day 11
essentially all fibers were helical. With the addition of 30 mM
NaCl, helical fibers first appeared on day 8 and all fibers were
helical by day 13. At 150 mM NaCl the transformation was
essentially halted. A few helical fibers were seen late in incubation
(day 25), but even at day 31 most samples showed no helical fibers
(Figure 3).

sectional area of the fiber leaving the junction. The larger fiber
often demonstrates helical structure with the appearance of two
fibers twisted together. This is typical of helix formation, a form of
fiber self-assembly commonly seen in macromolecular networks
[8]. Merging of helical fibers appears to require that they be free to
rotate so that the helices of the two fibers can wrap around each
other. We occasionally see a single helical fiber that appears to
divide into two smaller fibers over a short segment of its length,
which then rejoin (Figure 4, right panel). This suggests that
merging of the fibers into a bundle was inhibited at this point,
perhaps by misalignment of the helices of the merging fibers.

Assembly of Fiber Networks
On day 4 fibers were seen on AFM, however they were not
linked together and the mean distance between fibers on the
substrate was 1027 nm, SD = 553 nm (n = 37). No gross gel-like
behavior was seen. When gel was present by the tube inversion
criterion [15] the mean distance between fibers was 96.5 nm,
SD = 38.43 (n = 30), and fibers were linked into a continuous
network. This is consistent with Terech’s model of the transition
from a Newtonian fluid stage to a viscoelastic gel [8].
As incubation was continued past 30 days, the gel changed from
an initial colorless appearance to a translucent yellow and
appeared stiffer and stronger in consistency. This suggests that
chemical changes, possibly oxidation and cross-linking, continue to
occur in the fibers. However, little or no change in fiber density or
diameter was seen following the transition from fluid to gel.
Moreover, even after prolonged incubation of the gel, colloidal
spheres and monomers were still seen on AFM. In contrast, when
amyloid aggregation occurs without gel formation, these constituents can be rapidly depleted [6]. This suggests that formation of
the gel limits further aggregation.
Samples of gel applied directly to mica without dilution
(Figure 5, panel A) demonstrate a dense, interconnected network
of fibers. When lysozyme gels were diluted 1:100 in DI water and
mixed by repeated tube inversion, the gel swelled considerably and
a 10ml sample could be applied to mica in a monolayer (Figure 5,
panel B, enlarged in panel C). This demonstrates fibers of several
diameters; each fiber appears to be uniform in diameter over
distances of several microns. Fibers appear to merge where they
come into contact at crossing points in the network.
Early in the aggregation process, when the solution is incubated
without agitation, the solution appears heterogeneous by AFM.
The majority of the slide shows only scattered fibers, however

Assembly of Fiber Bundles
Examination of gels reveals fibers of several distinct diameters
suggesting that primary fibers of a uniform diameter may merge
one or more times to form fiber bundles. A single fiber is
occasionally seen to divide into two fibers (Figure 4). Is this a single
fiber branching into two during growth, or two separately formed
fibers in the process of merging to form a larger fiber? Merging of
existing fibers seems more probable as the two fibers approaching
the junction are invariably smaller, with about half the total cross-

Figure 1. Components of aggregating lysozyme. Left: AFM image
showing various structures seen in aggregating lysozyme on mica
substrate: (a) colloidal spheres, (b) primary fibers, (c) compound fibers,
(d) amorphous aggregates, (e) a continuous layer of protein monomers
bound to substrate. Right: After 1:1000 dilution the continuous protein
layer is no longer present. Colloidal spheres are still seen (a), as are
numerous discrete particles (b) with a height of 1:2+0:22nm (n = 20),
probably representing individual lysozyme monomers.
doi:10.1371/journal.pone.0094789.g001
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Figure 3. Effect of time and salt concentration on fiber helicity. Newly formed fibers are linear at all salt concentrations; at zero and 30 mM
NaCl the fraction of fibers displaying helical morphology increases consistently with time until all fibers are helical. This change occurs more rapidly at
lower salt concentrations. At 150 nM NaCl essentially all fibers remain linear.
doi:10.1371/journal.pone.0094789.g003

there are occasional clumps of fibers 3–5mm in size, comparable to
the size of physiological neurofibrillary tangles seen in Alzheimer’s
disease [16]. Grossly, one may see islands of gel 1–3 mm in
diameter suspended in the solution. This initial assembly may be
due to relatively weak hydrophobic interactions or van der Waals
forces at areas of contact between fibers.
As noted, vortexing at normal speed breaks lysozyme fibers into
short (v2mm) segments. When newly formed gels were extracted
by pipette, diluted 1:10,000 in DI water followed by vortexing
(30 sec) and applied to mica, short fiber segments were seen on
AFM, uniformly dispersed on the substrate. When samples of hard
gel incubated 30 days were similarly diluted, vortexed, and applied
to a mica substrate AFM again revealed fibers broken into short
segments, but they were not uniformly dispersed. Instead they
were found in widely scattered clumps, with fiber segments still
bound together at points of contact (Figure 5, panel D). This
suggests that the bonds between the fibers at points of contact
become stronger with time, and after 30 days are comparable in
strength to the fibers themselves, so that the fiber may break
before the bond at the point of contact. This is consistent,

under Teresch’s taxonomy, with evolution from a reversible
macromolecular network, or REMAN, to an irreversible macromolecular network or IRMAN [8].

Figure 5. Gel formation in lysozyme. AFM images of lysozyme
amyloid fiber network after 30 days incubation. The mixture is a firm gel
at this point. (A) Lysozyme gel, undiluted, showing dense network
structure. (B) When diluted with water 1:100 and gently mixed, the gel
swells and can be applied to the substrate in a monolayer, showing a
range of fiber sizes, bound together at points of contact. (C) Detail of B,
showing occasional merging of fibers at points of contact. (D) Gel was
diluted in water (1:10,000) and vortexed 630 sec. Gel fibers are broken
into short fragments but remain joined at points of contact. This
indicates development of strong covalent linkages between fibers,
typical of an irreversible macromolecular network or IRMAN [8].
doi:10.1371/journal.pone.0094789.g005

Figure 4. Fiber bundle formation. Lysozyme fibers aggregate by
lateral association to form bundles. Left, center: Arrows identify points
at which two fibers join to form a bundle. Appearance of the bundle
suggests the fibers wrap around each other in a spiral fashion, a process
described by Terech [8] as helix formation. This requires the fibers be
free to rotate. Right: Lysozyme fibers in a bundle may remain separated
over a short distance and then rejoin, suggesting fiber helices must be
aligned for bundling to occur.
doi:10.1371/journal.pone.0094789.g004
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Discussion
The kinetics of amyloid aggregation are highly dependent on
incubation conditions. A pH of 2.5 results in partial unfolding of
lysozyme, exposing hydrophobic regions and making it more
susceptible to aggregation. At pH 2.5, however, lysozyme has a
net charge of approximately +16 [17], resulting in coulomb
repulsion between lysozyme molecules which could inhibit
aggregation.
The presence of salt in the solution can alter protein
conformation and affect the colloidal forces between monomers,
small aggregates, and fibers which appear critical in amyloid
aggregation. If negatively-charged counterions are present they
would form a double layer around the positively-charged lysozyme
molecule which would be expected to mask these coulomb forces,
as described by the theory of Derjaguin, Landau, Verwey and
Overbeek (DLVO) [18].
Terech [19], working with aggregation of lithocholate, found
that increasing salt concentration led to a change from helical to
cylindrical fiber morphology similar to the differences we observed
in lysozyme. He ascribed the difference in fiber morphology to
shielding of coulomb repulsion between like-charged structures in
the fiber, resulting in a change in the conformation of the fiber
helix from an open spiral to a closed tube. Increasing salt
concentration also led to a striking acceleration in the aggregation
of fiber bundles into a gel-forming network. The presence of salt
has also been found to accelerate the transition from fluid to gel
phase in b-lactoglobulin [20] and in lysozyme/ethanol solutions[12]. Both differences in fiber morphology and shielding of
coulomb repulsion between fibers might contribute to the
acceleration of gel formation by salt. The differences we saw in
aggregation of lysozyme were similar to those seen by Terech in
lithocholate, i.e. a visible helical structure appeared only at low salt
concentration and gel formation was accelerated in the presence of
salt. Whether similar mechanisms are involved is unknown.
Two different types of amyloid are seen in the brain in
Alzheimer’s disease, both of which are associated with degenerative changes. Tau protein, a normal component of the
cytoskelton, aggregates inside neurons to form structures called
neurofibrillary tangles (NFTs), while amyloid beta peptide (Abeta), a protein fragment, aggregates in the extracellular fluid
(ECF) to form structures called plaques. Ruben [16] used
transmission electron microscopy to image neurofibrillary tangles
(NFTs) extracted from brain tissue and noted that the NFT
resembles a gel in structure. His image (Figure 6, Left) shows that
an NFT is a true molecular network rather than simply a
convoluted fiber as the name might suggest. Tau demonstrates the
helical structure commonly seen in gel-forming fibers, and, as in
lysozyme, the fibers often appear to merge at points of contact.
Moores [21] imaged A-beta amyloid fiber networks by AFM
(Figure 6, Right); A-beta also demonstrates a three-dimensional
network with pore size similar to that seen with lysozyme and tau.
This network was formed by deposition of A-beta from solution
directly onto a substrate. Extracellular plaques in the brain are
likely formed by a similar process since free colloids in suspension
would be carried out of the brain by the flow of ECF.
Gel formation has been reported with a wide variety of amyloid
fibers, including insulin [22], b-lactoglobulin [20,23], and short
synthetic peptides [24]. Protein aggregation under physiologic
conditions may be very slow, however neurons are exceptionally
long-lived and there is ample time for intracellular amyloid fibers
to form and assemble into macromolecular networks. While the
different imaging methods used limit our ability to make direct
quantitative comparisons, both tau and A-beta amyloids appear to
PLOS ONE | www.plosone.org

Figure 6. Macromolecular networks formed from tau and Abeta. Left: TEM image from Ruben [16] of intracellular neurofibrillary
tangle composed of tau protein, extracted from human brain tissue.
The sample was replicated by coating with 2 nm of platinum-carbon
and 12 nm of carbon. The organic material was then dissolved in
sulfuric acid and the metallic replica imaged by TEM. The NFT is
composed of helical fibers which form a three-dimensional network
with the fibers merging at points of contact, indicating that they are
bound together. The spaces between the fibers form pores of
consistent size, generally less than 100 nm. These features are
characteristic of an irreversible macromolecular network or IRMAN, a
structure identified by Terech as one of the four types of gel-forming
networks [8]. Right: AFM image from Moores [21] of human amyloid
beta peptide (A-beta), the primary constituent of extracellular plaques
in Alzheimer’s disease, induced to aggregate on a substrate. The image
demonstrates that A-beta can also spontaneously assemble to form an
amyloid fiber network with the structural characteristics of a gel.
doi:10.1371/journal.pone.0094789.g006

demonstrate the critical characteristics of an irreversible macromolecular network or IRMAN, one of the four principal types of
gels identified by Terech [8]. The structure of lysozyme amyloid
fiber networks appears similar in scale and geometry to amyloid
networks formed from tau or A-beta. Further study is needed to
compare the structure and properties of lysozyme gels with NFTs
and plaques, however we suggest that lyzozyme can be a useful
model for studying amyloid gel formation in disease.

Effects on Biological Transport Mechanisms
Movement of a solute or suspended colloid in a gel is complex,
and numerous models, many semi-empirical, have been proposed
[25]. Mechanisms by which transport may be hindered include
chemical bonding, colloidal interactions between the solute and
fibers such as coulomb forces, steric hinderance to diffusion,
mechanical blockage of particles close to or larger than the gel
pore size, tortuosity, and perhaps most importantly, hydrodynamic
drag between the fiber network and the solvent, which blocks
convection.
Diffusion. Cole [26] suggested that amyloid gels might
disrupt cell processes through their effects on diffusion. Dissolved
molecular solutes are much smaller than the pore size of amyloid
gels, however the rate at which they diffuse through a fluid is
reduced in the presence of either a gel or a suspended polymer,
primarily by steric obstruction [27]. Hydrogen bonds exposed on
the fiber surface also bind surrounding water molecules into an
ordered structure, increasing the effective fiber diameter. For
solutes transported by simple diffusion, the ratio between the
coefficient of diffusivity of a solute in a stationary fluid and in a
hydrogel was first described analytically by Lauffer [28] as:
D0 (1{aw)
~
D
(1{w)
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extracellular space to the ventricular and cortical surfaces where it
enters the cerebrospinal fluid (CSF).
When particles are transported through a fluid by diffusion,
their rate of movement varies inversely with hydrodynamic radius;
small particles consistently diffuse more rapidly than larger ones. A
similar effect is seen when particles of different sizes are
transported by forced convection through a gel [36]. However
Cserr found that the rate of movement of tracer molecules injected
into brain ECF in vivo was uniform across a wide range of
molecular sizes. This confirms that dissolved molecules do not
simply diffuse through brain tissue but are transported by
convection, i.e. bulk flow of the ECF, and that the channels
through which this flow occurs are not normally obstructed by gelforming fiber networks.
If an interstitial channel becomes filled with amyloid gel, how
would this affect flow of the ECF? Flow in a channel can be
characterized as laminar or turbulent based on Reynolds number:

where:
D9 = Coefficient of diffusivity in gel
D = Coefficient of diffusivity in solvent
a = shape constant for the obstructing structure, *5/3 for
randomly oriented rods
w = volume fraction of the gel
The specific volume of lysozyme in water is reported to
be.785 cm3/gm [29]. Thus, a typical amyloid gel produced with
lysozyme 20 mg/ml will have a fiber volume fraction of no more
than 2%, which would reduce the rate of diffusion of small
molecules and ions by only 1.2%, an insignificant change.
Similarly, Nicholson [30] reports minimal effects on small ion
diffusion in a 2% gel.
Simple diffusion is not, however, the predominate mechanism of
biological transport except at the very smallest scales. Diffusion is
driven solely by concentration gradient, and the difference in
concentration between source and destination required to
maintain a uniform flux of a diffusant increases linearly with
distance. For transport over significant distances the difference
between the concentration at the source and the destination
exceeds the tolerance of biological systems, thus transport often
requires other mechanisms.
Convection. Convective flow does not depend on concentration gradient and is thus not limited by distance. In a gel,
convective transport can occur whenever there is bulk flow of
solvent through the fiber network. In hydrogels with pore size
w100 nm the transport of solutes is dominated by convection
rather than diffusion [25]. Consistent with this, Tamagawa [31]
found that transport of a dye in polyacrylamide gel was greatly
accelerated if a small number of macropores (&100 nm) were
introduced. However these large pores were not thermodynamically stable and were rapidly filled in by the formation of new gel.
We found pore size to be quite uniform in mature lysozyme gels,
suggesting there are stabilization processes which fill in macropores but prevent fibers from aggregating into a solid mass. Pore
sizes in most amyloid gels appears to be in the 50–80 nm transition
range which permits diffusion but strongly impedes convective
flow.
Forced convection is produced by a pressure difference between
a source and destination; physiologic convection in the ECF has
been measured at.6mm/s [32]. When a gel is present hydrodynamic drag is greatly increased. Levick [33] examined a variety of
tissues with gel-like matrices and demonstrated that the interstitial
space in such tissues is filled by a network of fibers of two principal
types, the first composed of glycosaminoglycan and the second of
collagen. Hydraulic conductivity was found to range from
m4
for femoral head cartilage to 4:2|10{12
1:0|10{16
N|s
m4
for vitreous humor. Some tissues contain cells which receive
N|s
nutrients solely by convective flow through a gel, however this
appears to occur only in tissues with a relatively low metabolic
rate. Brain, in contrast, has one of the highest sustained metabolic
rates of any tissue, consuming 20% of the body’s total energy
budget [34].
In the extracellular compartment of the brain, based on the
distances involved, we would expect convection to be critical in the
transport of nutrients from capillaries to the cell body, in the
removal of metabolic wastes, and in the transport of neurotransmitters across synaptic spaces. The brain is uniquely devoid of
lymphatic channels. Tracer experiments by Cserr[35] demonstrated that ECF is secreted from capillaries at a rate of .1–.3mg per
gm of brain tissue per minute, and flows through the tissue
PLOS ONE | www.plosone.org

Re~

vD
n

In a typical ECF channel in the brain we may assume, as a first
approximation:
n = kinematic viscosity = 7|10{7 m2/s
D = hydraulic diameter = 1026 m
v = mean velocity of fluid = 1027 m/s
Substitution of the above values gives Reynolds number
Re~1:4|10{7 which confirms that flow is laminar. For laminar
flow through an unobstructed channel, volumetric flow rate is
given analytically by the Hagen-Poiseuille equation:

Q~

pR4 DP A2 DP
~
8Lg
8pLg

where:
Q = volumetric flow rate
P = difference in pressure over the channel length
g = dynamic viscosity
R = channel radius
A = channel cross sectional area
L = channel length
If the channel becomes filled with a porous medium such as
amyloid gel, according to Darcy’s Law[37],
Qm ~K

ADP
Lg

where:
Qm = volumetric flow rate through a medium
K = Darcy permeability coefficient
A = cross-sectional area of gel (perpendicular to flow)
L = length of gel in direction of flow
P = pressure difference across the gel
The Darcy permiability coefficient K can be approximated
under the Carman-Kozeny model of permeability [38] as:

K~

6

a2
4k
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lost in late disease, rather than local ECF flow in the region of
neuron cell bodies early in the disease.
Movement of Intracellular Transport Vesicles. A fiber
network can block the movement of structures larger than its pore
size by simple filtration. Even the normal cytoskeleton prevents
movement of mitochondria and similar-sized structures into
certain parts of the cell, apparently because of the spacing and
orientation of the microtubules [41].
Axoplasmic flow in neurons is bidirectional and therefore
cannot be due to convection of cytoplasm alone. It requires both
anterograde and retrograde movement of colloidal-sized vesicles
by active transport along microtubules of the cytoskeleton [42].
These vesicles are typically larger than the pore size of gels and
their movement would be blocked if the microtubule passes
through an amyloid fiber network. Tau NFTs can clearly be larger
than 1mm in vivo [16]. Gel particles of this size within an axon or
dendrite could block all axoplasmic flow in the process. Consistent
with this, loss of neuronal processes is often seen prior to cell death
in neurodegenerative disease [43,44].
Neurotransmitters are transported intracellularly in vesicles
which are 40–100 nm in diameter [45,46]. Movement of such
vesicles through a gel would be impeded by collisions with fibers,
and because of variability in pore size vesicles would at some point
encounter pores smaller than their diameter and be blocked. This
could limit availability of neurotransmitters at the synapse. If
trapped vesicles ultimately break down, neurotransmitters may be
released into the cytoplasm; the presence of free neurotransmitter
metabolites has been proposed as a promoter of further amyloid
aggregation [47].

where:

k~

4(1{w)3
2

w½2ln( 1 ){3z4w{w 
w

z

2(1{w)3
2
(1{w )
w½ln( 1 ){
2 
w
(1zw )

and:
w = volume fraction of network fibers
 = porosity = 1-w
a = pore size
k = shape factor
For a typical amyloid gel with a volume fraction of.02 and pore
size of 80 nm, K = *2:2|10{5 mm2 . If an unobstructed channel
becomes filled with amyloid gel, while pressure difference along
the channel remains unchanged, flow will decrease by
Qm 8pK
~
Q
A
where A = channel area in mm2 . The effects of blockage by gel
increase with channel size, but even for a relatively small channel
with an area of 1 mm2 :

Qm
~5:6|10{4
Q

Effects of the Solution Environment

Thus convective flow will be effectively halted if a channel as
small as 1mm2 in cross-sectional area becomes blocked by amyloid
gel over even a fraction of its length. The absence of convection
effectively halts transport of both large and small solutes, although
steric hindrance and filtration effects produce additional reductions in transport for larger structures.
If an interstitial channel becomes partially blocked at one point
by amyloid gel, the effective channel cross-section will be reduced
at the obstruction and local average flow velocity will be increased,
as will fluid shear at the channel walls. Because amyloid deposition
is accelerated by increased fluid shear [6] we would expect
amyloid to preferentially form at the point where the flow is
constricted by the obstruction, until the blockage is complete.
As the hydraulic permeability of the extracellular space
decreases, the rate of ECF flow would be expected to also
decrease if the pressure gradient between the capillaries and the
CSF remains constant. This may contribute to the reduced CSF
production seen in Alzheimer’s disease. In contrast, CSF
production is unaffected in Parkinson’s disease, in which amyloid
fiber formation is limited to the intracellular space [39]. Reduced
secretion and convective flow of ECF may also reduce the flow of
nutrients from capillaries to neurons, and of waste products from
the ECF to the venous system. Finally, the emptying of
neurotransmitter vesicles across the plasma membrane into the
ECF and movement of neurotransmitters across the synapse
requires convective flow, which could be hindered by the presence
of extracellular gels formed from A-beta fibers in the synaptic cleft.
Measurement of fluid convection in the brain at milimeter
resolution is possible in vivo using diffusion tensor imaging. Using
this method Head et al.[40] reported increased mean diffusion in
some brain regions in Alzheimer’s disease. However this study
examined directional flow along major nerve tracts and may
reflect gross anatomical changes as large numbers of neurons are
PLOS ONE | www.plosone.org

Amyloid fiber formation, the assembly of fibers into molecular
networks, and the conversion of fluids into gels all involve colloidal
interactions. The kinetics of these processes are highly dependent
upon environmental conditions including temperature, pH, and
the nature and concentration of counterions and amphoteric
molecules that can shield or enhance coulomb repulsion or alter
molecular adhesion. Understanding these effects may allow us to
inhibit colloidal aggregation of proteins by manipulating the
environment within and around the neurons in the brain. A
comprehensive predictive theory of amyloid aggregation is needed
if we are to identify optimal therapeutic strategies for amyloid
disease. One step toward such a theory may be the development of
a multidimensional phase diagram showing the relationship
between amyloid aggregation and each of the environmental
parameters that affect its kinetics or pathways.

Conclusion
In our study, increasing salt concentration did not affect fiber
formation, but inhibited the transition of amyloid fibers to a helical
conformation and accelerated the self-assembly of fibers into
macromolecular networks. Such networks convert the surrounding
fluid into a gel. The effects of amyloid gels on simple diffusion of
solutes are modest. However active transport of colloidal-sized
vesicles is critical to the function of neuronal processes; amyloid
gels can block this process by filtration. Convection, or bulk flow, is
essential to transport of dissolved molecules in the extracellular
fluid; amyloid gels can halt convection by creating hydrodynamic
drag. The primary cause of cell death in amyloid neurodegenerative disease may not be chemical toxicity, but rather the physical
effects of amyloid gels on the movement of fluids and suspended
particles.
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Abstract
Deposits of insoluble protein fibrils in human tissue are associated with amyloidosis and
neurodegenerative diseases. Different proteins are involved in each disease; all are soluble in their
native conformation in vivo, but by molecular self-assembly, they all form insoluble protein fibril
deposits with a similar cross β-sheet structure.
This paper reports the results of an experiment in molecular self-assembly carried out in
microgravity on the International Space Station (ISS). The Self-Assembly in Biology and the Origin
of Life (SABOL) experiment was designed to study the growth of lysozyme fibrils in microgravity.
Lysozyme is a model protein that has been shown to replicate the aggregation processes of other
amyloid proteins. Here the design and performance of the experimental hardware is described in
detail. The flight experiment was carried to the ISS in the Dragon capsule of the SpaceX CRS-5
mission and returned to Earth after 32 days. The lysozyme fibrils formed in microgravity aboard
the ISS show a distinctly different morphology compared to fibrils formed in the ground-control
(G-C) experiment. The fibrils formed in microgravity are shorter, straighter and thicker than those
formed in the laboratory G-C experiment. For two incubation periods, (2) about 8.5 days and (3)
about 14.5 days, the average ISS and G-C fibril diameters are respectively:
Period 2

DISS = 7.5nm ± 31%, and DG-C = 3.4nm ± 31%

Period 3

DISS = 6.2nm ± 33%, and DG-C = 3.6nm ± 33%.

Introduction
Deposits of insoluble protein fibrils are known to be associated with amyloidosis and
neurodegenerative diseases such as Alzheimer’s, Dementia and Parkinson’s (Ross and Poirier,
2004; Lansbury and Lashuel, 2006; Kelly, 1996). Several different proteins are involved in the
different diseases. All of these so-called amyloid proteins are soluble in their native conformation
in vivo, but over time, they all form insoluble protein fibril deposits with a similar cross β-sheet
structure (Sunde and Blake, 1997; Jim´enez et al., 2002).
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Amyloid proteins will also form protein fibril deposits in vitro with the same cross β-sheet
structure as in vivo. They self-assemble into fibrils directly from solution when the conditions;
such as, protein concentration, pH, ion concentration and temperature are right. Depending on
these parameters, different pathways to fibril formation may be followed. Protein monomers
either assemble directly into fibrils or follow an intermediate aggregation of oligomers form
before the formation of fibrils (Aggeli and Boden, 2006; Estroff and Hamilton, 2006; Perutz et al.,
2002; Hill et al., 2011; Necula et al., 2007; Pellarin and Caflisch, 2006). These different pathways
effect fibril diameter, length and helicity (Woodard et al., 2014; Ward et al., 2012; Dahlgren et al.,
2002; Kayed et al., 2003). The study of amyloid fibril formation in vitro helps to inform amyloid
disease research.
Amyloid formation is not limited to disease-associated proteins, but also occurs in proteins not
associated with any known amyloid diseases (Guijarro et al., 1998; Chiti et al., 1999; Kallberg et
al., 2001). Hen egg white lysozyme (HEWL) is a prime example of a non-disease associated protein
in which amyloid fibrils can form. It shares a very similar morphology with amyloid fibrils formed
from disease associated proteins (Bucciantini et al., 2002). Human mutants of lysozyme are an
example of a protein related to organ-specific forms of amyloidosis (Pepys et al., 1993; Canet et
al., 1999). These disease related mutants are also morphologically similar to native lysozyme (Hill
et al., 2011). Amyloid disease related proteins, which are much more difficult to acquire, will form
fibrils under normal physiological conditions, T~37OC; whereas, HEWL requires T~50OC. The
reason for this is that the proteins must be near their denaturing temperature for fibril formation
to occur. The growth of lysozyme fibrils has been extensively studied in the laboratory; it provides
a model for the study of this self-assembly process (Booth et al., 1997; Frare et al., 2006). Figure 1
shows atomic force microscope (AFM) images of early and late stages of the growth of fibrils from
a solution of lysozyme proteins.

Figure 1. AFM images of lysozyme aggregation showing advanced stages of the amyloid fibril
formation process (Woodard et al., 2014). Left: the merging of fibrils into a helix configuration is
indicated by the two arrows. Right: A tangled interlocking network prevents fibrils from rotating
and halts helix formation. (Note the different image scales).
To date, most protein aggregation studies have been carried out in ground-based laboratories.
After fibril formation and continued incubation these fibrils interact and form macromolecular
structures with mature fibrils interweaving with each other (see Figure 1). This network of fibrils
can suspend the solution and convert the surrounding fluid into a gel with increased viscosity and
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opacity (Terech, 2006). These networks create the building blocks for protein plaques to form
(Kodali and Wetzel, 2007; Chiti and Dobson, 2006). Currently the morphology of fibril growth
cannot be predicted (Bitan et al., 2005; Kowalewski and Holtzman, 1999).
Understanding the colloidal chemistry and biochemistry of amyloid fibril formation is helped
by controlling process parameters, such as manipulation of the solution’s stabilization with ions,
changes in temperature, or pH. It may be possible to inhibit or accelerate amyloid fibril formation.
For example, increased salt concentration in the initial buffer solution can increase aggregation
and gelation rates (Woodard et al., 2014; Hill et al., 2009, 2011; Fujiwara et al., 2003; Wang et al.,
1996).
Gravity has an effect on biological processes even at the cellular level (Tabony et al., 2007).
Self-assembly and self-organization of molecules into larger macromolecular structures can be
affected by the presence of this weak directional external force. In a space-based laboratory
gravitational pressure gradients in fluids do not develop, so natural buoyant convection is not
present. Microgravity is a realistic environment to emulate cellular conditions, where surface
tension effects dominate viscous effects. The fibril growth process must rely on the movement of
protein molecules onto and off of the growing fibrils. In microgravity, surface tension and
molecular diffusion will be the dominate interactions.
Although life probably arose in a planetary environment, molecular self-assembly is also of
interest to the study of the origin of life. The development of cellular activity was dependent upon
the creation of large complex molecular structures in the chemical and environmental conditions
present when life originated. Experiments carried out in microgravity may therefore lead to a
better understanding of the dynamics driving cellular molecular self-assembly process. Florida
Tech’s Self-Assembly in Biology and the Origin of Life (SABOL) study demonstrated protein fibril
growth in microgravity onboard the International Space Station (ISS) using a novel, autonomous
NanoLab. Protein fibrils grown in microgravity demonstrate a morphology significantly different
from samples grown on earth in a nearly identical Ground-Control (G-C) system.

Materials and Methods
Buffer/Lysozyme Solution
The buffer/lysozyme solution for the SABOL experiment was chosen to optimize the fibril
growth period from onset through gelation of 20 to 30 days, the estimated time in microgravity.
The optimal methods for lysozyme preparation, fibril formation, and fibril characterization are
well understood (Burnett et al., 2014; Hill et al., 2011; Woodard et al., 2014). The buffer solution
was prepared with 10mM glycine in DI water, titrated to pH 2.5 with HCl. To ensure uniformity
across samples, the titration was performed in a large beaker of solution prior to the addition of
lysozyme. The final HCl concentration was approximately 36mM. Lysozyme (BSG, Napa, CA) was
then dissolved in the buffer solution at a concentration of 20 mg/ml. Acidic conditions are required
and at this pH the lysozyme has a charge of approximately +26. Heating the sample close to the
denaturing temperature of 55OC (Hill et al., 2011) is also required. At this temperature lysozyme
begins to unfold from its native conformation and increased Brownian motion assists the Van der
Waals attractive forces in overcoming the electric repulsive forces leading to aggregation.
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Atomic Force Microscope
The samples were imaged with a Molecular Imaging multi-purpose scanner Atomic Force
Microscope (AFM). PicoView version 1.12 AFM software was used, and all images were acquired
in contact mode. A Bruker SNL-10 silicon-tip on nitride cantilever was used, and an Olympus IX71
optical microscope was used to center the laser light reflecting off the cantilever. The quadrant
photodiode’s position was then adjusted to null the signal. Cantilever probes are typically 600 nm
in height with a 10 nm radius of curvature and a force constant of 0.12 N/m. AFM tip with
curvature radii greater than 30 nm or damaged were replaced.
A voltage set-point of 3 volts was used, translating to 5.4 nN of load force due to an average of
15 mV/nm deflection sensitivity and .12 N/m cantilever elasticity. This set-point was used for the
majority of images. Raster speed ranged from 1 to 4 lines/sec, and all of images are 1024 x 1024
pixels. Fields of view (FOV) of 2x2, 5x5, 10x10 and 20x20 µm were the most common. Contact
mode, where the probe moves up and down to maintain the constant set point force, was used
throughout. Topographic images were used both to determine three-dimensional structure and
for dimensional measurements, while deflection images were used to demonstrate shape and
texture.
Lysozyme Fibril Deformation
Lysozyme fibrils deform under the force applied by the cantilever. The cantilever load force is
determined by the force set-point. A force set-point of 3 volts was used for all AFM images in the
SABOL experiment. A calibration was determined by measuring ground-based lysozyme fibril
heights for increasing values of the force set-point. Images were taken with the least amount of
force first, then increasing until the samples no longer produced readable data. Figure 2 shows
height vs. force set-point data for lysozyme fibrils. Each data point is an average of 20 lysozyme
fibril height measurements from each force set-point image. The error bars shown are the
measurement standard deviations.

Figure 2. Deformation of lysozyme samples under different load forces (force set-points). Each
data point is an average of 20 lysozyme fibril height measurements made at each force set-point.
Error bars are the measurement standard deviations. The dashed line is a linear fit to the data.
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Fibril height decreases with increasing load force. A linear fit to this trend, shown by the
dashed line, has an R-squared value of 0.93 and a y-intercept of 2.29 nm. All topographic images
in this study used a force set-point of 3 volts. Figure 2 can thus be used to correct height
measurements of lysozyme fibrils to heights with no load force applied:
ℎ = ℎ𝑚 ∗ 1.294
where hm is the measured height, 1.294 is the calibration constant and h is the undeformed height.
Sample Preparation
Samples of the aggregated protein were prepared for AFM imaging as follows: First, both
undiluted and diluted slides were prepared to ensure protein fibrils were visible against the flat
mica substrate and not covered with excess solution protein. Samples were preserved at 4OC, since
freezing causes’ damage to the fibrils.
Drawing lysozyme gels into a standard pipette resulted in fibril breakage due to the gel’s large
viscosity resulting in fluid shear as the gel was drawn through the small orifice of the pipette
(Woodard et al., 2014). Consequently, when pipetting fibrils and/or gels, the tips of the pipettes
were first cut off to enlarge the orifice diameter to ∼1mm.
To prepare AFM slides, 10µl of 0.01N NaOH was applied near the center of a freshly peeled
mica slide to precharge the substrate. After two minutes, 10µl of sample was applied to the
substrate at the same location. After an additional 10 minutes, the sample was rinsed with 2ml of
DI water by allowing the water to flow over the substrate to remove salts and unbound proteins.
The water was drained and any droplets adhering to the substrate were removed with a
tangentially applied soft jet of nitrogen gas. The slide was then dried in an oven set to 55OC for 2
hours.

The International Space Station Experiment
The Self Assembly in Biology and the Origin of Life (SABOL) experiment was designed to study
the self-assembly of lysozyme fibrils in microgravity. An exploded view of the hardware is shown
in Figure 3. The experiment is housed in a NanoRacks 1U chassis, measuring 10x10x15 cm. There
are 9 vials arranged in a 3x3 array. Each vial has linear stepper motor actuation mechanism, to
introduce protein powder into the buffer solution, an individual heater and thermal control
system. There is a custom aluminum shell, a support structure for the vials, and a USB connector
for power. There are two printed circuit boards. The side PCB is used to measure and control the
temperature of each vial individually and perform data acquisition. The top PCB contains the
components needed to operate the actuation mechanisms at the appropriate times. Time is based
on an internal battery powered timer to protect against ISS main power loss events.
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Figure 3. An exploded view of the SABOL experiment. The hardware was designed to fit within
the volume, mass and power constraints of a 1U NanoLab module. There are 9 independently
operated vials used to provide a range incubation times covering the growth phase of lysozyme
fibrils.
The fully assembled SABOL hardware with the outer cover removed is shown in Figure 4. All 9
linear stepper motors can be seen above the vial support structure and 3 of the insulated vials can
be seen below.

Figure 4. Fully assembled SABOL NanoLab with samples loaded shown just before the outer shell
was installed.

Actuation Mechanism
An important design element of the SABOL experiment was to ensure that the lysozyme
powder remained separated from the buffer solution until the incubation period in orbit is
initiated. Furthermore, the vials must maintain a seal at all times and not allow air bubbles to form.
The vials and all their internal components are made out of Polypropylene. Two views of a vial are
shown in cross-section in Figure 5. The image on the left shows a vial in the unactuated
configuration, the image on the right shows it in the actuated configuration. Each vial has two
separate compartments initially isolated from each other. One compartment, containing the buffer
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solution, consists of a 22 mm diameter tube with a volume of 2.5 ml bounded on the bottom by the
floating piston and on the top by the loading piston. The other compartment consists of the filling
slot on the side of the loading piston, with just enough volume to hold 0.05 g of lysozyme powder.
The loading piston has a threaded hole in its top that is attached to the shaft of a linear stepper
motor. Actuation occurs when the stepper motor drives the loading piston down, uncovering the
filling slot and bringing the lysozyme powder into contact with the buffer. The floating piston
reacts back to maintain a constant volume.

Figure 5. Cross-section of polypropylene vials before and after actuation.

Thermal Control System
Each vial has an independent thermal control system consisting of Nicrome heater wire
wrapped around each vial, a layer of insulation over the heater wire, and a thermocouple bonded
into a capped hole in the bottom of the floating piston. The control system consists of a simple setpoint regulation system T = To ±∆T originally chosen as To = 55OC and ∆T = 1.5OC. The 5 Watts of
electrical power available to the 1U module through its USB connector was only sufficient to run
4 of the heaters at once, so a heating schedule was developed where no more than 4 heaters were
on at a time. This allowed incubation times to cover from 3 to 27 days in increments of 3 days. One
vial remained unheated to serve as a control.
The start of an incubation period for a given vial is implemented as follows: first all heaters are
turned off to provide enough power to run a stepper motor. The stepper motor of the vial to be
actuated is turned on, run to completion, and then turned off. That vial’s heater is then turned on
and heaters for the other vials still within their incubation periods are turned back on. When the
time is reached for a vial’s incubation period to end, its heater is turned off. Since the heating and
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cooling time constants for the vials are near an hour and the incubation time periods are days the
few minutes it takes to execute the vial actuation has negligible effect on the incubation. The
incubation time period for a given vial is determined as the time the temperature exceeds 50OC.

Ground-Control NanoLab
An identical Ground-Control (G-C) NanoLab was built so that it could be run on ground with
the same timing protocols and environmental conditions as the ISS NanoLab, except for the effect
of microgravity.

Preparation and Flight
The day before the experiment was handed over to NanoRacks, samples were loaded as
follows: With the bushing and loading piston removed, each vial was filled with 2.5 ml of buffer
solution and the floating piston was pushed up bringing the fluid level up to the top of the vial.
Then dry lysozyme protein powder was placed in the open slot of the loading piston. The loading
piston was placed inside the bushing, sealing off the protein powder. The bushing with the loading
piston installed was then placed at the top of the vial and inserted in a manner that sealed the
buffer solution with no air bubbles. The complete vial assembly was then threaded onto the
stepper motor shaft. This was repeated for each of the nine vials.
The SABOL experiment was carried to the International Space Station (ISS) in the Dragon
capsule of the SpaceX CRS-5 mission and returned to Earth in the same Dragon capsule after 32
days. Table 1 gives the duration times for both the ISS and G-C NanoLab’s. The G-C NanoLab was
run for the same amount of time as the ISS NanoLab. No telemetry was available from either to
monitor their progress. The ISS NanoLab was kept near 4OC from deorbit throughout splashdown,
retrieval and transportation back to Florida Tech.
Table 1. NanoLab Timeline (EST)
Plugged In
Duration
ISS NanoLab
Jan. 13th 1:22 PM
25d 18h 28m
G-C NanoLab
Feb. 10th 4:41 PM
25d 18h 28m

ISS NanoLab Post-Flight Handling
The ISS NanoLab memory chip, containing temperature data, was accessible after removal of
the experiment’s outer shell. Figure 6 shows temperature as a function of time for all 9 vials. Vial
1 was a control that was not heated. The unheated or ambient temperature within the NanoLab,
as indicated by vial 1, remained between 33OC and 35OC for the duration of the experiment.
Previous testing showed that fibril growth would not start until the temperature was greater than
40OC. Vials 2 through 9 show proper heating for different amounts of time. As one vial turned off
another vial actuated the protein into the buffer solution. Then that vial was heated to the
incubation temperature.
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Figure 6. ISS Vial Temperature verses Time. Temperature profiles for each of the ISS NanoLab
vials shows the time when each heater was turned on, raising the temperature to within the
aggregation range (Hill et al., 2009; Woodard et al., 2014), held there for its incubation period
and then turned off.
Next, the four bolts holding the top and bottom support structure together were removed. All
9 vials were unscrewed from their stepper motors, being careful not to disturb the position of the
loading pistons. Each of the nine vials were placed in individual plastic bags labeled with the vial’s
position and stored in a 4OC refrigerator. The top support could then be examined to see if the
stepper motors had fully actuated their respective loading pistons. Figure 7 shows that only 3 of
the stepper motor shafts had extended, so only 3 of the vials had successfully actuated while in
orbit aboard the ISS. They were vials 5, 6 and 8.
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Figure 7. Top support plate that holds the vials in place. The stepper motor shafts stick through
this support, clearly showing that only vial positions 5, 6 and 8 were actuated.
The vial 5 heater was turned on at the beginning of the experiment and turned off at day 15.
The temperature remained at about 53OC for the duration of its operation. It dropped to 37OC
when turned off and decayed to 36OC by the end of the experiment. Vial 8 heater turned on at day
18. The temperature remained at about 51OC until the experiment was terminated at day 25.75.
The vial 6 heater was turned on at day 24. It remained at 51OC until the experiment was terminated
at day 25.75. Thus, these three vials provide samples with incubation times (Vial: Time) as follows:
(5: 15 day), (8: 7.75 day), (6: 1.75 day).
The loading pistons were extracted from each vial, samples were collected with a 200 µl
pipette and samples were prepared for imaging. The pre-extraction positions of the loading
pistons confirmed that only vials 5, 6 and 8 had actuated properly. Also, it was noted that the
loading piston slots of vials 5 and 8 had solution remaining in them, and a smooth layer of fluid
flush with the outside of the slot. The solution within in these slots appeared more viscous than
the majority of the solution inside the vial. A sample of solution from the loading piston slot was
taken for vials 5 and 8.

G-C NanoLab Handling
The Ground-Control experiment had some unintended differences from the ISS experiment.
The (G-C) NanoLab contained only 8 vials, as one was damaged during testing. To compensate for
this, a thermocouple was suspended in the position of vial 1 to measure ambient air temperature.
After completion of assembly and sample loading, the G-C NanoLab was plugged into a USB
converter of an uninterrupted power supply (UPS) at Florida Tech. The G-C NanoLab was powered
on for the same length of time as the ISS NanoLab, as shown in table 1. The G-C NanoLab was then
cooled to 4OC and kept at that temperature for 6 days to match the conditions of the ISS NanoLab.
The G-C NanoLab was then prepared for imaging in the same way as the ISS NanoLab. There was
no viscus solution in the loading piston slots as seen in the ISS vials.
Figure 8 shows temperature as a function of time for all vials of the G-C NanoLab. The actuation
and heating times were accidently reversed relative to the ISS NanoLab; the shorter incubation
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times were first on the G-C NanoLab, they were last for the ISS NanoLab. When the experiment
was stopped 1.25 days before the planed stop at day 27, this had the unintended effect of losing
that 1.25 days from different incubation intervals of the ISS and G-C data.

Figure 8. Temperature profile of each vial within the G-C NanoLab. The graph shows the time
when each heater was turned on, raising the temperature to within the aggregation range (Hill
et al., 2009; Woodard et al., 2014). The bold lines represent the temperature profiles from the
vials that incubated for periods of time close to the 3 vials that fully actuated in the ISS NanoLab.
Most of the vials in the G-C NanoLab reached the incubation temperature except vial 7. The
ambient air temperature inside the G-C NanoLab was between 30OC and 34OC. For comparison
with the ISS NanoLab, the following G-C NanoLab vials with the similar incubation times can be
used (9: 13.75 day), (4: 9 day), (2: 3 day). The time scale for changes in fibril growth is a few days
so this difference between ISS and G-C samples is still useful.
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Results and Discussion
Slides for AFM imaging were prepared, as discussed earlier, using solution taken from the
three ISS NanoLab vials that actuated properly: vials 5, 6 and 8. Figure 9 shows an AFM image of
solution taken from ISS NanoLab vial 8. This sample was incubated in microgravity for 7.75 days
at 51OC. The image was created with a 5 x 5µm FOV. There is a clear difference between the
lysozyme fibrils seen here and those routinely seen in samples formed in ground-based
laboratories, see for example, Figure 1. Fibrils formed in microgravity on the ISS are shorter,
straighter and thicker (larger diameter) than samples formed in the laboratory.

Figure 9. ISS vial 8, 7.75 days of incubation, 5 x 5µm FOV.
Fibrils formed in ground-based laboratories normally use a significantly different vial shape
and protein powder mixing system. To determine if the change in fibril morphology could be
attributed to the more complex process of actuation or the significantly different geometry of the
NanoLab vials, a complete set of slides for AFM imaging were prepared using solution taken from
the three G-C NanoLab vials with closely matching incubation times: vials 2, 4 and 9. Although not
ideal, the difference in incubation times of 1.25 days is still a useful comparison since the time
scale for significant change in fibril growth is on the order of days. Also, in microgravity, fluid
motion by surface tension is likely to pay a large roll so the comparison of fibril growth in identical
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vials is important. Remember the more viscous fluid present in two of the loading slots of the ISS
NanoLab.

Figure 10. Lysozyme fibrils formed in microgravity on the ISS versus lysozyme fibrils formed in
the G-C unit under the effects of gravity, all images have a 5µm FOV.
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Another difference between the ISS and G-C NaloLabs is the external forces due to launch, reentry and landing experienced only by the ISS NanoLab. During launch the buffer solution and
protein powder were in separate chambers so this should have no effect on fibril growth. Also the
re-entry and splashdown forces should have no effect since already grown fibrils are stable; the
NanoLab was in a transfer bag that included bubble wrap to dampen vibration; and the
temperature of the NanoLab was held well below the aggregation temperature.
Figure 10 shows representative images from each of the three incubation groups. The images
on the left are of ISS formed fibrils, those on the right are of G-C formed fibrils. The incubation time
in days is shown for each image. This set of images shows a clear morphological difference
between fibrils formed in microgravity and those formed in the ground-control unit. For the first
group; the ISS images show no fibril formation but numerous small isolated structures, the G-C
images show fully formed fibrils already longer than the 5µm FOV. For the second incubation
group; the ISS fibrils have formed but they are relatively straight and short (significantly less than
the 5µm FOV), the G-C fibrils are fully formed mature fibrils. For the third incubation group; the
ISS fibrils show continued growth with some fibrils almost as long as the 5µm FOV and maybe a
few more complex structures forming, the G-C fibrils show continued formation of long thin
complex structures.
One difference in the fibril structure present in these images is that the microgravity formed
fibrils consistently appear about twice as thick as the G-C formed fibrils. To quantify this
difference, the height and width of many fibrils was measured for several images from each ISS
and G-C incubation groups. Using the PicoView v1.12 software, a trace was made perpendicular to
every accessible fibril at 3 separate places on each fibril. The height and width were determined
from the trace. All together there were 18 ISS images used giving 513 fibril measurements and 14
G-C images used giving 232 fibril measurements.
The height measurements can be directly related to fibril diameter using the deformation
calibration determined earlier. The width measurements are less reliable since the radius of
curvature of the AFM tip is ≈10nm, considerably larger than the width of the fibrils.
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Figure 11. Heights of protein fibrils formed in microgravity compared to protein fibrils formed
in a Ground-Control experiment.
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Figure 11 shows a frequency distribution plot of fibril heights for each of the three incubation
periods. The upper figure is for the first incubation period. The average heights of the ISS and G-C
fibrils are HISS = 2.2 ± 0.8nm and HG-C = 2.3 ± 1.0nm respectively. The average height and standard
deviation are calculated directly from the data, not the gamma-fit trend line. At this incubation
period the heights are the same within the experimental error. It should be noted however that at
this stage the ISS images showed only small isolated structures and no fibrils.
The middle figure is for the second incubation period. The average heights of the ISS and the
G-C fibrils are HISS = 5.8 ± 1.8nm and HG-C = 2.6 ± 0.8nm respectively. This shows that ISS fibrils have
about twice the diameter as G-C fibrils.
The lower figure is for the third incubation period. The average heights of the ISS and G-C fibrils
are HISS = 4.8 ± 1.6nm and HG-C = 2.7 ± 0.9nm respectively. Again, the ISS fibrils have about twice
the diameter of the G-C fibrils.
Another characteristic of these data is that, for incubation groups 2 and 3, the frequency
distribution for the ISS grown fibrils is significantly broader than the G-C grown fibrils. This could
indicate an actual physical difference, with the microgravity formed fibril heights being more
variable than the G-C formed fibrils, or it could be that the measured errors in fibril heights are
proportional to the fibril heights. In the latter case the fractional error for the ISS and G-C
measurements should be the same in each incubation group. The fractional errors determined
from the data above are: incubation group 2, HISS = 5.8nm ± 31% and HG-C = 2.6nm ± 31% and for
incubation group 3, HISS = 4.8nm ± 33% and HG-C = 2.7nm ± 33%. So, it appears that errors in fibril
height measurements are proportional to fibril heights. This also indicates that the height-todiameter calibration determined with 2.7 nm diameter fibrils is applicable to ~ 5 nm fibrils as well.
Applying the calibration to these data gives the average fibril diameters as:
Incubation Group 2: DISS = 7.5nm ± 31%, and DG-C = 3.4nm ± 31%
Incubation Group 3: DISS = 6.2nm ± 33%, and DG-C = 3.6nm ± 33%.

Conclusion
The primary objectives of the SABOL experiment were to grow protein fibrils in microgravity
onboard the ISS and to develop the robust capability of conducting protein fibril research on the
ISS. Both of these objectives were met. Lysozyme fibrils were grown in microgravity and the
results indicate that this is a fruitful environment for the study of this molecular self-assembly
process. Two identical sets of hardware were constructed providing a flight unit and a groundcontrol unit for future research. Both systems performed well. The only major anomaly in the
experiment operation was that, for the flight unit, only 3 of the 9 vial actuation mechanisms
operated properly. This can be corrected with a small change in the vial design allowing for a linear
stepper motor with more force for any future experiments. This hardware can also be modified
and used to study other amyloid protein fibrils.
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Figure Legends
List of Figures
Figure 1. AFM images of lysozyme aggregation showing advanced stages of the amyloid fibril
formation process (Woodard et al., 2014). Left: the merging of fibrils into a helix configuration is
indicated by the two arrows. Right: A tangled interlocking network prevents fibrils from rotating
and halts helix formation. (Note the different image scales). -----Page 2
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Figure 2. Deformation of lysozyme samples under different load forces (force set-points). Each
data point is an average of 20 lysozyme fibril height measurements made at each force set-point.
Error bars are the measurement standard deviations. The dashed line is a linear fit to the data.
----- Page 5
Figure 3. An exploded view of the SABOL experiment. The hardware was designed to fit within
the volume, mass and power constraints of a 1U NanoLab module. There are 9 independently
operated vials used to provide a range incubation times covering the growth phase of lysozyme
fibrils.
-----Page 6
Figure 4. Fully assembled SABOL NanoLab with samples loaded shown just before the outer shell
was installed.
-----Page 7
Figure 5. Cross-section of polypropylene vials before and after actuation.

-----Page 8

Figure 6. Figure 6. ISS Vial Temperature verses Time. Temperature profiles for each of the ISS
NanoLab vials shows the time when each heater was turned on, raising the temperature to
within the aggregation range (Hill et al., 2009; Woodard et al., 2014), held there for its
incubation period and then turned off.
-----Page 10
Figure 7. Top support plate that holds the vials in place. The stepper motor shafts stick through
this support, clearly showing that only vial positions 5, 6 and 8 were actuated.
-----Page 11
Figure 8. Temperature profile of each vial within the G-C NanoLab. The graph shows the time
when each heater was turned on, raising the temperature to within the aggregation range (Hill
et al., 2009; Woodard et al., 2014). The bold lines represent the temperature profiles from the
vials that incubated for periods of time close to the 3 that fully actuated in the ISS NanoLab.
-----Page 12
Figure 9. ISS vial 8, 7.75 days of incubation, 5 x 5µm FOV.

-----Page 13

Figure 10. Lysozyme fibrils formed in microgravity on the ISS versus lysozyme fibrils formed in
the G-C unit under the effects of gravity, all images have a 5µm FOV.
-----Page 15
Figure 11. Heights of protein fibrils formed in microgravity compared to protein fibrils formed
in a Ground-Control experiment.
-----Page 17
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